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PREFACE
The purpose of this work is to begin understanding the role of neutrophils and the
release of neutrophil extracellular traps (NETs) in the potential for electrospun
biomaterial-guided tissue regeneration. Although they comprise 40-80% of the white
blood cells in circulation, neutrophil participation in the response to biomaterials in tissue
engineering applications has long been neglected in favor of macrophages. However, a
growing body of literature suggests that neutrophils have the potential to precondition the
tissue environment and drive tissue healing. Moreover, the dysregulated release of NETs
propagates thrombosis and fibrosis, two responses that are particularly detrimental to
biomaterial-guided tissue regeneration. Therefore, this work was undertaken to delve into
the release of NETs on electrospun biomaterials, evaluate their impact on the potential for
tissue healing, and elucidate mechanisms and methods of regulating biomaterial-induced
NET release.
Several chapters and portions of chapters within this dissertation have been
previously published or are under review in peer-reviewed journals. Chapter 1 contains
excerpts that were published in a book chapter entitled “Electrospun Tissue Regeneration
Biomaterials for Immunomodulation” in Immunomodulatory Biomaterials (2021) as well
as excerpts from the review “Neutrophils in Biomaterial-Guided Tissue Regeneration:
Matrix Reprogramming for Angiogenesis” in Tissue Engineering: Part B (2020). Chapter
2 is under review as an article entitled “Neutrophil Extracellular Traps in Inflammation
and the Preconditioning of Biomaterials for Tissue Engineering” in Tissue Engineering:
Part B (2021). Chapter 3 is published as “Electrospun Template Architecture and
Composition Regulate Neutrophil NETosis In Vitro and In Vivo” in Tissue Engineering:
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Part A (2017). Chapter 4 is published as “Surface Area to Volume Ratio of Electrospun
Polydioxanone Templates Regulates the Adsorption of Soluble Proteins from Human
Serum” in Bioengineering (2019). Chapter 5 is under review as an article entitled
“Human Neutrophil FcγRIIIb Regulates Neutrophil Extracellular Trap (NET) Release in
Response to Electrospun Biomaterials” in Acta Biomaterialia (2021). Chapter 6 is
published as “Localized Delivery of Cl-amidine From Electrospun Polydioxanone
Templates to Regulate Acute Neutrophil NETosis: A Preliminary Evaluation of the
PAD4 Inhibitor for Tissue Engineering” in Frontiers in Pharmacology (2018). Chapter 7
is under review as an article entitled “Electrospun Polydioxanone Biomaterials Loaded
with Chloroquine Modulate Template-Induced NET Release and the Inflammatory
Response from Human Neutrophils” in Frontiers in Bioengineering and Biotechnology
(2021). Last, portions of Chapter 9 are published as “Neutrophils in Biomaterial-Guided
Tissue Regeneration: Matrix Reprogramming for Angiogenesis” in Tissue Engineering:
Part B (2020).
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Generation Ph.D. Fellowship, Herff College of Engineering Fellowship, and the Steve
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ABSTRACT
The neutrophil has long been acknowledged as an abundant responder to an
implanted biomaterial, but its importance as a dynamic effector cell has only recently
been realized. The neutrophil response is especially important for in situ tissue
regeneration where acellular biomaterials must be populated by endogenous cells and
guide the growth of new tissues. More specifically, the release of neutrophil extracellular
traps (NETs), or extracellular chromatin structures decorated with toxic nuclear and
granular components, can cause collateral tissue damage, uncontrolled inflammation, and
fibrosis, thereby preventing functional tissue regeneration. Therefore, the purpose of this
work was to investigate the role of neutrophils and their release of NETs in the potential
for electrospun biomaterial-guided in situ tissue regeneration. We evaluate the hypothesis
that NETs are released in response to electrospun biomaterials, governed by biomaterial
design features, and further postulate that the release of NETs is intimately related to
biomaterial surface-adsorbed proteins and outside-in signaling, which can be regulated by
the local delivery of pharmacological additives. Using in vitro assays with primary
human neutrophils and in vivo subcutaneous implant models, we found that both
electrospun fiber size and composition regulate the in vitro and in vivo release of NETs.
Additionally, we show that the up-regulation of NETs on an implanted biomaterial
nucleates tissue fibrosis, demonstrating that NET release is a significant, physiological
preconditioning event in guided tissue regeneration. Moreover, through the
characterization and quantification of protein adsorption on the biomaterial surfaces, we
found that IgG, ligation of fragment crystallizable domain receptor IIIb, and signaling
through transforming growth factor beta-activated kinase 1 is involved in electrospun
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biomaterial-induced NET release. Finally, using drugs that inhibit two different
molecular pathway targets, we showed that biomaterial-induced NETs can be regulated
through the local delivery of active drugs in vitro and in vivo, improving tissue
integration and promoting a pro-healing neutrophil phenotype. Together, the findings of
this dissertation illustrate that the release of NETs is a significant preconditioning event
on an electrospun biomaterial. Therefore, designing immunomodulatory biomaterials to
regulate NET release and the neutrophil response may enhance in situ tissue regeneration
and the clinical application of electrospun biomaterials.
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CHAPTER 1
INTRODUCTION
Introduction
The neutrophil has long been acknowledged as an abundant responder to an
implanted biomaterial, but its importance as a dynamic effector cell that preconditions the
tissue environment has only recently been realized. Neutrophil preconditioning of the
biomaterial environment is especially important for in situ tissue regeneration where
acellular biomaterials must be populated by endogenous cells and guide the growth of
new tissues. Therefore, the purpose of this work is to investigate the role of neutrophils
and their release of NETs in the potential for electrospun biomaterial-guided in situ tissue
regeneration. We evaluate the hypothesis that NETs are released in response to
electrospun biomaterials, governed by biomaterial design features, and further postulate
that the release of NETs is intimately related to biomaterial surface-adsorbed proteins and
outside-in signaling, which can be regulated by the local delivery of pharmacological
additives. A greater understanding of biomaterial-neutrophil interactions and NET release
will enhance the design of immunomodulatory electrospun biomaterials that regulate
acute neutrophil interactions and guide functional in situ tissue regeneration. This chapter
discusses electrospun biomaterials for in situ tissue engineering and summarizes the
immune response to biomaterials with an emphasis on the neutrophil response.
Electrospun Biomaterials for In Situ Tissue Engineering
The goal of in situ tissue engineering is to design biomaterials that use the body as
a bioreactor to stimulate the regenerative capacity of autologous cells, tissues, and
organs. Rather than creating viable tissues in vitro, which is associated with costly
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technical and regulatory hurdles, the goal is to engineer an acellular biomaterial that
induces endogenous tissue regeneration 1. Thus, the biomaterial should provide some
biomimetic properties to instruct the interacting and infiltrating cells to drive the
regeneration of tissue while the biomaterial is resorbed. In many cases, the biomaterial
attempts to recapitulate the fibrous architecture of the ECM 2. While multiple fabrication
techniques exist, electrospinning and the resultant electrospun biomaterials are
increasingly popular for creating ECM-mimicking biomaterials for guided tissue
regeneration.
Electrospinning is a relatively simple method of producing continuous nano- to
micro-sized fibers that are collected into a non-woven substrate (Figure 1) 3. During the
electrospinning process, a potential difference is established between a polymer solution
and a collector, which drives the formation and collection of fibers. As such, the typical
system is easy to build and scale-up, making it a cost-effective method for producing
fibrous biomaterials at mass quantities. In addition, electrospinning is an appealing
fabrication technique because of its vast versatility for in situ tissue engineering.
Electrospun biomaterials can be made from natural polymers, synthetic polymers, or
blends of polymers, and the fiber size can be controlled to mimic the scale, composition,
and morphology of the natural ECM in the target tissue 4. The high SAVR of the fibers
and pore interconnectivity between the fibers are desirable for guiding cell attachment
and migration while allowing for nutrient and oxygen diffusion and waste removal.
Furthermore, the fibers can function as a foundation for innumerous application-specific
modifications to the biomaterial and can be customized by incorporating, adsorbing, or
chemically linking additives, such as proteins, small molecules, or drugs, to the
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biomaterial 5. Given the cost-effectiveness and versatility of the technique, electrospun
biomaterials have the potential for a far-reaching clinical impact in tissue engineering for
treating congenital abnormalities, trauma, or disease.

Figure 1. Schematic of the electrospinning process and a SEM of an electrospun
biomaterial made from PDO. In the example micrograph, the non-woven fibers mimic the
random orientation of some ECM fibers, and average fiber size is approximately 400 nm
(scale bar = 30 µm).
The Immune Response to Biomaterials
The need for in situ tissue engineering and electrospun biomaterials exists
because mammals tend to heal injured tissue imperfectly with a loss of function, resulting
in fibrosis and scarring, rather than regenerating the tissue. This imperfect healing is
believed to be the result of the immune system. Lower vertebrates and human fetuses,
which have limited immunity, have complete regenerative capacity while higher
vertebrates and adult humans with well-developed immunity have impaired regeneration,
suggesting an inverse relationship between immunity and regeneration 6. Historically,
interpretation of this inverse relationship suggested a need to block the immune system
for efficient tissue regeneration, but we now know that inflammation and immunity can
3

have profoundly positive impacts on tissue regeneration when regulated 7. Most
importantly, the regulation requires a coordinated response between immune cells to
facilitate progression from the acute inflammatory response towards resolution in order to
mitigate fibrosis. Thus, the most promising avenue for promoting functional regeneration
is engaging the immune system and modulating it down the pathway of resolution, repair,
and rebuilding, beginning with the neutrophil.
The implantation of a biomaterial (Figure 2) results in tissue damage, which
triggers acute inflammation and an innate immune response, characterized by neutrophil
recruitment 8. Signals such DAMPs, IL-8, and LTB4 are released from the ECM and
necrotic cells to recruit neutrophils from the circulation (Figure 2A) 9-11. These signals
establish a chemotactic gradient that can be immobilized in the ECM to direct neutrophil
migration. Aided by the increase in vascular permeability from the acute inflammatory
response, there is a rapid amplification of phenotypically plastic neutrophils in the local
microenvironment, referred to as neutrophil swarming (Figure 2B) 12. Within 25-40
minutes, neutrophils undergo extravasation from the vasculature and swarm infected or
sterile wounds before clustering around the site of tissue damage. LTB4, released from
endothelial cells after exposure to DAMPs, is also secreted by neutrophils to mediate
swarming in a feed-forward manner 12, 13. Furthermore, vascular damage resulting from
the surgical insult will lead to pooled blood, containing neutrophils, around the
biomaterial. As a result, biomaterial implantation establishes a dynamic and complex
microenvironment that is acutely infiltrated by neutrophils, eager to interact with and
respond to the biomaterial.
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Figure 2. Implantation of a biomaterial triggers an innate immune response and
neutrophil recruitment. (A) Injury up-regulates DAMPs, IL-8, and LTB4 to recruit
neutrophils from circulation. (B) Neutrophils are recruited to a biomaterial-induced injury
through LTB4 secretion in a feed-forward manner. (C) Swarming neutrophils interact
with the biomaterial directly or indirectly through surface adsorbed proteins. (D)
Neutrophils respond to the biomaterial and modulate the microenvironment through the
production of ROS, phagocytosis, degranulation, and the release of NETs. Additionally,
neutrophils can undergo apoptosis or reverse migrate back into circulation.
The swarming and clustering neutrophils either interact with the biomaterial
directly through binding sites on the material surface or indirectly through binding sites
on surface-adsorbed proteins (Figure 2C). Natural polymer biomaterials, made from
collagens, gelatin, and fibrinogen, are derived from the ECM and are inherently
bioactive. They contain binding sites for integrins, which can induce outside-in signaling
within neutrophils resulting in a multitude of effects 14. In addition, synthetic materials
present binding sites on their surface through the adsorption of blood plasma proteins 15.
Surface-adsorbed proteins may contain binding sites in their native conformation or may
reveal cryptic binding sites through conformational alterations due to adsorption 16.
Direct or indirect interactions with the biomaterial results in a dynamic interplay between
the material, the neutrophils, and the response.
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The biomaterial-interacting neutrophils can respond through several effector
functions to modulate the inflammatory state of the tissue (Figure 2D). Tools in their
arsenal of responses include the production of ROS, the ability to clear pathogens and
debris through phagocytosis, the exocytosis of granules through degranulation, and the
capacity to release NETs. Importantly, these processes determine the outcome after
biomaterial implantation by regulating the extent of inflammation and the rate of
resolution 17.
Final resolution of the innate immune response and removal of neutrophils from
the injury site are essential for biomaterial-guided in situ tissue regeneration. In the
classical wound healing response, neutrophil recruitment peaks within the first 48 hours
and declines rapidly over the next several days while macrophages infiltrate the
inflammatory site. This rapid response and subsequent decline suggest an important preconditioning function for neutrophils in the acute inflammatory phase. However, some
studies have shown that neutrophils can persist for several days and weeks in the
presence of inflammatory signals that decrease the levels of pro-apoptotic proteins 18-20.
For example, neutrophils have been found in the peritoneal cavity two weeks after the
implantation of alginate microcapsules, indicating their pro-longed participation in the
chronic response to a biomaterial 21. Removal of neutrophils can occur through
efferocytosis, where apoptotic neutrophils are cleared by macrophages, or can occur
through reverse migration, where neutrophils return to the vasculature during resolution
22, 23

. The efferocytosis of apoptotic neutrophils by macrophages is an anti-inflammatory

process that is essential for wound healing, implicating this as an important clearance
mechanism to resolve inflammation 24, 25. Ultimately, the biomaterial must be designed to
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direct the neutrophils to a restorative phenotype that promotes resolution of inflammation
followed by tissue regeneration.
Conclusion
Electrospun biomaterials hold great therapeutic potential for stimulating in situ
tissue regeneration and improving the quality of life for many patient populations.
Although macrophages have long been considered the maestros of tissue regeneration,
neutrophil recruitment precedes the arrival of macrophages, suggesting that macrophage
effector functions lie downstream from neutrophil effector functions. Therefore, while
macrophages are undoubtedly needed for in situ tissue regeneration, our understanding
and ability to design immunomodulatory biomaterials may be inherently limited by our
lack of understanding of the neutrophil’s preconditioning response.
The following work characterizes the release of NETs on electrospun
biomaterials, evaluates its impact on tissue regeneration, and investigates its regulatory
mechanisms. Of the neutrophil effector functions, the release of NETs was selected as the
primary focus of this work for two reasons. First, there was a significant gap in the
literature evaluating NET release in response to biomaterials, despite increasing evidence
from other inflammatory environments that NETs are present. Second, NETs have been
linked to thrombosis and fibrosis, two outcomes that are particularly detrimental to
biomaterial-guided in situ tissue regeneration. Ultimately, our results indicate that
electrospun biomaterial-induced NET release can be controlled through biomaterial
design and that it shapes the regenerative microenvironment and potential for functional
tissue regeneration and healing.
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CHAPTER 2
LITERATURE REVIEW
Introduction
An injury to a tissue or organ initiates a tissue repair program that is initially
characterized by inflammation and the local recruitment and accumulation of immune
cells at the wounded site 26. Independent of injury location, neutrophils are rapidly
recruited to the damaged area and dominate the acute response. The early and robust
recruitment of neutrophils is essential for preventing pathogen dissemination when
barriers such as the skin or mucosa are damaged because their multiple effector functions
efficiently kill bacteria. These effector functions include the production of ROS, the
release of granules, the phagocytosis of invaders, and the extrusion of NETs 17. NETs,
which are extracellular structures composed of decondensed chromatin and various
nuclear and granular components, were initially characterized in the context of host
defense as a mechanism to locally concentrate the noxious anti-microbial cargo of the
neutrophil and kill trapped pathogens 27. However, it is now well established that the
recruitment of neutrophils and the release of NETs occurs both in the context of infection
and in response to sterile injuries 28, 29, such as the implantation of a biomaterial or tissueengineered construct 21, 30, 31. Moreover, dysregulated neutrophil recruitment and NET
release can cause collateral tissue damage and uncontrolled inflammation, which are
particularly detrimental to biomaterial-guided tissue regeneration and repair. This review
discusses our knowledge of NETs and their role in inflammatory pathologies, including
cancer, thrombosis, and fibrosis, and the resolution of inflammation. In addition, we
discuss what is known about NETs in the response to biomaterials and highlight future

considerations for immunomodulatory biomaterial design to control the neutrophil
response and enhance tissue repair and regeneration.
The Biology of NETs
The Composition and Morphology of NETs
NETs are extracellular structures composed of a physical network of DNA
nanofibers that are decorated by bound proteins derived from several compartments
within the neutrophil. Although an initial description included only 25 proteins 32, more
recent proteomic analyses have identified nearly 700 proteins within NETs with the vast
majority implicated in autoimmunity and inflammatory disorders 33. Additionally, most
investigations into the protein cargo of NETs indicate that the proteomic profiles change
slightly depending on the stimuli and whether neutrophils are used from healthy donors
or a disease state 33-36. Therefore, while some differences likely exist when NETs are
released in response to biomaterials, the most abundant proteins in NETs substantially
overlap independent of disease state or stimulus, suggesting their relevance in
biomaterial-induced NET release. Here we present a non-exhaustive list of the most
important NET components to consider for tissue repair and regeneration (Table 1) and
recommend that interested readers reference the proteomic studies for a complete list of
NET components 32-34, 36-38.
Table 1. NET-bound protein cargo and their significance in tissue engineering.
Protein
Significance in Tissue Engineering
Cytoskeletal
β-actin 32-35, 38
DAMP that activates some immune cells 39
Vimentin 33, 34, 36, 38

Physiologic inhibitor of DNase 40, 41
Pro-inflammatory stimulus susceptible to citrullination
42
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Table 1 (Continued). NET-bound protein cargo and their significance in tissue
engineering.
Protein
Significance in Tissue Engineering
Cytoskeletal
Vimentin 33, 34, 36, 38
Stabilize activated platelets complexed with
plasminogen activator inhibitor 1 43
Exacerbate epithelial damage 44
Cytosolic
PAD4 36
S100-A8 Protein 32-34, 38

S100-A9 Protein 32-34, 38

S100-A12 Protein 32, 33, 38

Citrullinates proteins leading to inflammatory
responses 34
DAMP that activates some immune cells and
endothelial cells 45
Pro-inflammatory stimulus that triggers neutrophil
chemotaxis and adhesion 46
DAMP that activates some immune cells and
endothelial cells 45
Pro-inflammatory stimulus that triggers neutrophil
chemotaxis and adhesion 46
DAMP that activates some immune cells and
endothelial cells 45
Pro-inflammatory stimulus that triggers neutrophil
chemotaxis and adhesion 46

Granular
Cathepsin G 32, 33, 36, 38

Activates MMPs 47

MMP-8 34, 36
MMP-9 33, 34, 36, 38
MPO 32, 33, 35, 38
NE 33, 34, 36, 38

Promotes platelet activation and aggregation 48
Degrades ECM components 49
Degrades ECM components 49
Generates ROS 50
NE-DNA complexes inactivate plasminogen 51
Degrades all ECM components 52

33, 34, 36

NGAL
Nuclear
Histone 2A 32-34, 36, 38
Histone 2B 32-35, 38

Activates MMPs 53
Stabilizes MMP-9 to enhance activity 54
DAMP that activates pro-inflammatory responses from
immune cells 55
DAMP that activates pro-inflammatory responses from
immune cells 55
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Table 1 (Continued). NET-bound protein cargo and their significance in tissue
engineering.
Protein
Significance in Tissue Engineering
Nuclear
Histone 3 32-34, 36, 38
DAMP that activates pro-inflammatory responses from
immune cells 55
32-35, 38
Histone 4
DAMP that activates pro-inflammatory responses from
immune cells 55
33, 36
HMGB1
Induce NET release and pro-inflammatory responses 28
Non-Neutrophilic
Tissue Factor
Promotes thrombin generation 56
Contributes to thrombosis through thrombin generation
29, 57

The composition of NET-derived proteins can be grouped into four major
categories: cytoskeletal proteins, cytosolic proteins, nuclear proteins, and granular
proteins. Of the cytoskeletal proteins found in NETs, actin and vimentin are significant in
tissue healing. Actin is an evolutionarily conserved DAMP recognized by some immune
cells 39 that acts as a physiologic inhibitor of DNase 40, 41, which can degrade NETs.
Therefore, the presence of actin in NETs can contribute to immune activation and the
resistance of NETs to degradation, leading to aberrant NET accumulation and collateral
tissue damage 35. Similarly, vimentin, which can be secreted by activated neutrophils 58
and macrophages 59, can promote pro-inflammatory responses and is susceptible to
citrullination, an enzymatic modification intimately tied to neutrophil-driven autoimmune
disorders and NET release 42. Moreover, it can stabilize activated platelets complexed
with plasminogen activator inhibitor 1 and exacerbate epithelial damage 43, 44, hindering
tissue healing.
Of the array of cytosolic proteins found in NETs, the S100 proteins and PAD4
can have a significant impact on tissue healing for biomaterial applications. The S100
proteins, a set of calcium-binding proteins, have a broad range of functions in
11

inflammation and immune homeostasis 60. When they are released into the extracellular
space, S100 proteins function as DAMPs to activate immune cells and endothelial cells
45

. S100A8 and S100A9, together known as calprotectin 61, and S100A12 are abundantly

expressed in neutrophils and bind to TLR4 and RAGE to initiate pro-inflammatory
responses implicated in chronic neutrophil-driven inflammation 46, 62. Likewise, PAD4 is
an enzyme that citrullinates histones to facilitate chromatin unraveling during NET
release 63 but also citrullinates other extracellular proteins, contributing to autoantibody
generation in inflammatory pathologies 34, 64. Therefore, while an inflammatory response
is necessary for tissue healing, the highly localized expression of S100 proteins and
PAD4 on NETs can lead to overactivation of an inflammatory response and drive chronic
responses rather than resolution.
Majority of the NET protein cargo are granular proteins with diverse enzymatic
activity 33. The two granular proteins commonly associated with NET formation are NE
and MPO. Most of the proteolytic activity of NETs is attributed to NE 38, which can
target and degrade all ECM components 52 and activate MMPs 53. NET-bound MPO on
the other hand exerts its affects through the generation of ROS 50, and elevated levels are
associated with poor prognosis in several cardiovascular disease states 65. Additional
granular proteins found in NETs include MMP-8 and MMP-9, which can also contribute
to ECM degradation 49, and NGAL, the stabilizer of MMP-9 54, 66. The serine protease
cathepsin G is also found in NETs and can process MMPs into their active form 47 and
promote platelet activation and aggregation 48. Together, this milieu of granular proteins
contributes to NET-driven inflammation through the excessive degradation of the ECM
and activation of pro-inflammatory signals.
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NETs also contain proteins of nuclear origin including histones and chromatinbound proteins. Histones are of particular importance in inflammation and tissue healing
because they are recognized as DAMPs, leading to pro-inflammatory responses from
immune cells 55. Moreover, histones have been shown to directly induce epithelial and
endothelial cell death that contributes to tissue destruction 67. In addition, non-histone
nuclear protein HMGB1 is also a DAMP with diverse functions in inflammation and
immunity 68. NET-bound HMGB1 has been shown to aggravate systemic lupus
erythematosus 69, potentially participate in acute gouty inflammation 70, and induce NET
release and pro-inflammatory responses in liver injury 28. As such, these NET-bound
nuclear proteins participate in the regulation of the inflammatory microenvironment with
predominantly pro-inflammatory effects.
Besides proteins from defined neutrophil compartments, proteins that are not of
neutrophil origin can also bind to NETs and play an important role in the response to
NETs in tissue healing. The most noted example in literature is tissue factor, the primary
initiator of the extrinsic coagulation cascade. Although some reports suggested that
neutrophils can synthesize and secrete tissue factor 57, 71, more recent proteomics studies
did not find tissue factor bound to NETs isolated from ultrapure populations of
neutrophils 32-34, 36-38, suggesting that NET-bound tissue factor is not of neutrophil origin.
Nonetheless, NET-bound tissue factor promotes thrombin generation 56 and has been
shown to contribute to thrombosis in acute myocardial infarction as well as in
antineutrophil cytoplasmic antibody associated vasculitis 29, 57. Therefore, the ability of
NETs to bind active tissue factor could be especially detrimental to biomaterial
applications with blood-contacting biomaterials.

13

The diverse NET-bound proteins concentrate in NETs based on their interaction
with the charged DNA fibers, but the source of the DNA from within the neutrophil is
subject to debate. NET formation was originally described by the release of nuclear
chromatin 27, but since the initial description, an additional type of NETs characterized by
the release of mitochondrial DNA has been described 72, 73. In one example,
mitochondrial NETs were released from viable neutrophils after priming with GM-CSF
and stimulation of TLR4 or complement factor 5a receptor 72. Eosinophils are known to
release mitochondrial DNA through a similar mechanism 74. In another example,
mitochondrial NET release was identified after traumatic injury and trauma surgery 73.
Most neutrophil biologists now accept that NETs can be composed of nuclear or
mitochondrial DNA, which may impact the NET protein cargo, but the physiologic and
mechanistic distinction remains unclear 75. As such, there is potential that both nuclear
and mitochondrial NETs are released in response to biomaterials, but this has yet to be
specifically investigated. In our work, when abundant NETs are observed on electrospun
biomaterials, there is an absence of intact nuclei, suggesting the NETs are primarily of
nuclear origin 31, 76.
NETs are typically described as having a cloud-like morphology that can grow
beyond the size of a neutrophil (Figure 3). However, the morphology can vary between
cloud-like structures and elongated fibrous extrusions, but these differences are attributed
to agitation during sample preparation rather than physiologically relevant,
morphological differences 75. The cloud-like morphology of NETs is likely related to
their indiscriminate release from the cell, thought to be driven by entropic chromatin
swelling, that has been observed both in vitro and in vivo using live microscopy 35, 77-79.
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On our electrospun biomaterials imaged by fluorescence microscopy, NETs appear to
randomly cover the surface of the biomaterial, which others have similarly observed 21, 31,
80

. Given their volume and ability to cover surfaces, it is easy to imagine that the

extensively decorated DNA fibers can precondition a pro-inflammatory environment
when released in response to stimuli other than invading pathogens.

Figure 3. Fluorescent micrographs of NETs on electrospun biomaterials. Although they
appear two-dimensional when viewed from (A) the top in epifluorescence microscopy,
NETs are 3D structures with height and volume, which is evident when viewed in (B) a
Z-stack of fluorescent micrographs. In these images, human neutrophils were cultured on
the electrospun biomaterial for 3 hours. Extracellular chromatin is stained red with
STYOX orange, cell membrane is green with Alexa FluorTM 488 conjugated wheat germ
agglutinin, and nuclei are blue with DAPI. (A) Scale bar is 100 µm. (B) Scale bar in the
z-axis is 55 µm.
Stimuli and Pathways of NET Release
The release of NETs is a distinct, coordinated process that requires sequential
steps to facilitate chromatin unraveling and ultimately the extrusion of NETs 81. During
nuclear NET release, the nuclear and granular membranes disintegrate, the nucleus
decondenses, and the DNA mixes with cytoplasmic and granular components. The
process culminates with rupture of the cell membrane and release of the proteindecorated NET into the extracellular space. However, the signaling pathways and
involvement of critical enzymes, such as NOX2 production of ROS to free NE and MPO
15

from granules 82, activation of NF-κB 83, and PAD4 citrullination of histones to facilitate
chromatin unraveling 63, vary greatly depending on the stimuli acting on the neutrophil.
Additionally, the kinetics of NET release have been reported to vary from 10 minutes to
24 hours and are also stimuli dependent 84, which further emphasizes the importance of
studying NET release within a specific disease state or lack thereof. Multiple nonphysiological and physiological infectious, inflammatory, and immunologic stimuli are
documented in the literature to trigger in vitro and in vivo NET release. Here, we
highlight the stimuli and known signaling pathways most relevant for biomaterial and
tissue engineering applications (Figure 4). Interested readers should reference
Hoppenbrouwers et al. for a thorough list of stimuli, their studied concentration ranges,
and their impact on NET release with corresponding references 84.
The most frequently used NET stimulus for in vitro studies is PMA, a plantderived compound that bypasses receptor engagement and actives PKC to initiate its
signaling cascade 27, 34, 85. Downstream of PKC, PMA-induced NET release requires
NOX2 production of ROS and PAD4 activation 77, 86. The benefit of PMA as an in vitro
stimulus is that it consistently triggers NET formation with reported 100% efficacy across
a broad range of concentrations 84. However, the detriment of PMA is that it is not
physiologically relevant since it does not play a role in in vivo physiological processes.
Therefore, it is now recognized that the use of PMA as an in vitro stimulus for NET
formation should be approached with caution, especially in the context of biomaterials
and the tissue repair program. If the goal is to study the neutrophil response during acute
inflammation in an in vitro model or to evaluate potential inhibitors of NET release,
PMA should not be used as a stimulus since it does not play a physiological role in acute
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inflammation. Alternatively, if the goal is to stimulate maximum NET release for the
purpose of quantifying NET formation in vitro, PMA may be an appropriate positive
control. For example, our group uses PMA to represent 100% NET formation in our in
vitro assay for quantification of biomaterial-induce NETs, and we express our results as a
percentage of NET release relative to PMA 87, 88.

Figure 4. Stimuli and signaling pathways of NET release most relevant for biomaterials
and tissue engineering applications. Question marks indicate pathways that have not been
extensively investigated. PMA is the most widely used non-physiological NET stimulus
requiring PKC, NOX2, and PAD4 for NET release 77, 86. LPS, which is relevant in the
context of infection, signals through JNK and also requires NOX2 and PAD4 89. The
signaling pathways for IL-8, IL-1β, and TNF-α are not as well studied, but recent data
indicates they do not require NOX2 for NET release 90, 91. Data suggests IL-8 induced
NET release requires calcium flux 92 whereas TNF-α signals through TAK1 91. Activated
platelets can prime neutrophils for NET release through binding of P-selectin to PSGL-1
and directly stimulate NET release through HMGB1 binding to RAGE, although the
signaling pathway has not been elucidated 93-95. Biomaterials can also induce NET
release, but the receptors and signaling pathways have yet to be evaluated and likely vary
depending on the type of biomaterial. Finally, requirements for NF-κB activation and
mobilization of NE and MPO are dependent on the stimuli, but have been found to
participate in NET release 83, 96-99.
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Similar to PMA, LPS is widely used as an in vitro NET stimulus and may or may
not be appropriate in the context of biomaterials and tissue regeneration 27, 34, 86, 100, 101.
LPS has been shown to signal through TLR4 and JNK, though one group has
demonstrated a TLR4-independent mechanism, and requires NOX2 production of ROS
and PAD4 for NET release 87, 89, 102. Derived from the outer membrane of gram-negative
bacteria, LPS is composed of a lipid A component, a core containing an oligosaccharide,
and an O-antigen that is the major basis for bacterial serotyping 103. Thus, if NET release
is being studied in an infected tissue environment, LPS may be an appropriate
physiological control for assessing the efficacy of inhibitors. Unfortunately, contradicting
data exists in the literature with some groups reporting LPS and neutrophil interactions
trigger NET release while others report that they do not 100, 104, 105. These different results
can be primarily attributed to variability of the O-antigen between different types of LPS,
which has been found to selectively regulate NET formation as a consequence of bacteria
serotyping 102. Moreover, the same study illustrated differential regulation in vitro under
serum and platelet-free conditions, indicating that both the type of LPS and culture
conditions should be carefully considered when studying LPS-induced NET release.
In addition, several pro-inflammatory cytokines and chemokines are efficient
inducers of NET release and are important to consider for biomaterial-guided tissue
regeneration. IL-8, the archetypal neutrophil chemoattractant secreted by damaged cells
and neutrophils, has been shown to stimulate NET release at low concentrations but have
no effect at high concentrations 27, 81, 90, 105, 106. Likewise, IL-1β is released during acute
tissue injury and can exacerbate tissue damage, which can be partially attributed to its
ability to stimulate NET release 71, 107, 108. TNF-α is also rapidly released after tissue
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injury to enhance immune cell recruitment and stimulates NET formation 90, 108, 109. While
the signaling pathways for these pro-inflammatory mediators have been debated, recent
data suggests that IL-8, IL-1β, and TNF-α signal through their respective receptors and
trigger NET release in a ROS-independent manner 90, 91. Given their involvement in acute
inflammation, IL-8, IL-1β, and TNF-α should be considered important NET stimuli in
tissue regeneration applications.
Activated platelets are a source of multiple growth factors and inflammatory
mediators, which can activate neutrophils and trigger the release of NETs 93, 94, 110.
Alternatively, resting platelets cannot stimulate NET release 104, suggesting that the upregulated expression of certain platelet receptors after activation and secretion of growth
factors and inflammatory mediators are critical. In fact, platelet P-selectin has been found
to prime neutrophils for NET release through binding to PSGL-1 93, and platelet
presentation of HMGB1 after activation also stimulates NET formation through RAGE in
a NOX2-independent mechanism 94, 95. The ability of activated platelets to stimulate NET
release is intriguing for biomaterial-guided tissue regeneration since platelet rich plasma
and platelet-derived growth factors have been found to resolve inflammation and enhance
tissue healing in multiple tissue engineering studies 111. It is possible that the high
concentration of growth factors within platelet rich plasma overcomes the negative
consequences of NET release in these scenarios, but this has not been investigated.
The last stimulator of NET release that is important for the application of
biomaterials to tissue engineering and regeneration is the biomaterial itself. Our group
and others have shown that a range of biomaterials stimulate NET formation, including
electrospun biomaterials 31, 88, titanium 80, carbon and polystyrene nanoparticles 112,
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TeflonTM 113, and a tissue-engineered trachea 30. The stimulation of NET release is likely
intimately related to the surface-adsorbed proteins on the biomaterial, which can vary
greatly based on the surface chemistry and topography of the biomaterial 114. Because
investigations of NETs on biomaterials is a new consideration in tissue engineering,
much work remains to determine variability between different types of biomaterials and
the signaling pathways involved. Nonetheless, no matter the stimuli, exact kinetics, or
signaling pathways, acute NET release is a significant preconditioning event occurring
early in the tissue repair program that modulates the potential for tissue healing.
Inhibitors of NET Release
Similar to the stimuli triggering NET formation, multiple inhibitors can be used to
block the release of NETs and their efficacy is dependent on the stimuli and signaling
pathway. Because of the diversity of signaling pathways, it is unlikely that inhibition of
one pathway abrogates all NET formation. Nonetheless, several common
pharmacological targets (Table 2) exist due to their recurring involvement in NET
release. While a plethora of inhibitors have been used specifically for elucidating the
signaling pathways in NET release, here we focus on the targets and inhibitors of NET
release with physiological implications.
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Table 2. Common targets and inhibitors of NET release. Applications mentioning NET
release were evaluated in vitro whereas applications mentioning a physiological impact
were evaluated in vivo.
Target
Inhibitor
Application
PAD4
Cl-amidine
Protects against cardiac dysfunction in
myocardial infarction 115
Reduces vascular damage in lupus 116
Suppresses colitis 117
Reduces arthritis 118
Reduces biomaterial-induced NET
release 76
GSK484
ROS

Reduces ionomycin and S. aureus
induced NET release 119
Reduces NET release induced by
Candida albicans 120

Tempol

TSG-6

Suppresses LPS-induced NET release 121

Luteolin

Suppresses arthritis 122

Kaempferol

Reduces tumor metastasis 123

Manuka honey

Reduces biomaterial-induced NET
release 88

GW311616A

Reduces tumor metastasis 96

Sivelestat

Rescues endotoxic shock 97

Secretory
leukocyte
protease inhibitor

Inhibits TNF-α and S. aureus induced
NET release 124

Anti-MPO
antibody

Reduces NETS in response to influenza
virus primed epithelial cells 98

AZM198

Attenuates endothelial damage 99

Other Targets
NE

MPO

21

Table 2 (Continued). Common targets and inhibitors of NET release. Applications
mentioning NET release were evaluated in vitro whereas applications mentioning a
physiological impact were evaluated in vivo.
Target
Inhibitor
Application
Other Targets
Acetylsalicylic
acid

Inhibits TNF-α induced NET release 83

BAY 11-7082

Inhibits TNF-α induced NET release 83

Ro 106-9920

Inhibits TNF-α induced NET release 83

JAK

Tofacitinib

Reduces vascular damage 125

Calcineurin
pathway

Ascomycin

Attenuates IL-8 induced NET release 92

Cyclosporine A

Attenuates IL-8 induced NET release 92

Chloroquine

Reduces hypercoagulability in cancer 126

NF-κB

Autophagy

Decreases acute pancreatitis severity 127
Receptors

Inhibits LPS-induced NET release 128

Anti-Mac-1
antibody

Inhibits NET release in response to
immobilized ICs 129
Anti-FcγRIIIb
antibody

Inhibits NET release in response to
immobilized ICs 129

Anti-FcγRIIa
antibody

Inhibits NET release in response to
endocytosed ICs 130

Roflumilast

Reduces IL-8, fMLP, and C5a induced
NET release on fibrinogen surfaces 131

The most frequently targeted enzyme for NET inhibition is PAD4 because its
activity was initially described as essential for chromatin decondensation during NET
release 132, 133. Widely studied inhibitors of PAD4 include Cl-amidine, a general
irreversible inhibitor of PADs 91, 132-134, and GSK484, a selective reversible inhibitor of
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PAD4 91, 115, 119. Both have been used successfully in vitro and in vivo to attenuate NET
release in several pathologies 116-118, 135. Our group has even incorporated Cl-amidine into
electrospun biomaterials to modulate biomaterial-induced NET release and showed that
its local delivery could improve tissue integration and regeneration 76. However, since
NET release can occur independent of PAD4 as previously discussed 136, 137, PAD4 may
not be a ubiquitous target for NET inhibition.
Down regulation of ROS has also been evaluated for blocking NET release since
seminal studies in NET release used PMA, a powerful activator of NOX2 and ROS. Most
studies have used ROS scavengers to quench ROS activity generated from various
superoxide generating enzymes. Examples include Tempol, a stable redox-cycling drug
120

, the anti-inflammatory protein secreted by stem cells, TSG-6 121, and natural flavones

and flavonoids 122, 123. Recently, we used Manuka honey, which contains multiple
flavones and flavonoids, to attenuate electrospun biomaterial-induced NET release 88.
Nonetheless, the requirement for ROS in NET release is also debated, and recent data
indicates that ROS is likely not essential for NET formation but contributes to the process
91, 102, 137

, which explains why ROS inhibitors may indirectly modulate NET release.

A variety of other signaling molecules and enzymes are involved in NET release
and have been targeted to inhibit NET formation. Because most of the proteolytic activity
of NETs is attributed to NE, several groups have evaluated inhibitors of NE 86, 96, 97, 124.
Likewise, antibodies or inhibitors of MPO have been investigated due to the contribution
of MPO to NET release and tissue damage 98, 99, 138. Additional targets include NF-κB 83,
JAK 125, the calcineurin pathway 92, and autophagy 126, 127, 139. Up-stream of all of these
signaling molecules and enzymes are the receptors that initiated the outside-in signaling,
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which have also been targeted to a lesser extent to modulate NET release. Blocking of
Mac-1 140 and FcγRs 129, 130 with neutralizing antibodies has been shown to reduce NET
release, and indirect inhibition of platelet-neutrophil interactions with Roflumilast was
also efficacious for reducing NETs 131. Together, these data indicate that although the
complexity of NET release has initially complicated our ability to demarcate specific
signaling pathways, numerous pharmacological targets exist to down regulate NET
release in a variety of pathologies, including biomaterial-induced NET release.
NETs in Inflammatory Pathologies
As the number of studies on NETs in in vitro systems and in vivo models has
grown, so too has the number of physiological implications attributed to NETs. In line
with their first described function, NETs are critical in the defense against bacteria,
viruses, and fungi, especially in scenarios when the skin or mucosa are damaged 27, 102, 141,
142

. By trapping the invader in close proximity to the lytic anti-microbial compounds

associated with the DNA structure, NETs efficiently kill the pathogen 27, 50. Another
interesting function of NETs that is attributed to their localized, toxic proteases is their
anti-inflammatory action when clustered in aggregated NETs 143. It is believed that the
large aggregation of NETs around MSU crystals observed in gout actually attenuates
inflammation by degrading cytokines and chemokines 144. Nonetheless, the antiinflammatory action of NETs seems to be highly specific to gout and infection prevention
with the vast majority of investigations finding that NETs are typically pro-inflammatory
and central to a number of inflammatory pathologies. Here, we will discuss the
involvement of NETs in cancer, thrombosis, and fibrosis because of their relevance to
biomaterials and tissue regeneration.
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Cancer
Inflammation is a hallmark of cancer, and the proliferation of tumors has been
described as wounds that fail to heal due to misappropriated mechanisms of inflammation
in tissue regeneration 145, 146. As such, an appreciation for the involvement of NETs in
cancer could give important insight into the role of NETs in biomaterial-guided tissue
regeneration applications. Most of the literature indicates that NETs facilitate cancer
metastasis in a number of tissue environments, including breast, liver, pancreatic,
ovarian, lung, and gastroesophageal metastases 147-151. In these studies, the NETs function
as structures that attract and capture circulating cancer cells to promote their adhesion 96,
148, 151

. Subsequently, NETs activate cancer-associated fibroblasts, which have a similar

morphology to myofibroblasts in wound healing, and promote the deposition of a fibrous
stroma in the developing metastasis 147, 152, 153. Aside from metastasis, the contribution of
NETs to primary tumor growth is not well understood, but some have speculated that
NET release may propagate tumor cell proliferation by stimulating the recruitment of
additional immune cells, fueling the pro-tumoral inflammatory environment 154. Last,
surgical stress has been shown to induce NET release that is enhanced in hypoxic tumors,
suggesting that the hypoxic environment created by the surgical site around a biomaterial
may also increase NET release 155. Together, these studies indicate that NETs are
important both as physical structures and activators of fibrous stroma deposition in tumor
pathogenesis, resulting in misappropriated mechanisms of tissue healing.
Thrombosis
In addition to functioning as a scaffold for tumor proliferation, NETs contribute to
cancer pathology by promoting thrombosis 126, 156, 157. The procoagulant activity of NETs
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has also been observed in myocardial infarction 29, antineutrophil cytoplasmic antibody
associated vasculitis 57, deep vein thrombosis 85, 158, 159, heparin-induced
thrombocytopenia 135, and sepsis 79. The thrombogenicity of NETs is attributed to their
ability to bind and expose functional tissue factor 29, 33, 57, 71 as well as promote platelet
aggregation and stabilization through a positive feedback loop 29, 159, 160. Additionally,
NETs can disrupt the endothelium 161, which induces a more pro-coagulative endothelial
cell phenotype characterized by retraction of cell-cell junctions 156. Thus, the ability of
NETs to initiate and support the coagulation cascade through multiple mechanisms is a
concern for tissue engineering, especially for blood-contacting biomaterials where
thrombosis can lead to detrimental consequences.
Fibrosis
Dysregulated NET release also promotes tissue fibrosis in multiple tissue and
organ environments. Similar to fibrous stroma deposition in cancer 147, 152, 153, NETs
activate lung fibroblasts and induce their differentiation into myofibroblasts, contributing
to fibrosis 162, 163. Likewise, NETs enhance the fibrotic potential of dermal fibroblasts in
systemic lupus erythematosus 56 and cutaneous fibrosis in systemic sclerosis 164 and
correlate with scar formation in post-epidural fibrosis 165. Interestingly, in the case of
gout where aggregated NETs seem to have an anti-inflammatory effect 35, the gouty tophi
are surround by a fibrous capsule to isolate the stimuli from the microenvironment 166.
This may also explain why NETs lead to fibrosis in other scenarios where the body is
attempting to wall off the inflammatory stimuli in an effort to restore homeostasis, an
undesirable response in most biomaterial applications.
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NETs in the Resolution of Inflammation
Since NETs retain their toxicity and proteolytic activity until degradation, NETs
participate in the resolution of inflammation when their dismantling occurs efficiently
during the acute inflammatory response, which can be skewed when their release is
dysregulated 27. NETs are primarily degraded by endonucleases, DNase I, and DNase Ilike 3 167. Multiple studies have shown that exogenous DNase I treatment can abrogate
the toxic effects of NETs in several pathologies, including thrombosis and fibrosis 163, 165,
168-170

. Moreover, accelerated NET degradation by DNase I has also been shown to

improve neovascularization and vascular repair after stroke 169, highlighting that their
degradation is central for the resolution of inflammation and progression in the tissue
repair program. However, physiological concentrations of DNase I are not sufficient to
completely degrade NETs, so macrophages engulf partially digested NETs in an
immunologically silent manner, much like macrophage engulfment of apoptotic
neutrophils 171, 172. In contrast to their silent clearance, an overproduction of NETs during
inflammatory pathologies can lead to pro-inflammatory responses from interacting
macrophages 173. Together, these data indicate that a fine balance between the presence of
NETs and their degradation exists in order to avoid inflammation and tissue damage
while propagating the tissue repair program.
NETs are also intimately related to the resolution of inflammation in their absence
of release because neutrophils are then able to influence tissue healing through their
active restorative functions 174, 175. Examples of the pro-healing functions of neutrophils
include phagocytosis of debris, release of growth factors, and the initiation of
angiogenesis 17. The contribution of neutrophils to the resolution of inflammation in
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sterile tissue injuries has largely been studied in the context of ischemic injuries, where
the purpose of the tissue repair program is to promptly initiate angiogenesis to restore
blood flow. Angiogenesis is proceeded by neutrophil recruitment in many models, and
these studies have found that neutrophil depletion significantly delays healing 176-179.
Moreover, these models have shown that neutrophils rapidly swarm to an injury within
25-40 minutes after its induction before clustering around the site of tissue damage,
suggesting their integral involvement in tissue repair 12. It is speculated that the absence
of neutrophils delays proper healing in these sterile injuries because the resolution of
inflammation is programmed for and requires the regulated activation and deactivation of
neutrophils 180. Alternatively, when inflammation is triggered by an unnatural stimulus,
such as high glucose in diabetes, alcohol, autoimmune antibodies, or a biomaterial,
neutrophils struggle to respond appropriately, which results in maladaptive effector
functions 180. Taken together, NET release and the resolution of inflammation are
inherent programs within the neutrophil’s molecular machinery, and understanding how
to regulate them with immunomodulatory biomaterials may significantly enhance tissue
regeneration by avoiding inadvertent neutrophil activation.
NETs and Biomaterials for Tissue Engineering and Regeneration
Engineering immunomodulatory biomaterials for controlling the immune
response is not a new concept, but the application to regulating neutrophils and NET
release to enhance tissue regeneration has only been realized in recent years. As with
macrophages, the interest of tissue engineers in neutrophils increased with an increasing
body of literature on neutrophil-driven angiogenesis and tissue remodeling in tumor
biology 49, 181, 182. As more studies revealed that NETs contribute to collateral tissue
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damage and chronic inflammation, our interest has grown in understanding NET release
as a preconditioning event in the response to biomaterials and the tissue repair program.
Given that surgical stress, hypoxia, and trauma can trigger NET release 155, 183, it is easy
to conceptualize that implantation of a biomaterial and its ability to induce NET release
from swarming neutrophils 12 can contribute to a dysregulated inflammatory environment
that is not conducive to functional tissue healing. Most investigations into biomaterialinduced NET release have focused on understanding how the composition, surface
chemistry, and topographical features of the biomaterial regulate NET release to avoid
their adverse effects. Here, we summarize what is known about NETs and biomaterials
(Figure 5) in thrombosis, fibrosis, and tissue integration and conclude with future
considerations for tissue engineering applications.
Thrombosis
Since NETs amplify platelet aggregation and bind active tissue factor 79, 85, NETs
can synergistically promote coagulation with platelets in response to biomaterials.
Recently, Sperling et al. evaluated the effects of biomaterial surface chemistry on NET
release and thrombin generation 113. The authors found that hydrophobic biomaterials
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Figure 5. NET release on biomaterials regulates thrombosis, fibrosis, and tissue
integration. Several studies illustrate that NETs enhance thrombin generation and
coagulation on biomaterials, occurring more readily on hydrophobic biomaterials 113, 184,
and elevated biomarkers are found in the plasma of hemodialysis patients 185.
Additionally, increased NET release on the surface of biomaterials polarizes
macrophages towards an inflammatory phenotype 80, 186, up-regulates fibrosis and impairs
tissue integration 21, 31, 186, which has been seen in the clinical application of a tissueengineered trachea 30. Finally, swift resolution of neutrophil-driven inflammation is
needed for healing and an understanding of how to regulate NET release through
immunomodulatory biomaterials may enhance biomaterial-guided tissue regeneration.
increased the release of NETs compared to hydrophilic surfaces 113. Moreover, they
demonstrated that NET release on hydrophobic TeflonTM AF resulted in elevated
thrombin generation and coagulation, linking biomaterial-induced NET release and
thrombogenicity to a clinically used biomaterial. Likewise, elevated biomarkers of NETs
are found in the plasma of hemodialysis patients 185, which suggests that hydrophobic
hemodialysis membranes may stimulate NET release and contribute to thrombosis seen
in patients undergoing dialysis 187. Similar work evaluating cobalt-chromium, an alloy
commonly used in cardiovascular implants, illustrated that thrombin generation and NET
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release occurred in the presence of platelets and can exacerbate endothelial cell
dysfunction and coagulation 184. Together, these studies link NET formation to
biomaterial-induced thrombosis and emphasize the importance of assessing neutrophil
activation when considering the hemocompatibility of biomaterials.
Fibrosis and Tissue Integration
Several groups have also focused on the impact of NETs in fibrosis and tissue
integration. Vitkov et al. found that NETs are released in response to rough titanium
biomaterials that stimulate osseointegration 188, but the impact of NETs on the
inflammatory response and potential for tissue integration was not evaluated in this work.
To address it, NET formation on smooth, rough, and rough-hydrophilic titanium surfaces
was then studied to determine how the neutrophil response impacts macrophage
polarization 80. In these experiments, rough hydrophilic titanium biomaterials decreased
pro-inflammatory responses and NET release whereas the smooth and rough hydrophobic
titanium surfaces increased NET release, indicating that neutrophils sense the biomaterial
surface and respond differentially. The authors then showed that the neutrophil
conditioned media from the smooth and rough hydrophobic surfaces enhanced proinflammatory macrophage polarization, which was attenuated when the neutrophils were
treated with NET inhibitors. Similarly, Won et al. eloquently demonstrated that 3D
printed polycaprolactone biomaterials with hierarchical microchannels decreased NET
release and enhanced macrophage polarization to the pro-healing phenotype, which
correlated with increased angiogenesis and reduced fibrosis, compared to control 3D
printed biomaterials 186. Our group has also shown that both the polymer and topography
of electrospun biomaterials can regulate NET release and that up-regulated NET release,
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occurring on hydrophobic polydioxanone with a high surface area topography, correlates
with fibrotic encapsulation 31. Jhunjhunwala et al. obtained similar results with implanted
microcapsules, observing NETs on the surface up to three days after implantation, and
speculated that the surface-coating NETs nucleated fibrosis 21. Last, in the only published
clinical example to date, a decellularized cadaver trachea implanted into a 12 year old
boy was found to have NETs on the luminal surface for the first 8 weeks after surgery,
which the authors postulated delayed epithelialization 30. Together, these data indicate
that neutrophils sense the biomaterial and precondition the environment for differential
immune cell activation and the subsequent tissue repair program, significantly impacting
tissue integration and fibrosis.
Conclusion
NET release is an active process programmed into the neutrophil’s molecular
machinery to prevent infection. However, the dysregulated release of NETs contributes to
multiple pathologies, including cancer, thrombosis, fibrosis, and biomaterial-related
complications. Moreover, NET release prevents the neutrophil from exerting its prohealing potential, further impairing tissue repair. Although the body of literature is still
small, the release of NETs on biomaterials appears to be a significant preconditioning
event that influences the potential for tissue healing with largely detrimental
consequences. More extensive evaluations of neutrophils and NET release in response to
biomaterials will likely aid in the development of immunomodulatory biomaterials that
avoid maladaptive immune responses and improve the therapeutic potential of tissueengineered biomaterials and their applications in the clinical setting.
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CHAPTER 3
ELECTROSPUN TEMPLATE ARCHITECTURE AND COMPOSITION
REGULATE NEUTROPHIL NETOSIS IN VITRO AND IN VIVO
Introduction
Biomaterials used in tissue engineering applications elicit a multifaceted and
highly orchestrated, innate immune response, hallmarked by inflammation. On
implantation, injury to surrounding tissues stimulates the release of chemical signals, and
blood proteins immediately adsorb on the surface of the biomaterial 189. After chemical
signals trigger the immune response, the innate immune cells subsequently interact with
the protein-coated material, recruit additional immune cells, and begin orchestrating
either fibrosis or tissue repair and regeneration 190. An emerging focus of tissue
engineering is designing acellular tissue regeneration templates with architectures and
compositions that harness the body’s innate immune response and use it as a bioreactor to
promote in situ regeneration of new tissues. Rather than designing inert scaffolds, the
goal is to design temporary templates that dynamically initiate and guide the innate
healing process through tissue integration and regeneration while preventing fibrosis 191.
Neutrophils, the sentinels of the innate immune system, are highly mobile
phagocytes that are recruited rapidly and in large quantities by chemotaxis to a site of
acute inflammation 192-194. Historically, minimal attention was given to neutrophils and
their role in tissue regeneration194-196. However, new evidence suggests that the
neutrophil’s activity and interaction with biomaterials deserve critical attention.
Specifically, by adapting to microenvironmental cues and synthesizing and secreting an
array of cytokines, chemokines, and MMPs, neutrophils exhibit multifaceted

physiological effects, including angiogenesis and regeneration 96, 192, 193, 197, 198.
Furthermore, research in the field of tumor biology has revealed that TANs have
considerable plasticity of phenotype, displaying an N1 anti-tumor phenotype or an N2
pro-tumor phenotype, which is regulated by the tumor microenvironment and its
constituent factors 181, 191. These contrasting TAN phenotypes are synonymous with the
macrophage M1 and M2 paradigm, which varies from the promotion of inflammation to
the promotion of angiogenesis and tissue growth 181.
In addition to their ability to secrete potent factors like TIMP-free MMP-9 182,
neutrophils activated by microbial or chemical factors are able to expel their DNA along
with granular contents to form NETs 27. This process, deemed NETosis, was only
discovered in 2004 and is not well understood 27, 81, especially its implications in in situ
template preconditioning and guided tissue regeneration. On the decondensing of
chromatin, aided by histone citrullination 132, and the disintegration of granules, the
neutrophil cell membrane ruptures to extrude a cloud-like, fibrillary network of DNA,
decorated with proteins and histones, into the microenvironment 104. Neutrophils dying
through the NETosis mechanism do not display ‘‘eat me’’ signals like apoptotic or
necrotic cells do before cell membrane disruption. This prevents their pre-emptive
clearing by macrophages and facilitates complete NET extrusion 199. Furthermore, it has
been proposed that NETosis is a response to noxious stimuli that are too large to be
phagocytosed, such as biomaterials 21, 141, which is supported by findings that large
particles like cholesterol crystals induce NETosis 70, 200. Taken together, this suggests that
NETs may be extruded on the surface of implanted tissue regeneration templates and
precondition the ensuing innate immune response.
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This article evaluates the hypothesis that NETs are generated in response to
electrospun tissue templates and that the degree of template-bound NETosis is a function
of template architecture (i.e., fiber diameter) and composition. PDO, COL, and a blend of
the two polymers, PC, were electrospun with varying yet controlled architecture of SD
and LD fibers and pores. NETosis was examined in vitro with freshly isolated, human
peripheral blood neutrophils and in vivo with a subcutaneous implant rat model and
analyzed based on template architecture, composition, and more specifically, architecture
within a composition. Furthermore, NETosis was examined in vitro at multiple time
points to elucidate its potential temporal regulation by template architecture and
composition. Ultimately, understanding NETosis will facilitate design of electrospun
templates and other biomaterials that harness the body’s innate immune system as a
bioreactor to promote, guide, and enhance in situ tissue integration and regeneration.
Materials and Methods
Fabrication and Characterization of Electrospun Templates
For this study, COL was isolated from rat tails following the protocol previously
described by Rajan et al. 201. Briefly, collagen type I obtained from rat tail tendons was
dis- solved in acetic acid, frozen at -80°C, and lyophilized. PDO (Sigma Aldrich Co.) and
COL were dissolved overnight in HFP (Oakwood Products, Inc.) at ratios of 100:0,
90:10, and 0:100 v/v at low (60 mg/ mL) and high (PDO 140 mg/mL and COL 110
mg/mL) concentrations to fabricate SD and LD regeneration templates, respectively.
Solutions of PDO, COL, and PC were placed in a syringe on a syringe pump
(Model No. 78-01001; Fisher Scientific) with an 18-gauge blunt needle tip (2.5 cm
length) attached to the positive voltage lead of a power supply (Spellman CZE1000R;
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Spellman High Voltage Electronics Corp.). Solutions were dispensed at a rate 2 mL/h for
COL LD, 3 mL/h for COL SD, 4 mL/h for PC SD and PDO SD, 5 mL/h for PC LD, and
6 mL/h for PDO LD with a voltage applied to the solution of ++22 kV for PDO SD and
PDO LD, +25 kV for PC SD, PC LD, and COL LD, and +28 kV for COL SD. The airgap
distance was 12.7 cm for all solutions. Fibers were collected on a grounded stainless steel
rectangular mandrel (20 x 75 x 5 mm), rotating at 1250 rpm and translating 6.5 cm/s over
13 cm.
Templates were coated with 5 nm of gold palladium by sputter coating in an
argon gas field before imaging via scanning electron microsopy (FEI NN650 FEG, Nova
NanoSEM™ with field emission gun) at +20 kV with a working distance of 5 mm.
Templates were characterized regarding fiber and pore diameters by analyzing the SEMs
with FibraQuant™ 1.3 software (nanoTemplate Technologies, LLC). The average fiber
diameter and pore diameter with corresponding standard deviations were calculated by
averaging a minimum of 200 semi-automated random measurements per image and 60
random manual measurements per image, respectively.
Human Neutrophil Isolation
Neutrophils were isolated from blood obtained from healthy donors from Key
Biological Services in accordance with protocols approved by the University of
Tennessee Institutional Review Board. During disinfection and plating of the templates,
fresh human peripheral blood neutrophils were isolated following a modified version of
published protocols 202, 203. Briefly, neutrophils were purified at room temperature from
heparinized whole blood of healthy donors and collected from the pellet of an Isolymph
density gradient (Gallard Schlesinger Chemical) under endotoxin-free conditions. The
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contaminating erythrocytes were lysed in ice-cold hypotonic 0.2% sodium chloride
solution for 30 seconds, and the solution was rendered physiological saline by addition of
hypertonic 1.6% sodium chloride solution, resulting in neutrophil viability >98% as
assessed by trypan blue dye exclusion. The neutrophils were washed once in 1x HBSS
and resuspended at a density of 4 x 106 cells/mL in HBSS with 0.2% human serum and
10 mM HEPES.
Neutrophil Seeding
Before disinfection, pure COL templates were crosslinked in 25 mM EDC
(Thermo Scientific Pierce™) in ethanol for 18 hours at room temperature 204. Six 10-mm
diameter discs (thickness 500 ± 100 µm) of each template type were punched and
disinfected with a 30 minute ethanol soak, followed by three 10 minute washes with
HBSS. The disinfected templates were then placed in a 48-well culture plate and kept
hydrated with HBSS before seeding of neutrophils. Immediately following neutrophil
isolation, templates were seeded with 150 µL of the cell suspension to generate 600,000
cells/well. After waiting for 10 minutes to allow the neutrophils to settle by gravity, an
additional 150 µL of HBSS was carefully added to the wells. All templates were cultured
under standard culture conditions (37°C and 5% CO2) for 3 and 24 hours, after which the
plates were placed on ice to inhibit further stimulation of the neutrophils. Supernatant
was removed from the cellularized templates, and the cells were fixed in their wells on
the templates with 10% buffered formalin. Fixed templates were stored in formalin at
4°C until analysis.
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Fluorescent Detection of NETs
The surface of fixed, cellularized templates (n = 3, biological and technical
replicates represented by three different donors seeded on templates) was imaged with
fluorescent microscopy for quantitative analysis of the degree of NETosis in response to
the templates. Templates were removed from formalin and stained with 100 nM SG
extracellular DNA stain (Cat. No. S7020; Life Technologies) in DI water for 10 minutes
at room temperature followed by DAPI fixed cell nuclei stain (Cat. No. R37606; Life
Technologies) at stock concentration for 5 minutes at room temperature. Three DI water
washes were performed between each step, and stained templates were covered with a
glass coverslip.
Two images were taken randomly from different regions of each template with an
Olympus microscope (Model BX43F) equipped with an Olympus DP73 highperformance digital color camera and fluorescent light source (DAPI and SG excited at
358 and 504 nm, respectively) at 20x magnification. Using cellSens® Standard 1.9
Digital Imaging software (Olympus Corp.), exposure times of each channel were kept at
200 ms to avoid saturated pixels. DAPI and SG images of the same region were overlaid,
and the background was subtracted by defining a region of interest containing no cell
nuclei or extruded NETs.
To determine the relative degree of NETosis, the B:G ratio, representing the area
of an image occupied by intact cell nuclei compared to the area occupied by extruded
NETs, respectively, was quantified. Using MATLAB® Release 2012a, the number of
blue (DAPI), green (SG), and cyan (double staining of DAPI and SG) pixels in an image
was quantified with a minimum threshold of 110 for all three colors. The number of cyan
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pixels was subtracted from the number of green pixels, and the modified number of green
pixels was used to formulate a B:G ratio. An average B:G ratio and corresponding
standard deviation were calculated for each template type.
IR On-Cell Western Blot
An On-cell Western assay was performed to quantify template-bound CitH3.
Fixed, cellularized templates were removed from formalin and rinsed with 1x PBS
(HyCloneTM; GE Healthcare). Free aldehyde groups were quenched with three washes of
25 mM glycine in PBS for 5 minutes at room temperature and blocked with Odyssey®
Blocking Buffer (Part no. 927-40000; LI-COR) for 1.5 hours at room temperature.
A standard curve was generated to quantify template-bound CitH3 using human
histone H3 (citrulline R2 + R8 + R17) peptide (Product code ab32876; Abcam) spotted
on an Immobilon®-FL PVDF membrane (Cat. no. IPFL00010; EMD Millipore
Corporation) at 23.5, 11.7, 5.96, 2.93, 1.46, 0.73, 0.37, 0.18, 0.09, and 0.00 ng per spot in
DI water. After allowing it to dry overnight, the spotted membrane was blocked with
Odyssey Blocking Buffer for 1 hour at room temperature.
The templates (n = 3, biological and technical replicates) and membrane were
incubated with anti-histone H3 (citrulline R2 + R8 + R17) antibody (Product code
ab5103; Abcam) at a 1:200 dilution in Odyssey Blocking Buffer overnight at 4°C. All
templates and membrane were washed five times with 0.1% Tween-20 in PBS
for 5 minutes at room temperature with gentle shaking and subsequently incubated with
IRDye 800CW donkey anti-rabbit (Part no. 926-32213; LI-COR) at a 1:20,000 dilution in
Odyssey Blocking Buffer for 1 hour at room temperature, protected from light. Noncellularized templates, serving as negative controls, were incubated with secondary
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antibody only. After four washes with 0.1% Tween-20 in PBS and a fifth wash with PBS,
the templates and membrane were scanned on the 800 nm channel of the Odyssey CLx
IR Imaging System (LI-COR) with automatic intensity adjustment to obtain fullthickness template fluorescence and analyzed using Image Studio Version 5.x (LI-COR).
For the standard curve, fluorescent intensities were measured using circular
markers encompassing the area of a spot. The intensities and corresponding mass of
CitH3 were plotted and fit with a line of best fit. Then, the fluorescent intensities of the
templates were measured using circular markers placed on the center of the template. The
intensities were extrapolated to give total fluorescence for a 10 mm punch and converted
to the mass of template-bound CitH3 using the standard curve.
In Vivo Study
To elicit the most drastic responses as determined by the in vitro model, 10 mm
diameter discs of SD and LD PDO templates were implanted on the dorsa of four
Sprague-Dawley rats (250-300 g, male and female) following the protocol approved by
the University of Memphis Institutional Animal Care and Use Committee. Templates
were sterilized with peracetic acid (Product no. 77240; Sigma-Aldrich®) 205, and all
materials were handled aseptically. Templates were hydrated for 10 minutes with sterile
1x PBS before implantation to minimize air within the template.
The rats were anesthetized by 5% isoflurane in an induction chamber, and
anesthesia was maintained with 1-2% isoflurane delivered through a nose cone.
Antisepsis was provided with iodine, and after creating incisions, four isolated
subcutaneous pockets were tunneled on the dorsa of each animal by blunt dissection. One
template lying flat was implanted per pocket to minimize void space around the template.
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Four replicates per template type (n = 4) were implanted for the 24-hour time point, and
two replicates per template type (n = 2) were implanted for the 7-day time point. The skin
was closed with a single suture. The animals were euthanized 24 hours and 7 days after
implantation. After euthanasia, the subcutaneous pocket was opened, templates were
explanted (7-day templates excised with surrounding tissue), and subsequently fixed with
10% buffered formalin. Templates were stored in 10% buffered formalin at 4°C until
analysis.
Template Staining and Evaluation
Fixed, excised templates were processed and stained to evaluate the in vivo
response to the different template architectures. For cryosectioning, templates were
soaked in 30% sucrose solution overnight, embedded in Tissue-Plus® O.C.T. Compound
(Fisher HealthCare), frozen at -20°C, cryosectioned at a thickness of 15 µm, and mounted
on glass slides. Replicates from 24 hours were stained with DAPI and SG following the
same methods defined for the in vitro samples and with Shandon Kwik-Diff (Cat. no.
9990701; ThermoScientific) following the manufacturer’s protocol. In addition, 7-day
samples were processed and stained with H&E following standard protocol. Sections
were qualitatively evaluated for cell migration through the template and the overall
inflammatory response.
IR On-Cell Western Blot
Template-bound CitH3 was quantified on 24 hour templates (n = 4) following the
On-cell Western assay protocol used for the in vitro templates.
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Statistical Analysis
Statistical analysis was performed using Microsoft® Excel Real Statistics to
determine significant differences at an a priori level of p < 0.05. For template
characterization and quantification of template-bound CitH3, analysis of the data was
conducted using a Kruskal-Wallis one-way ANOVA test and Tukey-Kramer HSD
multiple comparison procedure. For the fluorescent detection of NETs, analysis of the
data utilized a Welch’s ANOVA test and the Games-Howell multiple comparison
procedure.
Results
Template Characterization
SEM analysis confirmed that low and high polymer concentrations resulted in
small and large fiber and pore diameters, respectively (Figure 6). All LD templates
resulted in fiber diameters that were statistically larger than their SD counterparts (1.0-2.0
µm vs. 0.25-0.35 µm, p < 0.05). Similarly, all LD templates resulted in pore diameters
that were statistically larger than their SD counterparts (6.0-8.0 µm vs. 1.0-1.25 µm, p <
0.05).
In Vitro Results
Fluorescent Detection of NETs
Fluorescent microscopy revealed varying degrees of NETosis in response to the
different template architectures and compositions (Figure 7), which were evaluated with
B:G ratios quantified by an image analysis algorithm written in MATLAB (Figure 8).
Blue and green signify SG and DAPI staining. During NETosis, the plasma membrane
maintains its integrity, while the nuclear and granular membranes disintegrate 206.
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Figure 6. Processing solution concentration alters fiber diameter and pore diameter. (A)
SEMs of electrospun templates (scale bar is 30 µm). (B) Resulting electrospun template
fiber diameter and pore diameters. *Signifies a significant difference between SD and LD
template counterparts (p < 0.05).
Because SG is unable to penetrate an intact plasma membrane 207, double staining of
DAPI and SG, resulting in cyan, denotes cells that may be undergoing cellular changes,
other than NETosis, that are associated with a compromised plasma membrane 206.
Therefore, blue, green, and cyan represent intact viable cells, extruded NETs, and intact
cells with compromised cell membranes, respectively. To accurately quantify the degree
of NETosis as the B:G ratio and obtain a true measurement of extruded NETs, cyan
pixels were subtracted from the green pixels before calculating the B:G ratio. A B:G ratio
greater than 1 signifies a larger area of the template occupied by intact cells than by
extruded NETs, suggesting a relatively low degree of NETosis, with the inverse for a B:G
ratio less than 1, suggesting a relatively high degree of NETosis.
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Figure 7. Representative fluorescent micrographs demonstrating varying degrees of
NETosis in response to templates of different architectures and compositions. Images of
in vitro cellularized templates at (A) 3 hours and (B) 24 hours stained with DAPI and SG
(scale bar is 50 µm).

Figure 8. Template architecture and composition modulate NETosis as indicated by B:G
ratios. B:G ratios quantifying NETosis at 3 and 24 hours. *Indicates a significant
difference (n = 3, p < 0.05). No statistical differences were found between SD and LD
template counterparts at 24 h.
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Historically, extended in vitro experiments with isolated human neutrophils have
not been considered feasible or reliable because of the neutrophil’s brief half-life in vitro
208

; however, fluorescent microscopy revealed that a portion of the template-adhered

neutrophils at 24 hours were stained with DAPI only (Figure 7B), indicating the
maintenance of an intact cell membrane and thus cell viability. In addition, previous work
has relied on artificial stimulation with manganese to enhance neutrophil adhesion 209.
Our studies did not utilize manganese stimulation, and neutrophil adhesion on the
templates was evident at both 3 and 24 hours (Figure 7). These results are similar to
previous experiments with mast cells, which were also thought to require stimulation for
adhesion, but were found to adhere unassisted in vitro 210.
At 3 hours, all LD templates, regardless of composition, resulted in B:G ratios
greater than 1 (Figure 8). For PDO and PC, SD counterparts resulted in B:G ratios less
than 1. PDO LD and PC LD had significantly higher B:G ratios (6x and 12x increase,
respectively) compared to their SD counterparts (p = 0.003, not indicated in Figure 8).
These results suggest that a LD template primarily composed of PDO induces a lower
degree of NETosis in vitro compared to SD templates.
In addition, all COL templates at 3 hours resulted in B:G ratios greater than 1.
The B:G ratio for COL SD was significantly higher (10x increase) than the other SD
templates (p = 0.003). Moreover, although not statistically greater (p = 0.34), the B:G
ratios for all COL templates were higher than those for PDO LD and PC LD templates,
which suggests that incorporation of COL, regardless of architecture, minimizes the
degree of NETosis beyond that of PDO template architecture. Together, these data
indicate that the degree of NETosis exhibited in response to a tissue regeneration
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template in the critical, initial hours following implantation does not solely depend on the
template architecture free from its composition, but rather depends on a specific template
architecture for a given composition.
For all templates that had a B:G ratio greater than 1 at 3 hours, the B:G ratio
decreased at 24 hours with significant differences between time points for PDO LD (p =
0.002) and PC LD (p = 0.03) (Figure 8). The decreased B:G ratios for templates
exhibiting a low degree of NETosis at 3 hours suggest that the templates may be
temporally modulating NETosis. In other words, these templates may be slowing the
onset of NETosis. Inversely, for all templates that had B:G ratios less than 1 at 3 hours,
the B:G ratio increased at 24 hours with no statistical differences. This may be the result
of the delicate NETs degrading or detaching from the templates as time progresses.
IR On-Cell Western Blot
To quantify template-bound CitH3, the PVDF membrane spotted with CitH3 was
scanned on the Odyssey system and analyzed. The standard curve revealed a linear
relationship (y = 3998.8x, R2 = 0.9165) between intensity and CitH3. Using the equation
obtained from the standard curve, the total amount of template-bound CitH3 was
quantified for each template type. The amount of extracellular CitH3 expressed on the
templates appears to be largely dependent on template architecture and composition
(Figure 9). Citrullination of histone H3 is a critical step during NETosis, allowing for the
extrusion of an NET, and CitH3 is known to be contained within NETs after extrusion
128

. Because the cells were not permeabilized for the On-cell Western, increased CitH3

can be correlated to a high degree of NETosis, while decreased CitH3
can be correlated to a low degree of NETosis.
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Figure 9. Template architecture and composition modulate NETosis in vitro as indicated
by template-bound CitH3. Quantified template-bound CitH3 on templates at (A) 3 hours
and (B) 24 hours. *Signifies a significant difference between SD and LD template
counterparts (n = 3, p < 0.05).
At both time points, templates with smaller fiber diameters and pore diameters
resulted in higher amounts of template-bound CitH3 compared to templates with larger
fiber diameters and pore diameters, with a significant difference between PDO SD and
PDO LD at both 3 and 24 hours (p < 0.05). Specifically, PDO SD expressed 8.06 ± 2.64
ng of CitH3 at 3 hours, which is five times the amount on PDO LD, and 8.94 ± 2.24 ng of
CitH3 at 24 hours. This stark contrast again demonstrates, via quantification of
extracellular, template-bound CitH3, that the degree of NETosis is regulated by template
architecture. Furthermore, the COL SD template expressed 3.9 ± 0.73 ng of CitH3,
significantly less than PDO SD, at 3 hours (p < 0.05), and 4.0 ± 1.8 ng of CitH3, also less
than PDO SD, at 24 hours. This decrease in CitH3 again suggests that template
composition also plays a crucial role in the degree of NETosis.
Interestingly, the amount of template-bound CitH3 did not decrease from 3 to 24
hours for PDO SD and PC SD, as anticipated based on the results from fluorescent
microscopy (Figure 9B). This interesting finding suggests that the CitH3 may remain
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template bound at later time points, even after the NETs have detached or been degraded.
Considering the strong positive charge of histones and the largely negative charge of
adsorbed proteins on the templates, it is possible that the attraction between CitH3 and
the proteins is great enough to conserve the presence of CitH3 for extended periods of
time.
In vivo Results
Template Staining and Evaluation
A preliminary in vivo study was executed to evaluate the physiological
significance of the in vitro model. Cryosectioning and staining of the PDO SD and PDO
LD templates from the rat subcutaneous pocket show that the overall response to the
templates in vivo, as orchestrated by the acute confrontation of the neutrophil, varies
significantly based on fiber diameter of the template. DAPI and SG staining (Figure 10A)
and Shandon Kwik-Diff staining (Figure 10B) highlight the extreme differences between
templates at 24 hours. A dense, cell layer can be seen surrounding the PDO SD templates,
whereas the PDO LD templates possess an even distribution of cells throughout their
thicknesses. Moreover, at 7 days, the H&E staining (Figure 10C, D) reveals the formation
of a capsule-like tissue (i.e., pink staining) separating the SD template from the
surrounding tissue. In contrast, the PDO LD template is partially integrated with the
surrounding tissue and has high cellularity around its borders at 7 days. Since the only
factor that varied in this initial in vivo study was template architecture, these results
emphasize the importance of better understanding the innate immune response to a
material and subsequent healing as modulated by material design.
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Figure 10. Fiber diameter modulates evoked cell distribution through PDO templates and
marginal tissue integration in vivo. The white space between the template and
surrounding tissue is an artifact of sectioning. Cross sections of SD and LD templates
stained with (A) DAPI and SG and (B) Shandon Kwik-Diff stain at 24 hours and (C and
D) H&E stain at 7 days (scale bars are 100 µm for (A–C) and 50 µm for D). It is
important to note that a capsule-like tissue (*) separates the template (X) from the
surrounding tissue for the SD templates, but not the LD templates.
IR On-Cell Western Blot
As seen with the in vitro templates, the degree of extracellular, template-bound
CitH3 in vivo appears to be dependent on template architecture (Figure 11). PDO SD
expressed 1376 ± 286 ng of CitH3, which is significantly greater than the mass of 422 ±
30 ng of CitH3 on PDO LD (p = 0.02). The three and a half-fold increase in CitH3 is
indicative of a high degree of NETosis in response to PDO SD templates.
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Figure 11. Electrospun PDO template architecture modulates NETosis in vivo as
indicated by template-bound CitH3. Quantified template-bound CitH3 on templates at 24
hours in vivo. *Signifies significant difference between templates (p < 0.05).
In addition, the in vivo mass of extracellular template-bound CitH3 is one and two
orders of magnitude greater than the in vitro mass on LD and SD PDO,
respectively. In the in vitro model, the number of neutrophils was restricted to the seeding
density, which inherently limited the mass of CitH3. In the in vivo model, the
templates were implanted subcutaneously by blunt dissection, which resulted in an acute
inflammatory response at the implant site and allowed for the recruitment of readily
available, circulating neutrophils, thus giving rise to the increased mass of CitH3. Most
notably, even with the restricted number of neutrophils in vitro and the complex
response involving multiple cell types in vivo, the in vitro and in vivo models follow the
same significant trends. In both cases, the mass of CitH3 is four to five times higher on
PDO SD than PDO LD.
Discussion
Understanding the role of NETosis in priming electrospun templates may act as a
guide for designing templates that promote synergy between neutrophils and other innate
immune cells leading to innate immune system-guided in situ regeneration. Our objective
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was to determine a relationship between template architecture and composition and the
degree of NETosis. By electrospinning PDO, COL, and PC at low and high
concentrations, resulting in statistically different templates with anticipated fiber
morphologies and size distributions 211, 212, any variation in the degree of NETosis seen
on SD and LD template counterparts can be considered a function of template
architecture. Likewise, any variation in the degree of NETosis seen on templates with the
same architecture, but varying compositions, can be attributed to the template
composition.
Using freshly isolated human peripheral blood neutrophils, we demonstrated that
it is possible to study neutrophil interactions with templates in vitro in non-TCP
microenvironments that are more physiologically relevant and do not rely on artificial
stimulation to facilitate neutrophil-template interactions. Notably, we demonstrated that
both template architecture and composition affect the degree of NETosis in response to
tissue templates, as evidenced by the variations between B:G ratios and extracellular,
template-bound CitH3.
In general, we demonstrated that template architecture plays a significant role
with more hydrophobic, synthetic polymer templates and that the incorporation of a more
hydrophilic, natural polymer attenuates NETosis regardless of architecture. With both
fluorescent microscopy and the On-cell Western blot, we showed that the incorporation
of COL decreases NETosis, potentially by enhancing the bioactive surface functionality
of the templates 212, 213, and thus biocompatibility. Furthermore, the incorporation of
COL, segregated to the external surface of blended composition electrospun fibers 214,
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increases the hydrophilicity of the template, which has previously been shown to improve
the biocompatibility of electrospun templates 215.
For primarily PDO templates, an increased fiber diameter (i.e., micron-size)
induces a significantly lower degree of NETosis compared to a decreased fiber diameter
(i.e., nanosize), which is potentially the result of the associated non-restrictive pore sizes
allowing for uninhibited cell migration into the template. Our data also suggest that there
is a potential temporal modulation of the neutrophil’s response via template architecture
and composition, demonstrated by templates with a low degree of NETosis at 3 hours and
a slightly increased degree of NETosis at 24 hours. Most importantly, the significant and
notable trends regarding synthetic PDO templates were magnified in vivo using a rat
subcutaneous pocket model, thus validating the methods used for the in vitro model.
Considering the in vitro and in vivo results, a high degree of NETosis appears to
correlate to inflammation and fibrous encapsulation of a biomaterial, which is not
surprising since excessive NET formation has been linked to a number of pathologies and
diseases in recent years 216-220. The PDO LD templates, which were integrated with the
surrounding tissue after 7 days in vivo, stimulated a low degree of NETosis in vitro, while
the PDO SD template, coated in CitH3 and other potent proteins contained within NETs,
led to minimal marginal tissue integration. Thus, a low degree of NETosis and the
associated neutrophil phenotype (i.e., N1 or N2) may better prime the microenvironment
for tissue integration and regeneration by reducing inflammation and the presence of
harmful factors, such as histones and granule proteins. Characterizing the cell population
surrounding and infiltrating these templates may also provide valuable information
regarding NETosis and the attenuation or promotion of the foreign body response. Most
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importantly, the preliminary in vivo study suggests that there is a critical link between the
neutrophil’s acute confrontation and degree of NETosis, its temporal modulation, and the
overall response to and integration of an electrospun template.
The mechanisms of NETosis are not yet fully understood because previous
research has relied on pharmacological stimuli, such as PMA, or microbes to trigger
NETosis; nonetheless, significant insight has been gained in recent years. In general
agreement, various stimuli such as microbes and their by-products (i.e., LPS), cytokines
(i.e., IL-8, TNF-α, and others), and ICs can induce NETosis via binding to TLRs (i.e.,
TLR2 and TLR4), FcγRs, cytokine receptors, complement receptors 221, and integrins
(i.e., β2 integrin) 222. Binding of stimuli to these receptors leads to an intracellular Ca2+
influx from the endoplasmic reticulum stores and opening of membrane channels,
resulting in PKC activity, assembly of NOX2, and rupture of granular and nuclear
membranes. Simultaneously, histones are citrullinated to facilitate chromatin
decondensation, mixing of cellular contents, and final extrusion of NETs 223.
Clearly, there are many factors to consider and characterize in the complex
neutrophil response to other biomaterials, including how the variation of template
hydrophilicity and SAVR may be affecting the adsorption of serum proteins and binding
of surface receptors 221, 222, triggering different degrees of NETosis. More direct
approaches to modifying NETosis through the neutrophil’s acute confrontation may be
prevalent in the near future and would likely assume an important role in the subsequent
design of biomaterials for optimal integration.
Nonetheless, one looming question that remains unanswered is the effects of the
preconditioning event orchestrated by the initially interacting neutrophils. For this study,
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we identified that PDO templates with a larger fiber and pore diameter reduce the degree
of template-bound NETs. Because a PDO template with larger fiber and pore diameters is
also known to shift macrophage phenotype toward the regenerative M2 phenotype and
encourage angiogenesis 224, we conclude that a low degree of NETosis may correlate to a
neutrophil N2 phenotype, subsequent macrophage M2 phenotype, and ultimately,
angiogenesis and regeneration.
Conclusion
Taken together, it is evident that this preliminary, first-of-its-kind study yielding
significant insight into neutrophil NETosis in response to biomaterials only scratches the
surface of the highly complex innate immune response that drives inflammation and
rejection of a biomaterial or integration and regeneration. Over the last decade, the
macrophage has received significant attention as the key cell determining success or
failure of tissue regeneration templates. In contrast, this work suggests that we must focus
on the acute confrontation between the neutrophil and biomaterial if we wish to achieve
tissue regeneration. Most significantly, we have demonstrated that NETosis is acutely
modulated by electrospun template architecture and composition in vitro and in vivo and
shown that a high degree of NETosis in vivo may result in a pro-inflammatory
microenvironment that inhibits marginal tissue integration and angiogenesis. Further
characterization of extruded NETs by immunoreactivity assays that colocalize CitH3 with
other neutrophil granule contents contained within NETs may provide additional valuable
information for further characterizing the response to electrospun templates and the
microenvironment it creates. Our results thus far suggest that investigating the
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neutrophil’s specific response to electrospun templates and other biomaterials is an
avenue of utmost importance.
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CHAPTER 4
SURFACE AREA TO VOLUME RATIO OF ELECTROSPUN
POLYDIOXANONE TEMPLATES REGULATES THE ADSORPTION OF
SOLUBLE PROTEINS FROM HUMAN SERUM
Introduction
The greatest challenge for the clinical translation of biomaterials in tissue
regeneration applications is guiding integrative and functional tissue regeneration. The
cellular and molecular events immediately following implantation establish the
microenvironment that determines the biological performance of implants. During the
immediate innate immune response, lipids, ions, sugars, and soluble proteins from the
blood rapidly adsorb on the surface of the biomaterial to facilitate cell interactions with
the biomaterial. The instantaneous and dynamic adsorption of protein on a material
surface is known as the Vroman effect 225. In general, smaller low-molecular weight
proteins and those present at high concentrations adsorb first on the surface of a material.
As time progresses, these proteins may be displaced by larger, high molecular weight
proteins that have a greater affinity for the material surface. Material surface properties,
such as hydrophobicity or hydrophilicity, charge, roughness, surface area, and chemistry,
all govern protein adsorption and potential conformational changes while providing some
selectivity 16. Protein adsorption, in turn, influences the recruitment and attachment of
vascular, stromal, and inflammatory cells over the course of several hours to orchestrate
the foreign body response, which ultimately culminates in fibrous tissue encapsulation or
elusive, functional tissue regeneration. While it is generally well-accepted that the
outcome is largely dependent on the extent of the foreign body response, it is becoming

increasingly recognized that the neutrophil and its interactions with the biomaterial play a
central role in establishing the optimal microenvironment for functional tissue
regeneration 17.
Neutrophils, the most abundant white blood cell in the blood, are the first
dynamic line of defense interacting with surface-adsorbed proteins on the biomaterial
within the first hour of the inflammatory response 8, 12. Through outside-in signaling via
receptors on the cell surface, the diverse stimuli from the surface-adsorbed proteins are
transduced into intracellular signals, ultimately resulting in a cellular response.
Neutrophil responses can include phagocytosis, degranulation, and the generation of
ROS, which together create an intense attack that modulates the local microenvironment
surrounding the biomaterial 23, 49. In addition to these well-described mechanisms of
defense, neutrophils can also release NETs through NETosis to trap and neutralize
invading pathogens 27. NETosis, a specialized form of anti-microbial cell death, results in
the extrusion of a voluminous, 3D structure composed of decondensed chromatin,
histones, various granule factors, and other anti-microbial proteins. While beneficial for
combating infection, the dysregulated release of NETs is detrimental and associated with
chronic inflammation, autoimmune disorders, tissue fibrosis, and thrombosis 134, 226, 227.
NETs are also released in response to various biomaterials including titanium
plates, nanoparticles, and electrospun templates 31, 112, 188 Our group recently
demonstrated that NETs are differentially released on the surface of electrospun PDO
tissue regeneration templates 31. Templates composed of SD fibers (0.2-0.4 µm) elicit a
significantly greater release of NETs from interacting neutrophils compared to templates
made of LD fibers (1.0-3.0 µm), suggesting that the microenvironment created by the
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template architecture regulates the neutrophil response. More importantly, we also
showed that the increased presence of NETs on the surface of the SD electrospun
templates impairs tissue integration and promotes development of a fibrotic capsule in
vivo in a rat subcutaneous implant model 31. Given that neutrophils interact with the
surface of the biomaterial through adsorbed proteins, the protein constituents and their
quantities on the electrospun template surfaces may be intimately linked to differential
release of NETs, thereby playing a central role in establishing a microenvironment
conducive to functional tissue regeneration.
In this study, we evaluated the adsorption of eight proteins of interest: (1)
albumin, (2) complement C1Q, (3) complement C3, (4) IgG, (5) IgM, (6) vitronectin, (7)
fibrinogen, and (8) fibronectin on the surface of electrospun PDO templates. The purpose
of the work was to characterize protein adsorption on the PDO templates in order to
begin understanding how it may be linked to the differential engagement of neutrophil
surface receptors leading to strikingly different NET responses 31. PDO templates were
electrospun with SD and LD fibers to generate materials with a high and low SAVR,
respectively. We hypothesized that greater protein adsorption would occur on the SD
templates with high SAVR. To replicate the culture conditions of our previous work, the
templates were incubated with 0.2% human serum for different periods of time, and
protein adsorption on the templates was quantified with in situ IR-based
immunodetection to assess the effects of SAVR on protein adsorption. We found that SD
templates with high SAVR adsorbed significantly more protein than LD templates with
low SAVR. Furthermore, we determined that IgG adsorbs in the greatest quantity and
most rapidly on the SD templates, suggesting it may play a role in signaling NET release.
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Ultimately, understanding the constituents and dynamics of protein adsorption on
electrospun tissue regeneration templates may provide insight into the potential
mechanisms regulating NET release from neutrophils and their subsequent contribution
to template-guided tissue regeneration.
Materials and Methods
Template Fabrication and Characterization
PDO (Bezwada Biomedical, LLC) was dissolved overnight in HFP (Oakwood
Products, Inc.) at 67 and 135 mg/mL to generate SD and LD templates, respectively. The
solutions were loaded into a 5 mL syringe (Becton, Dickinson and Company, Pro. No.
309646) and attached to a 22.5-gauge (Becton, Dickinson and Company, Pro. No.
305156) and 18-gauge blunt needle (Becton, Dickinson, and Company, Pro. No. 305196)
for SD and LD templates, respectively, that was connected to the positive lead of a
Spellman CZE1000R power source (Spellman High Voltage Electronic Corp.). The
syringe was placed on a syringe pump (Fisher Scientific, Model No. 78-01001), and the
67 and 135 mg/mL solutions were dispensed at 0.5 and 4 mL/h with an applied voltage of
+11 and +25 kV, respectively. The fibers were collected over an airgap distance of 10 cm
for the SD templates and 27.9 cm for the LD templates on a grounded stainless steel
cylindrical mandrel (2.5 cm diameter, 10 cm width), rotating at 1250 rpm and translating
6.5 cm/s over 13 cm.
To generate SEMs, the templates were sputter coated (Electron Microscopy
Sciences, EMS 550) with 5 nm of gold-palladium in an argon gas field and imaged with a
FEI Nova NanoSEMTM at +20 kV with a working distance of 5 mm and spot size of 3.
The SEMs were then characterized to determine template fiber diameter using
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FibraQuantTM 1.3 software (nanoTemplate Technologies, LLC) from a minimum of 250
semi-automated random measurements per image. The SAVR for 6 mm diameter
punches of the SD and LD templates (n = 20) was then determined using Equations 1 and
2:
𝐸𝑞𝑢𝑖𝑣𝑎𝑙𝑒𝑛𝑡 𝑓𝑖𝑏𝑒𝑟 𝑙𝑒𝑛𝑔𝑡ℎ [𝑐𝑚] =
𝑚2

𝑆𝐴𝑉𝑅 [𝑐𝑚3 ] =

𝑚𝑎𝑠𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑡𝑒𝑚𝑝𝑙𝑎𝑡𝑒 [𝑔]
𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 [

𝑔
]∗𝜋∗(𝑓𝑖𝑏𝑒𝑟
𝑐𝑚3

𝑟𝑎𝑑𝑖𝑢𝑠 [𝑐𝑚])2

𝐸𝑞𝑢𝑖𝑣𝑎𝑙𝑒𝑛𝑡 𝑓𝑖𝑏𝑒𝑟 𝑙𝑒𝑛𝑔𝑡ℎ [𝑚]∗2∗𝜋∗𝑓𝑖𝑏𝑒𝑟 𝑟𝑎𝑑𝑖𝑢𝑠[𝑚]
𝑡𝑒𝑚𝑝𝑙𝑎𝑡𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 [𝑐𝑚3 ]

(1)

(2)

The material density of PDO (Equation 1) is 1.40 g/cm3 as determined by
standard pycnometry with a Quantachrome Instruments Ultrapyc 1200e pycnometer
(Model MUPY-31). The volume of the templates (Equation 2) was determined by
measuring the thickness of the 6 mm diameter punches and multiplying it by the area of a
6 mm diameter circle to generate cylindrical volume.
IR-Based Immunodetection Assay and Validation
To quantify the adsorption of protein, we developed an IR-based
immunodetection assay using standard curves and validated the method. First, a standard
dilution for each protein (Table 3) was generated on Immobilon-FL PVDF membrane
(EMD Millipore Corporation) using a Bio-Dot Microfiltration Apparatus (BIO-RAD)
according to manufacturer instructions. Briefly, 30 µL of protein (n = 3) diluted in HBSS
was allowed to flow through the membrane by gravity for 45 minutes before applying the
vacuum to draw through the remaining protein solution. The membranes were dried
overnight before proceeding with processing and IR-based immunodetection.
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Table 3. Protein was spotted onto a PVDF membrane to create standard curves for
quantification of protein adsorption. Each point in the standard curves was produced from
three replicates.
Protein
Upper Limit of
Lower Limit of
Dilution
Standard Curve [ng]
Standard Curve [ng] Factor
Human albumin (Novus
Biologicals, Cat. No.
148
0.07
3
NBP2-47623)
Human complement
C1Q (Millipore Sigma,
100
17.8
3/4
Cat. No. 2048761MG)
Human complement
C3b (Millipore Sigma,
600
4.7
2
Cat. No. 204860)
Human fibrinogen
(Invitrogen, Prod. No.
800
4.1
2/3
RP-43142)
Human fibronectin
(ThermoFisher
150
20.0
3/4
Scientific, Cat. No.
33016015)
Human IgG (Invitrogen,
1250
19.5
2
Prod. No. 31154)
Human IgM (Millipore
Sigma, Cat. No.
900
0.11
2
4017991MG)
Human vitronectin (Life
Technologies, Cat. No.
35
2.6
3/4
PHE0011)
Next, the standard dilutions were blocked with 5% non-fat milk (Nestle) in PBS
for one hour at room temperature before overnight incubation with primary antibodies
diluted in 5% milk at 4°C (Table 4). Following, three five-minute washes with 0.1%
Tween-20 in PBS were performed at room temperature with gentle agitation. The
standard dilutions were then incubated with secondary antibodies conjugated to IR dyes
(Table 4) diluted in 5% milk with 0.1% Tween-20 and 0.01% SDS for one hour at room
temperature to facilitate IR detection of adsorbed proteins. After two five-minute washes
with 0.1% Tween-20 in PBS and a final five-minute wash with PBS, the standard
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dilutions were scanned on the 680 and 800 nm channels of the Odyssey CLx IR Imaging
System (LI-COR) with automatic intensity adjustment to generate fluorescence for each
spot on the standard dilutions. Finally, using Image Studio version 5.x (LI-COR),
relative fluorescent intensities of the spots were acquired by placing circular markers over
the area of the spots.
To validate the method, known amounts of each protein (n = 3) within the
working ranges of the standard curves (Table 5) were applied to the PVDF membrane,
dried overnight, and processed for IR-based immunodetection as described for the
Table 4. Primary antibodies were paired for immunodetection of two adsorbed proteins
per template via two-color IR detection. The paired primary antibodies were from
different species while the secondary antibodies were from the same species.
Paired Protein
Primary Antibody Dilution Secondary Antibody Dilution
Detection
IRDye 680LT goat
Mouse anti-albumin
1:2000
anti-mouse (LI-COR, 1:20,000
(Abcam ab10241)
Part no. 926-68052)
Albumin and
IgG
IRDye 800CW goat
Rabbit anti-IgG
1:2000
anti-rabbit (LI-COR, 1:20,000
(Abcam ab109489)
Part no. 925-32211)
Mouse antiIRDye 680RD goat
complement C3
1:1000
anti-mouse (LI-COR, 1:20,000
Part no. 925-68070)
Complement C3 (Abcam ab11871)
and Fibronectin Rabbit antiIRDye 800CW goat
fibronectin (Abcam 1:1000
anti-rabbit (LI-COR, 1:20,000
ab32419)
Part no. 925-32211)
Mouse antiIRDye 680RD goat
complement C1Q
1:2000
anti-mouse (LI-COR, 1:20,000
(Invitrogen MA1Part no. 925-68070)
Complement
83963)
C1Q and IgM
IRDye 800CW goat
Rabbit anti-IgM
1:1000
anti-rabbit (LI-COR, 1:20,000
(Abcam ab212201)
Part no. 925-32211)
Mouse antiIRDye 680LT goat
vitronectin (Abcam 1:600
anti-mouse (LI-COR, 1:20,000
Vitronectin and
ab13413)
Part no. 926-68050)
Fibrinogen α
Rabbit antiIRDye 800CW goat
chain
fibrinogen α chain
1:2000
anti-rabbit (LI-COR, 1:20,000
(Abcam ab92572)
Part no. 925-32211)
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standard dilutions. Only four standard curves were validated based on data indicating that
four of the eight proteins of interest adsorbed on the electrospun templates, which is
detailed below.
Table 5. Known amounts of each protein were adsorbed to PVDF to validate the standard
curves. Each point was produced from three replicates.
Protein
Point 1 [ng] Point 2 [ng] Point 3 [ng] Point 4 [ng] Point 5 [ng]
Albumin
0
1
5
50
100
IgG
0
30
200
500
1000
IgM
0
1
50
400
800
Vitronectin
0
3
10
20
30
In Situ Protein Adsorption
For in situ protein adsorption, 6 mm diameter punches of the SD and LD
templates (n = 6) were disinfected with a 30-minute ethanol (Fisher Chemical, Cat. No.
A407-1) wash followed by three washes with 1x HBSS (Corning cellgro) for 10 minutes
each. The disinfected templates were then placed in a 96-well cell culture plate, and 150
µL of 0.2% normal pooled human serum (MP Biomedicals, LLC, Cat. No. 0823201) in
HBSS or 150 µL of HBSS were added to the templates. The templates were incubated at
37°C with 5% CO2 for 0.25, 0.5, 0.75, 1, 2, 3, and 6 hours. After each time point, the
serum solution was removed from the wells and discarded, and the templates were
washed with 1x PBS for 5 minutes with gentle agitation at room temperature to remove
non-adsorbed protein. The templates were then fixed and stored in 10% buffered formalin
at 4°C overnight until analysis.
IR-Based Immunodetection of Adsorbed Proteins on Templates
The adsorbed protein on the electrospun templates was quantified using the
standard curves for each protein. First, free aldehyde groups on the fixed templates were
quenched with three five-minute washes of 100 mM glycine in PBS with gentle agitation
63

at room temperature. Then, the templates were processed for IR-based immunodetection
as described for the standard curves. Each template was incubated with two primary and
secondary antibodies to facilitate detection of two adsorbed proteins per template (Table
4). Relative fluorescence of the templates incubated with HBSS only was subtracted from
the relative fluorescence of the templates incubated with serum to remove background
fluorescence. Finally, protein adsorption was normalized to the mass of the 6 mm
diameter punches.
Statistical Analysis
Data are presented as mean ± standard deviation. Fiber diameters and SAVRs
were analyzed with a two-tailed t-test with Welch’s correction. For the standard curves,
nonlinear regression was performed, and goodness of fit was assessed with a replicates
test for lack of fit. For validation of the IR-immunodetection assay, linear regression was
performed, and the coefficient of determination was calculated. Analysis of protein
adsorption was executed with a two-way ANOVA and Tukey multiple comparison
procedure. All statistical analyses were performed in GraphPad Prism 6 at a significance
level of 0.05.
Results
Electrospun Template Fiber Diameter Controls Surface Area
The low and high concentration PDO solutions resulted in electrospun templates
with SD fibers and LD fibers, respectively (Figure 12A-B). The SD templates had
significantly smaller (p < 0.05) fiber diameters with an average of 0.43 ± 0.20 µm
compared to the LD templates with fiber diameters of 1.93 ± 0.72 µm (Figure 12C). The
fiber diameters of the SD templates correlated to an average SAVR of 2.07 ± 0.33
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m2/cm3, which is significantly greater (p < 0.05) than the average SAVR for the LD
templates of 0.55 ± 0.07 m2/cm3 (Figure 12D). Because the SD templates have nearly 4times the surface area per volume, these data indicate that the SD templates have
significantly more surface area available for protein adsorption.

Figure 12. Electrospun SD and LD PDO templates. Representative SEMs of (A) SD and
(B) LD electrospun PDO templates (magnification = 1000x, scale bars = 30 µm). (C)
Fiber diameter of the SD templates is significantly smaller than the LD templates which
correlates to significantly greater (D) SAVR. Graphs show mean ± standard deviation.
* p < 0.05.
IR-Based Immunodetection Quantifies Protein Adsorption
For each protein, a standard curve was created to quantify adsorption through IRbased immunodetection. Figure 13 shows the standard curves with the nonlinear
regression for vitronectin, IgM, albumin, and IgG. There was no adsorption of
complement C1Q, complement C3, fibrinogen, and fibronectin detected on the
electrospun templates, so these standard curves are not shown. For vitronectin (Figure
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13A), the nonlinear regression (Equation 3) produced a well-fitting curve with no
evidence of an inadequate model from the lack of fit test (p = 0.99). Similar results were
obtained for IgM (Figure 13B, Equation 4, p = 0.98), albumin (Figure 13C, Equation 5, p
= 0.62) and IgG (Figure 13D, Equation 6, p = 0.65).

Figure 13. Standard curves generated from IR-based immunodetection. Dilutions of (A)
vitronectin, (B) IgM, (C) albumin, and (D) IgG were vacuum blotted onto PVDF
membranes, dried, and processed for detection with IR-based immunodetection. Each
point in the standard curves was generated from three replicates. Error bars represent
standard deviation.
𝑦=
𝑦=
𝑦=
𝑦=

115003𝑥
(57.53 + 𝑥)
43725𝑥
(292.1 + 𝑥)
13200𝑥
(0.89 + 𝑥)

− 373.6𝑥

y = relative fluorescence, x = ng of vitronectin

(3)

− 5.052𝑥

y = relative fluorescence, x = ng of IgM

(4)

y = relative fluorescence, x = ng of albumin

(5)

y = relative fluorescence, x = ng of IgG

(6)

+ 45.83𝑥

11247𝑥
(107.2 + 𝑥)

+ 2.84𝑥
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Additionally, the assay was validated for albumin, IgG, IgM, and vitronectin
(Figure 14) by adsorbing known amounts of each protein to PVDF membranes and
assessing the interpolation from the standard curves. For all four proteins, the linear
regressions for adsorbed protein versus the interpolated value from the standard curves
have slopes near 1.0 and high coefficients of determination, indicating that the assay
accurately quantifies the mass of adsorbed proteins. Together, these standard curves were
used to quantify adsorption of vitronectin, IgM, IgG, and albumin on the templates based
on relative IR fluorescence.

Figure 14. Validation of the IR-based immunodetection assay. Adsorption of known
amounts of (A) vitronectin, (B) IgM, (C) albumin, and (D) IgG were plotted against the
interpolated values from the standard curves. Each point was generated from three
replicates. Error bars represent standard deviation.
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SAVR Regulates In Situ Protein Adsorption
In order to highlight the differences in adsorption due to SAVR, the mass of
adsorbed protein was normalized to mass of the 6 mm diameter template punches.
Figures 15-18 show the results from the IR-based quantification of the in situ adsorption
of vitronectin, IgM, albumin, and IgG. There was no detection of complement C3,
complement C1Q, fibronectin, or fibrinogen. Notably, the Odyssey CLx Imaging System
utilizes two IR lasers that penetrate through 3D structures. This facilitates full-thickness
quantification of protein adsorption on the complex surface geometry of the electrospun
templates.
For vitronectin (Figure 15), adsorption was not detected until the 1-hour time
point for the LD templates and the 6-hour time point for the SD templates. Upon
adsorbing on the LD templates, the mass of vitronectin did not change over time. Despite
the delay on SD templates, the amount of vitronectin adsorption at 6 hours was
significantly greater (p < 0.05) than on the LD templates, indicating that the high SAVR
of the SD templates facilitated greater protein adsorption. Nonetheless, the adsorption of
vitronectin on both templates was not detectable until at least 1 hour after exposure to
serum. In the physiological environment, neutrophils have already swarmed to the site of
inflammation, clustered around the biomaterial, and began interacting and responding
within the first hour, which suggests that vitronectin adsorption may not play an integral
role in the initial template-induced release of NETs 12.
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Figure 15. Vitronectin adsorption on electrospun PDO templates. Data shown as mean ±
standard deviation from three independent experiments. # significant difference between
SD and LD templates (p < 0.05).
Figure 16 shows the results from the IR-based quantification of IgM adsorption.
The adsorption of IgM was not detected until the 0.50-hour time point for the SD
templates and the 0.75-hour time point for the LD templates. Adsorption on the SD
templates initially decreased between the 0.50 hour and 1 hour and then gradually
increased between the 2-hour and 6-hour time points, suggesting that the dynamics of
adsorption are temporal. At all time points, adsorption of IgM was greater on the SD
templates, and by 3 hours, it was significantly greater (p < 0.05) on the SD templates
compared to the LD templates. These results indicate that the high SAVR of the SD
templates promote greater protein adsorption compared to the LD templates. Nonetheless,
the relatively low levels of IgM adsorption, similar to those for vitronectin, suggest that
IgM does not significantly contribute to the template-induced release of NETs.
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Figure 16. IgM adsorption on electrospun PDO templates. Data shown as mean ±
standard deviation from three independent experiments. # significant difference between
SD and LD templates (p < 0.05), * significant difference from 0.25 through 2-hour time
points for SD (p < 0.05).
In contrast to vitronectin and IgM, albumin (Figure 17) was detected on the SD
and LD templates at all time points and increased significantly over time for both
templates. From 0.25 hours to 6 hours, there was greater adsorption on the SD templates
compared to the LD templates, and by 6 hours, albumin adsorption was significantly
greater on the SD templates compared to the LD templates (p < 0.05). While increasing
on both, the rate of albumin adsorption on the SD templates was nearly 2-times greater,
with an average increase of 270 ng per hour, compared to the LD templates, which
increased on average by 110 ng per hour. These data suggest that the high SAVR of the
SD templates accelerated the adsorption of albumin and resulted in greater total
adsorption over time. Because it was detected at all time points, it is possible that the
adsorption of albumin contributes to the regulation of the neutrophil response.
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Figure 17. Albumin adsorption on electrospun PDO templates. Data shown as mean ±
standard deviation from three independent experiments. * significant difference from
0.25, 0.50, and 0.75-hour time points (p < 0.05), ** significant difference from all other
time points for SD templates (p < 0.05), *** significant difference from 0.25 through 1hour time points for LD templates (p < 0.05), # significant difference between SD and
LD templates (p < 0.05).
Similar to albumin, IgG (Figure 18) was detected on the SD and LD templates at
all time points. However, by half an hour, adsorption of IgG was significantly greater on
the SD templates compared to the LD templates (p < 0.05). Though it increased
significantly on the SD templates, IgG adsorption did not significantly increase over time
on the LD templates. The average rate of adsorption on the SD templates was 20,200 ng
per hour compared to 5,400 ng per hour for the LD templates. The strikingly different
rates of adsorption resulted in nearly 4-times greater IgG adsorption on the SD templates
by half an hour. These results suggest that significantly more IgG is adsorbed on the SD
templates in the critical first hour after exposure to serum, which may contribute to the
contrasting cell responses to SD and LD templates. Furthermore, compared to albumin,
IgG adsorption on the SD and LD templates over the first hour is 200-times greater and
100-times greater, respectively. Based on the high magnitude of IgG adsorption, these
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data indicate that IgG may play a significant role in directing the differential release of
NETs in response to electrospun polymeric biomaterials.

Figure 18. IgG adsorption on electrospun PDO templates. Data shown as mean ±
standard deviation from three independent experiments. ** significant difference from all
other time points for SD templates (p < 0.05), # significant difference between SD and
LD templates (p < 0.05).
Finally, Figure 19 shows the total protein adsorption on the templates based on
the detectable and quantifiable adsorption of vitronectin, IgM, albumin, and IgG. For all
time points, total protein adsorption was greater on the SD templates compared to the LD
templates, and by half an hour, the difference was significant (p < 0.05). While the
average rate of adsorption on the LD templates was 14,000 ng per hour, the average rate
of adsorption on the SD templates was 40,000 ng per hour. These data are dominated by
the adsorption of IgG and suggest that in general, the high SAVR of the SD templates
facilitates greater protein adsorption compared to the LD templates. Taken together, the
IR-based immunodetection of our eight proteins of interest indicate that the significant
adsorption of IgG on the surface of the electrospun SD templates is driven by SAVR,
which may orchestrate outside-in signaling to stimulate NET release from interacting
neutrophils.
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Figure 19. Total protein adsorption on electrospun PDO templates. The graph shows
mean ± standard deviation from three independent experiments. ** indicates a significant
difference from all other time points for SD templates (p < 0.05), # indicates a significant
difference between SD and LD templates (p < 0.05).
Discussion
The neutrophil is increasingly recognized as a dynamic, central player in the
foreign body response to a biomaterial. Recent work examining neutrophil interactions
with electrospun tissue regeneration templates has shown that the architecture of the
electrospun templates differentially regulates the release of NETs and that an abundance
of NETs impairs tissue regeneration in vivo 31. Because neutrophils represent the first line
of defense interacting with and responding to an electrospun template, it is expected that
their responses, including NET release, have significant implications in the
microenvironment modulation around a biomaterial and the progression of templateguided in situ tissue regeneration. In this study, we aimed to characterize protein
adsorption on SD and LD electrospun templates to begin understanding if protein
adsorption drives the differential engagement of neutrophil receptors to regulate NET
release.
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Electrospun PDO templates were fabricated from low and high concentration
solutions to generate SD and LD templates with significantly different fiber diameters
and SAVRs. In order to make comparisons, the SD and LD templates for this study were
fabricated with the same average fiber diameters of the templates used to evaluate NET
release in our previous work 31. The SD templates had a fiber diameter that was nearly 4times smaller than the LD templates, correlating to a SAVR that was nearly 4-times
greater. Therefore, the significantly smaller fiber diameter of the SD templates provided
more surface area for the potential adsorption of protein per unit mass of the electrospun
templates.
Using an IR-based immunodetection which was validated for protein
quantification, we examined the adsorption of eight proteins: (1) albumin, (2)
complement C1Q, (3) complement C3, (4) IgG, (5) IgM, (6) vitronectin, (7) fibrinogen,
and (8) fibronectin. While other proteins are present in the serum which may be adsorbed
to the templates, it is not feasible to study all protein constituents, and these eight proteins
were selected for their high concentrations in serum and important roles in innate
immunity. To replicate the methods from our previous experiments, we incubated the
templates with commercially available 0.2% serum in HBSS that is produced by clotting
31

. Because our aim was to begin understanding how protein adsorption was regulated by

SAVR and its potential implications in NET release, we did not quantify adsorption with
purified protein solutions. Purified protein solutions would likely exhibit different
adsorption profiles for each of the eight proteins, given that the Vroman effect is partly
dependent on which proteins are present and their concentrations. Using purified
solutions would undermine the complexity of an in vitro and in vivo microenvironment
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with a milieu of proteins 228. Additionally, the concentration of each protein in the serum
was not quantified before the experiments because our goal was not to determine what
percentage of available protein adsorbs to the templates. However, we did verify that the
total protein concentration for the serum fell within the normal range of 6.0 – 8.0 g/dL
228

.
The results indicate that there was no detectable adsorption of complement C3,

complement C1Q, fibrinogen, or fibronectin on the SD and LD templates. Since the
experiment utilized 0.2% serum, which is depleted of most fibrinogen and fibronectin
during coagulation, a lack of fibrinogen and fibronectin adsorption onto the templates
was not surprising 229. In addition, neither complement C3 or complement C1Q
adsorption was detected on the SD or LD templates. Despite their significant roles in
innate immunity, the lack of complement adsorption may be due to their low affinity for
the material surface and their relatively low concentrations in serum, which cannot
compete with the high concentrations of other proteins such as albumin and IgG 228, 230232

. For vitronectin, IgM, albumin, and IgG, the results indicate that SAVR regulates

protein adsorption and that the high surface area of the SD templates adsorbs
significantly more protein compared to the LD templates with low surface area. These
results were anticipated since it is established that surface area regulates protein
adsorption on biomaterial surfaces. Furthermore, no significant desorption of these
proteins was observed over the 6-hour study, indicating that their affinity for the material
surface was great enough to prevent competitive displacement by other high molecular
weight proteins in this specified time frame.
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Vitronectin, a low molecular weight glycoprotein, plays a role in cell adhesion
and spreading. With regards to the neutrophil, it has been shown to modulate adhesion,
contribute to pro-inflammatory processes, and inhibit neutrophil apoptosis through
integrin-dependent signaling pathways 233-235. The adsorption of vitronectin to the
electrospun templates was delayed until 1 hour after exposure to serum on the LD
templates and 6 hours after exposure to serum on the SD templates. In addition, the
magnitude of adsorption was lower compared to other detected proteins. Given this
information, the adsorption of vitronectin on the electrospun templates likely does not
regulate template-induced NETosis, but may influence neutrophil viability and thus their
ability to modulate the microenvironment through other cell responses such as
degranulation and the secretion of cytokines and chemokines 23, 49.
Similar to vitronectin, the adsorption of IgM was delayed until half an hour after
exposure to the serum for the SD templates and 0.75 hour after exposure to the serum for
the LD templates with relatively low levels of adsorption occurring on both the SD and
LD templates. Compared to other immunoglobulins, IgM only accounts for 10-15% of
the antibodies present in the serum, which together with its affinity for PDO, may explain
the delayed, low levels of adsorption 236. Even though IgM can play a central role in
complement activation and thus the neutrophil response to the biomaterial, our data
suggest it is likely not a central player in the regulation of NET release on the surface of
the electrospun templates 230.
Contrasting to vitronectin and IgM, both albumin and IgG adsorbed rapidly and
readily to the surface of the SD and LD templates. Albumin adsorption increased over
time on the templates and was significantly greater on the SD templates, suggesting that
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the high SAVR facilitated greater protein adsorption. As a non-adhesive protein that
plays an integral role in maintaining oncotic pressure, albumin has been reported to work
synergistically with adhesive proteins to regulate cell adhesion and spreading by
exposing binding sites on the adhesive proteins 237. In the case of neutrophil interactions,
albumin has been shown to promote adhesion but prevent spreading and the generation of
hydrogen peroxide 238. Recently, Neubert et al. showed that albumin actually inhibits
NET release when neutrophils are treated with pharmacological stimuli and cultured in
the presence of albumin 239. Therefore, although significantly more albumin adsorbed to
the surface of the SD templates, these data suggest that albumin does not play a direct
role in regulating NET release, and another dominant protein on the surface of the
material may be responsible for stimulating NETosis.
In fact, compared to albumin, 100- to 200-times more IgG adsorbed on the
surface of the electrospun templates over the first hour, suggesting that the greatest
proportion of the surface area is covered by IgG. These results are not surprising because
IgG is the second most abundant protein in serum, present at a concentration of 11
mg/mL, and is the most abundant immunoglobulin in circulation 240. The absorption was
also significantly greater on the surface of the SD templates by half an hour, and the rate
of adsorption over the 6-hour study was 4 times greater on the SD templates compared to
the LD templates. These data indicate that IgG is the dominant protein on the surface of
the SD templates, potentially regulating the outside-in signaling leading to the differential
release of NETs.
We are not the first to quantify IgG adsorption on the surface of biomaterials. IgG
has previously been shown to adsorb readily to the surface of biomaterials through strong
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hydrophobic interactions that can alter its secondary structure 16. These strong
hydrophobic interactions inhibit its desorption from the surface of a material, which is
consistent with previous work showing that the dynamics of the Vroman effect are not as
prominent on hydrophobic surfaces like our PDO templates 241, 242. On the surface of
hydrophobic TeflonTM, Vermeer et al. found that IgG adsorbs through denaturation of the
Fab fragments, leaving the Fc fragment unperturbed for potential recognition by cell
receptors and outside-in signaling 243.
The neutrophil expresses two types of FcγRs, which play a major role in
mediating phagocytosis and the secretion of inflammatory mediators 244. In resting
neutrophils, FcγRIIIb binds most of the ligand on the surface of the antibody-coated
substrate 245. However, when a neutrophil is activated during inflammation, a high
number of strongly signaling FcγRIIa receptors engage the IgG-covered target, working
synergistically with FcγRIIIb to initiate inflammatory signaling 246. Traditionally, this
signaling promotes the phagocytosis of the noxious stimuli, but recent work has shown
that opsonization of beads with IgG promotes a rapid increase in NET release that
functions collaboratively with phagocytosis 67. It is plausible that because our electrospun
materials cannot be phagocytosed, all of the signals generated by FcγR ligation are
transduced into rapid and abundant NET release on the IgG-coated SD templates.
Moreover, recent work studying TLR-FcγR crosstalk in neutrophils has shown that
engagement of TLR7/8 by soluble ICs induces shedding of FcγRIIa 247. The shedding of
FcγRIIa reduces the phagocytic capacity of neutrophils and shifts the signaling toward
NETosis. Together, these studies support our finding that the SAVR-dependent
adsorption of IgG may be the major polarizing event occurring on electrospun templates,
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resulting in the engagement of cell receptors that up-regulate the release of NETs on SD
templates.
In order to determine if IgG adsorption is intimately linked to biomaterial-induced
NETosis, future work will include investigating how IgG adsorbs to the electrospun PDO
templates and if the adsorption induces conformational changes. In addition, modulating
the composition of the serum or inhibiting the activity of the FcγRs on the neutrophils
will be critical for linking receptor ligation to NET release. Upon understanding the role
of IgG, the surface properties of the electrospun templates can be modulated to regulate
adsorption and possible induced conformational changes in the initial critical hours of the
acute inflammatory response. In summary, we have shown that the adsorption of protein
from human serum is regulated by electrospun template SAVR and that the high surface
area of the SD templates significantly increases protein adsorption. Furthermore, we
found that IgG adsorbs abundantly to the SD templates, which may drive outside-in
signaling to up-regulate the release of NETs, a topic of further investigation. Due to the
increasingly acknowledged role of the neutrophil in functional tissue regeneration, this
work provides a foundation for the future development of biomaterials that harness the
dynamic responses of the neutrophil to promote wound healing and accelerate their
translation into the clinical setting.
Conclusion
The release of NETs on the surface of electrospun tissue regeneration templates
may function as a significant preconditioning event that orchestrates the progression of
the foreign body response and potential for functional tissue regeneration. Recent work
shows that SD templates, which have high SAVR, up-regulate the release of NETs
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compared to LD fibers, resulting in impaired tissue regeneration. In this study, we found
that SD templates significantly increase the adsorption of soluble serum protein.
Additionally, we showed that IgG adsorbs rapidly on the surface of SD templates and at
the greatest quantity compared to other proteins. Given the role of IgG in innate
immunity and the release of NETs, these findings suggest that IgG may be linked to the
differential modulation of NETosis on electrospun templates as a function of SAVR.
Ultimately, understanding how protein adsorption on electrospun templates regulates
neutrophil interactions will enhance the design of immunomodulatory biomaterials that
utilize the neutrophil as an initiator and driver of biomaterial-guided tissue regeneration.
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CHAPTER 5
HUMAN NEUTROPHIL FCΓRIIIB REGULATES NEUTROPHIL
EXTRACELLULAR TRAP (NET) RELEASE IN RESPONSE TO
ELECTROSPUN POLYDIOXANONE BIOMATERIALS
Introduction
For several decades, electrospun biomaterials have been used to create ECM
analogs for a variety of tissue engineering applications 2, 4, 11. Because electrospinning
systems are relatively easy to build and adapt to large-scale production, electrospinning is
a cost-effective fabrication technique for producing non-woven substrates of continuous
fibers in large quantities. Furthermore, electrospun biomaterials offer vast versatility and
adaptability for tissue engineering, including in vitro and in situ tissue regeneration. For
in situ tissue regeneration, the purpose of the electrospun biomaterial is to guide the body
as a bioreactor to stimulate the regenerative capacity of autologous cells, tissues, and
organs 1. Given the reliance on autologous cells to infiltrate the biomaterial, the
inflammatory and immune response to the electrospun biomaterial are of utmost
importance for biomaterial-guided in situ tissue regeneration 26.
In recent years, our group has focused on characterizing and understanding the
neutrophil response to electrospun biomaterials 17, 31, 76, 88, 248, 249. Peaking in numbers near
24 to 48 hours after implantation, neutrophils are the first dynamic cell population
recruited to an electrospun biomaterial 8. Their rapid and numerous recruitment suggests
an important role in preconditioning the inflammatory state of the local environment,
which may have a long-term impact on the potential for tissue regeneration 181, 250. At an

inflammatory site, neutrophils influence the tissue milieu through several effector
functions, including the release of NETs 27.
NETs are extracellular structures composed of chromatin filaments, histones, and
proteolytic enzymes normally found within the cytoplasm and granules 27. Although they
are integral to pathogen containment 27, 50, 141, NETs can also be tissue destructive,
resulting in prolonged inflammation and pathogenesis due to aberrant enzyme release and
histone toxicity 216, 223. In fact, NETs have been implicated in several non-infectious
inflammatory diseases, such as autoimmune disorders, thrombosis, cancer, and tissue
fibrosis 100, 134, 162, 227, 251, 252. Because of this, the potential deleterious effects of NETs
have recently garnered attention in the field of biomaterials. Our group and others have
shown that the release of NETs on the surface of a biomaterial is a significant
preconditioning event that promotes inflammation and fibrosis 21, 31, 80. In particular, we
found that the fiber size of electrospun PDO regulates NET release with small fiber
diameters significantly up-regulating NET release and fibrotic encapsulation relative to
large fiber diameters. Together, these data suggest that one potential strategy to enhance
biomaterial-guided in situ tissue regeneration is to regulate NET formation and its
adverse effects through biomaterial design.
A variety of artificial and physiological stimuli have been shown to regulate NET
release, including pharmacological compounds like PMA that act intracellularly and
ligands that initiate outside-in signaling through various receptors 84, 136, 253. Previously,
we evaluated the adsorption of eight serum proteins on the surface of the electrospun
PDO to begin elucidating the fiber size-dependent stimuli regulating NET formation on
our biomaterials 114. We found that nearly 2-times more IgG adsorbs to the surface of
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small fiber biomaterials compared to the large fiber biomaterials within 15 minutes and
that IgG adsorption was 100- to 200-times greater than any other protein, suggesting IgG
signaling may increase the propensity to form NETs on small fibers. In fact, neutrophils
constitutively express two FcγRs for IgG, FcγRIIa (CD32a) and FcγRIIIb (CD16b) 245.
Both have been found to participate in the release of NETs stimulated by ICs 129, 130, 135,
254, 255

. Moreover, activated neutrophils express FcγRI (CD64) within 4-6 hours of

activation 256-258, and Mac-1 (CD11b/CD18) can cooperate with FcγRs in the release of
IC-induced NETs 129. Given the prominent surface adsorption of IgG on our electrospun
biomaterials, we hypothesize that IgG and FcγR signaling may be intimately linked to
biomaterial-induced NET release.
In this work, we explored the role of IgG and FcγR signaling in electrospun
biomaterial-induced NET release with human neutrophils. The propensity to release
NETs was increased and decreased by increasing and decreasing adsorbed IgG,
respectively, suggesting a functional link between IgG and NET formation. Then,
blocking of FcγRIIIb, but not FcγRI, FcγRIIa, or Mac-1 (CD11b/CD18), resulted in a
decrease in fiber-size dependent NET release, indicating a specific receptor mediated
neutrophil response. Finally, incubation with 5Z-7-oxozeaenol, an inhibitor of FcγRIIIb
signaling through TAK1 254, led to a decrease in NET formation on both biomaterials.
Together, these data show for the first time that surface adsorbed IgG, ligation of
FcγRIIIb, and activation of TAK1 are involved in biomaterial-induced NET release. Our
results indicate that regulation of IgG adsorption and FcγR signaling in neutrophils may
be used to modulate NET release in biomaterial-guided tissue regeneration applications.
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Materials and Methods
Electrospinning Biomaterials
Biomaterials were fabricated from PDO by electrospinning as previously
described 114. Briefly, PDO (Cat. No. 6100, Bezwada Biomedical, Hillsborough, NJ,
USA) was dissolved overnight in HFP (Cat. No. 003409-1KG, Oakwood Products, Estill,
SC, USA) at 50 and 120 mg/mL and electrospun with optimized parameters (Table 6)
from a 5 mL syringe connected to an 18-gauge and 5 cm long blunt needle. Fibers were
collected on a stainless steel, 100 mm long x 25 mm diameter cylindrical mandrel that
was grounded and rotating at 1250 rpm while oscillating horizontally at 6.5 cm/s over 13
cm. For experiments, 8 mm diameter discs of the biomaterials, ranging in thickness from
0.05 to 0.10 mm, were cut using a biopsy punch (Cat. No. P825, Acuderm Inc., Fr.
Lauderdale, FL, USA) and stored in a desiccator until use. Prior to cell culture, the
biomaterials were disinfected by ultraviolet irradiation using an 8 W lamp (Cat. No.
EN280L, Spectroline, Westbury, NY, USA) at a working distance of 9.5 cm. The
samples were disinfected for 10 minutes on each side in a sterile, laminar flow hood and
kept disinfected for cell culture.
Table 6. Electrospun biomaterials were fabricated with optimized parameters.
Fiber Size
PDO Concentration Flow Rate Airgap
Applied
(mg/mL)
(mL/h)
Distance (cm) Voltage (+ kV)
Small Fibers
50
0.55
28
25
Large Fibers
120
4.0
28
28
Biomaterial Characterization
SEMs were acquired and analyzed in FibraQuant 1.3 software (nanoTemplate
Technologies, LLC) to quantify fiber diameter as previously described 76. Briefly, 150
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semi-automated random measurements per SEM were taken to determine the average and
corresponding standard deviation for fiber diameter.
Isolation and Culture of Primary Human Neutrophils
Heparinized, whole peripheral blood was obtained by venipuncture from
unidentified, healthy donors from Tennessee Blood Services. Since purchased or donated
samples are not traceable back to the donor, it does not qualify as human subjects
research as determined by the University of Memphis Institutional Review Board on
November 22, 2016. Neutrophils were then isolated by density separation as previously
described 31, 76, 259. Once isolated, neutrophils were resuspended in HBSS without
calcium, magnesium, or phenol red (Cat. No. 14175095, Thermo Fisher Scientific,
Waltham, MA, USA) and with 10 mM HEPES and 0.2% autologous serum at a
concentration of 1 million neutrophils/mL. After placing the disinfected biomaterials (n =
4) in a 96-well plate, 40 µL of the cell culture media were added to each well to hydrate
the biomaterials. For TCP wells (n = 4), 30 µL of the cell culture media were added prior
to cell seeding. Subsequently, 100 µL of the cell suspension containing 100,000
neutrophils were added to each well. All wells then received 10 µL of heparin (Cat. No.
H3393, Sigma Aldrich, St. Louis, MO, USA) at a final well concentration of 10 U/mL to
dissociate NET-associated MPO as previously described 50, 88. The positive and negative
controls were TCP with 100 nM PMA (Cat. No. P8139, Sigma Aldrich, St. Louis, MO,
USA) and TCP with 0.15% DMSO, respectively. The neutrophils were cultured on the
biomaterials at 37°C and 5% CO2 for 3 hours, and the TCP wells were cultured for 6
hours. Following culture, the samples were placed on ice for 10 minutes to inhibit
neutrophil stimulation prior to fixing in 10% buffered formalin (Cat. No. SF1004,
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Thermo Fisher Scientific, Waltham, MA, USA) for 1 hour at room temperature. Three
experiments were performed with unique donors (2 males, between 18 and 40 years of
age, and 1 female, 25 years of age), and the results were pooled for analysis.
Addition of IgG to Biomaterials
To examine the dose-dependent effects of IgG on NET release, the biomaterials
(n = 4) were hydrated with 1, 100, or 440 µg of human IgG (Cat. No. 31154, Thermo
Fisher Scientific, Waltham, MA, USA) in 40 µL of HBSS for cell culture. The mass of 1,
100, and 440 µg of IgG were selected to mimic the mass of IgG in 40 µL of cell culture
media, the mass of IgG needed to saturate the biomaterial surfaces, and the mass of IgG
at physiological concentration, respectively. Controls were biomaterials hydrated with 40
µL of cell culture media.
Depletion of IgG from Biomaterials
To reduce the mass of surface-adsorbed IgG, IgG was depleted from autologous
serum using DynabeadsTM Protein G (Cat. No. 10004D, Thermo Fisher Scientific,
Waltham, MA, USA) 260. Prior to use, DynabeadsTM Protein G were dialyzed in 12,00014,000 molecular weight cutoff dialysis tubing in 1 L of PBS for 48 hours at 4°C with
gentle agitation. The PBS was refreshed every 12 hours. After dialysis, 100 µL of
DynabeadsTM were added to the wells on a 96-well plate, placed on a handheld magnetic
plate washer (Cat. No. NC1403679, Thermo Fisher Scientific, Waltham, MA, US), and
washed five times with 250 µL of HBSS. Once the final wash was removed, 250 µL of
0.2% autologous serum in cell culture media was added to the DynabeadsTM and
incubated for 30 minutes at room temperature with gentle agitation. Human IgG (Cat. No.
31154, Thermo Fisher Scientific, Waltham, MA, USA) diluted to a concentration of 0.2%
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in HBSS was used as an isotype control to validate the depletion. After incubation, the
IgG-depleted supernatant was collected and sterile filtered with a 0.2 µM sterile filter.
Subsequently, the biomaterials (n = 4) were hydrated with 40 µL of the IgG-depleted cell
culture media prior to seeding the neutrophils. Controls were biomaterials hydrated with
40 µL of complete cell culture media containing 0.2% serum.
Validation of IgG Depletion
The depletion of IgG from autologous serum and the biomaterial surface was
validated using immunodetection to quantify IgG as previously described 114. Briefly, 30
µL of 0.2% autologous serum, IgG-depleted autologous serum, 0.2% isotype control IgG,
and IgG-depleted isotype control (n = 3) were vacuum blotted on Immobilon-FL PVDF
membrane (IPFL00005, EMD Millipore Corporation, Burlington, MA, USA) and dried
overnight before processing and immunodetection. Free aldehyde groups on the fixed
biomaterials were quenched with 100 mM glycine, and the PVDF membranes and
biomaterials were then blocked and incubated with rabbit anti-IgG (ab109489, Abcam,
Cambridge, MA, USA) followed by IRDye 800CW goat anti-rabbit (Part No. 925-32211,
LI-COR, Lincoln, NE, USA). After washing, the PVDF membranes and biomaterials
were scanned on the 800 nm channel of the Odyssey CLx IR Imaging System (LI-COR).
The relative fluorescence of biomaterials incubated with HBSS only was subtracted from
the relative fluorescence of the biomaterials from cell culture to remove background
fluorescence, and the mass of IgG was interpolated from a standard curve. For the
biomaterials, IgG adsorption was normalized to the mass of the 8-mm diameter sample.
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Receptor Blocking
To block receptors, neutrophils were incubated with 10 µg/mL Fab blocking
fragments for FcγRI (Cat. No. 216-580, Ancell, Bayport, MN, USA), FcγRIIa (Cat. No.
181-580, Ancell, Bayport, MN, USA), and FcγRIIIb (Cat. No. 165-580, Ancell, Bayport,
MN, USA) and a blocking antibody for CD11b (Cat. No. BDB553308, Fisher Scientific,
Waltham, MA, USA) at 37°C for 10 minutes. IgG Fab (Cat. No. 278-580, Ancell,
Bayport, MN, USA) and IgG (Cat. No 401401, BioLegend, San Diego, CA, USA) were
used as isotype controls. After resuspending, neutrophils were seeded on the biomaterials
(n = 4) that were hydrated with 40 µL of cell culture media. Untreated cells seeded on the
biomaterials (n = 4) served as controls.
Inhibition of TAK1
In order to inhibit signaling through TAK1, neutrophils were incubated with 10
nM 5Z-7-oxozeaenol (Cat. No. 49-961-01MG, Fisher Scientific, Waltham, MA, USA) or
0.1% DMSO as a negative control on ice for 30 minutes 254. After resuspending,
neutrophils were seeded on the biomaterials (n = 6) that were hydrated with 40 µL of cell
culture media. Untreated cells seeded on the biomaterials (n = 4) served as controls.
Quantification of NET Release
The release of NETs was quantified by measuring the concentration of NETdissociated MPO in the cell culture supernatant using an MPO Human Instant ELISA Kit
(Cat. No. BMS2038INST, Thermo Fisher Scientific, Waltham, MA, USA) 50, 88. Briefly,
the cell culture supernatants were transferred to a clean cell culture plate and centrifuged
at 500 xg for 5 minutes to pellet any free neutrophils. Then, 50 µL of the centrifuged
supernatant was collected and assayed using the MPO Human Instant ELISA Kit
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following manufacturer instructions. To quantify percent NET release on the
biomaterials, the concentration of MPO was normalized to the concentration of MPO in
the TCP positive control at 6 hours, representing maximum NET release.
Fluorescence Microscopy
Samples were stained with 5 µM SYTOX orange (Cat. No. S34861, Thermo
Fisher Scientific, Waltham, MA, USA) and NucBlue™ Fixed Cell ReadyProbes™
Reagent (DAPI, Cat. No. R37606, Thermo Fisher Scientific, Waltham, MA, USA) and
imaged as previously described 88. Samples were incubated sequentially for 5 minutes at
room temperature with each stain. Three washes with PBS for 5 minutes each were
performed between each stain. The stained cells and NETs were visualized on an
Olympus BX43 fluorescent microscope, and images were acquired in cellSens Standard
1.9 (Olympus Corp.). After image acquisition, contrast was enhanced using the
automated function in cellSens.
Statistical Analysis
Statistically significant differences between fiber diameters were determined
using a Mann-Whitney test. Statistical differences for the depletion of IgG were
determined using a Kruskal-Wallis test with Dunn’s multiple comparisons procedure. All
other differences were tested with an ANOVA and Holm-Sidak’s multiple comparisons
test. Statistical analyses were performed in Prism version 8.4.3 (GraphPad Software, San
Diego, CA, USA) at a significance level of 0.05. Data are reported as mean ± standard
deviation.
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Results
Electrospun PDO Biomaterials Were Fabricated with Small and Large Fibers
PDO was electrospun to create small and large fibers (Figure 20A). The average
fiber diameters for the small and large fibers are 0.38 ± 0.10 µm and 2.1 ± 0.36 µm,
respectively (Figure 20B). The small fiber biomaterials up-regulate the release of NETs
while absorbing 2-times more IgG on their surface compared to large fibers, suggesting a
role for increased IgG signaling in biomaterial-induced NET release 31, 114. As in our prior
work, these small and large fiber electrospun biomaterials allow us to further probe the
role of IgG in biomaterial-induced NET release.

Figure 20. Electrospun PDO biomaterials were fabricated with small and large fibers.
(A) Representative SEMs of the small and large fiber biomaterials. Micrographs were
acquired at 1000x magnification and scale bars are 30 µm. (B) Fiber diameters of the
electrospun biomaterials. Measurements (n = 150) were taken in FibraQuant 1.3 software.
* p < 0.0001 was determined using a Mann-Whitney test.
IgG Increases NET Release
Neutrophils were isolated from the whole blood of healthy donors and seeded on
electrospun biomaterials with increasing masses of IgG to examine the potential
stimulatory role of IgG in biomaterial-induced NET release (Figure 21A). As expected,
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neutrophils had an increased propensity to release NETs on the small fibers compared to
the large fibers (Figure 21B) with nearly 2-times the release of NETs on small fibers.
With the addition of 1 µg of IgG, the release of NETs was similar to the level of the
controls on both small and large fibers. With the addition of 100 µg of IgG to saturate the
surface of the biomaterials, NET release was significantly increased on both the small
and large fiber biomaterials. Moreover, the release of NETs on the large fibers was
increased to the level of the small fibers, indicating a stimulatory effect for IgG. The
trends were similar with the addition of 440 µg of IgG, or IgG at physiological
concentration, but there was no further increase in NET release observed. Together, these
dose-response data indicate that IgG stimulates biomaterial-induced NET release.
Depleting IgG Decreases NET Release
In addition to stimulating NET release with the addition of IgG, we also examined
if the depletion of IgG from autologous serum would attenuate NET release. First, we
developed a method to deplete IgG using DynabeadsTM protein G (Figure 22A). For both
an isotype control of IgG and the autologous serum, our depletion protocol resulted in
greater than 97% reduction in IgG concentration. For the isotype control, the
concentration dropped from 11.1 ± 4.02 mg/mL to 0.30 ± 0.03 mg/mL. For the
autologous serum, the concentration was reduced from 10.9 ± 2.78 mg/mL to 0.08 ± 0.05
mg/mL. To verify that this reduction translated to a reduction in biomaterial surfaceadsorbed IgG, we quantified IgG adsorption on the small and large fibers after culture
with neutrophils (Figure 22B). As expected, nearly 2-times the mass of IgG was adsorbed
on the small electrospun fibers compared to the large fibers when the biomaterials were
hydrated with cell culture media containing 0.2% autologous serum. However, when the
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biomaterials were hydrated with the IgG-depleted serum, the adsorption of IgG was
significantly reduced on both small and large fibers, verifying that the depletion of IgG
from the cell culture media translates to reduced surface adsorption. We then quantified
the release of NETs in response to the decreased IgG adsorption (Figure 22C) and found
that the release of NETs trended towards a decrease on the small fibers, but did not
change on the large fibers (Figure 22D).
Blocking FcγIIIb Decreases Biomaterial-Induced NET Release
Next, we blocked FcγRI, FcγRIIa, FcγRIIIb, and CD11b to test their potential
contribution to NET release. On the small fiber biomaterials (Figure 23A and C), of the
control whereas blocking of FcγRI, FcγRIIa, and CD11b resulted in no change in NET
release. Contrastingly, NET release was near equivalent on the large fiber biomaterials
with no change in NET release upon blocking any of the receptors (Figure 23B and D).
Given that blocking of FcγRIIIb on the small fiber biomaterials reduced NET release to
the level of the large fiber biomaterials, the data suggest that ligation of FcγRIIIb and its
subsequent signaling are involved in biomaterial-induced NET release.
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Figure 21. Increasing IgG on the electrospun biomaterials increases NET release. (A)
Fluorescent micrographs of neutrophils on the electrospun biomaterials at 3 hours after
seeding. Staining of NETs (red) and nuclei (purple) reveals that increasing IgG upregulates NET release independent of electrospun fiber size. Scale bar is 50 µm. (B)
Percent NET release at 3 hours as quantified by the ELISA for NET-disassociated MPO.
The quantification of percent NET release (n = 4) indicates that increasing IgG on the
biomaterials stimulates NET release with a maximum stimulatory effect upon saturation
of the material surface with 100 µg of IgG. The data represent the mean ± standard
deviation of three independent experiments with unique donors. * p < 0.05 and ** p <
0.0001 were determined using an ANOVA and Holm-Sidak’s multiple comparisons test.
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Figure 22. Decreased IgG adsorption decreases NET release on the small but not large
fiber electrospun biomaterials. (A) Concentration of IgG in isotype control (n = 3) and
serum (n = 3) before and after depletion with DynabeadsTM protein G. The depletion
procedure reduced the concentration of IgG by 97.4% and 99.3% for the isotype control
and serum, respectively. The stock concentration of the isotype control was 11 mg/mL. *
p < 0.05 was determined using a Kruskal-Wallis test with Dunn’s multiple comparisons
procedure. (B) IgG adsorption on the electrospun biomaterials after 3-hour culture with
neutrophils. The controls hydrated with cell culture media (n = 4) adsorbed significantly
more IgG compared to the samples hydrated with IgG-depleted cell culture media (n = 4).
** p < 0.0001 was determined using an ANOVA and Holm-Sidak’s multiple
comparisons test. (C) Fluorescent micrographs of neutrophils on the electrospun
biomaterials at 3 hours after seeding. Staining of NETs (red) and nuclei (purple) reveals
that decreasing IgG down-regulates NET release on small fibers. Scale bar is 50 µm. (D)
Percent NET release at 3 hours as quantified by the ELISA for NET-disassociated MPO.
The quantification of percent NET release (n = 4) indicates that decreasing IgG on the
small fiber biomaterials decreases NET release. * p < 0.05 was determined using an
ANOVA and Holm-Sidak’s multiple comparisons test. For all graphs, the data represent
the mean ± standard deviation of three independent experiments with unique donors.
blocking of FcγRIIIb led to a significant reduction in NET release to approximately half
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Figure 23. Blocking FcγIIIb decreases biomaterial-induced NET release on small but not
large fiber biomaterials. (A and B) Fluorescent micrographs of neutrophils on the
electrospun biomaterials at 3 hours after seeding. NETs are shown in red and nuclei in
purple. Scale bars are 50 µm. (C and D) Percent NET release at 3 hours as quantified by
the ELISA for NET-disassociated MPO. The quantification of percent NET release (n =
4) indicates that blocking FcγIIIb on the small fiber biomaterials significantly reduces
NET formation whereas no effect is observed on the large fiber biomaterials. The data
represent the mean ± standard deviation of three independent experiments with unique
donors. * p < 0.05 was determined using an ANOVA and Holm-Sidak’s multiple
comparisons test.
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Inhibition of FcγRIIIb Signaling through TAK1 Attenuates NET Release
To further verify the involvement of FcγIIIb in biomaterial-induced NET release,
we inhibited TAK1, an enzyme required for FcγIIIb signaling in NET release 254.
Inhibition of TAK1 with the selective inhibitor 5Z-7-oxozeaenol led to a significant
reduction in NET release on both the small and large fiber biomaterials (Figure 24A and
B). On the small fibers, NET release decreased from 13.5 ± 4.65% to 4.28 ± 2.67%, a
two-fold decrease. On the large fibers, the release of NETs was reduced from 7.24 ±
1.97% to 3.30 ± 0.62%, which is roughly the same level of NET release as the TCP
control. Taken together, these data indicate ligation of FcγIIIb with IgG and subsequent
signaling through TAK1 participate in electrospun biomaterial-induced NET release.

Figure 24. Inhibition of FcγIIIb signaling through TAKI attenuates NET release on both
small and large fiber biomaterials. (A) Fluorescent micrographs of neutrophils on the
electrospun biomaterials at 3 hours after seeding. NETs are shown in red and nuclei in
purple. The scale bar is 50 µm. (B) Percent NET release at 3 hours as quantified by the
ELISA for NET-disassociated MPO. The quantification of percent NET release (n = 6)
indicates that inhibition of TAKI reduces NET formation on both the small and large
fiber electrospun biomaterials. The data represent the mean ± standard deviation of three
independent experiments with unique donors. * p < 0.05 and ** p < 0.0001 were
determined using an ANOVA and Holm-Sidak’s multiple comparisons test.
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Discussion
Electrospun biomaterials offer putative advantages for in situ tissue engineering
applications because of their versatile biomimetic structure, relatively simple fabrication,
and cost-effectiveness. However, understanding the inflammatory and immune response
to these biomaterials for guided tissue regeneration is a challenge that requires further
investigation for translation into the clinical environment. Recently, our group and others
have investigated the activation of neutrophils and release of NETs in response to
biomaterials 21, 31, 80, 186. The dysregulated release of NETs contributes to inflammation
and fibrosis in several pathologies and has been described for thrombosis, cancer, and
biomaterials in vivo, including our electrospun biomaterials 21, 31, 100, 134, 162, 186, 227, 251, 252.
In addition, multiple inflammatory diseases are linked to IC-induced NET release,
including systemic lupus erythematosus 77, rheumatoid arthritis 261, anaphylaxis 262, and
small vessel vasculitis 263. Previously, we showed that greater IgG adsorption occurs on
biomaterials that up-regulate NET release 114, but it remained unclear whether this
surface-adsorbed IgG is responsible for stimulating biomaterial-induced NET formation
similar to IC-induced NET release. Here, we demonstrate for the first time that IgG
adsorption, binding to FcγRIIIb, and signaling through TAK1 stimulates and regulates
the release of NETs from human neutrophils on the surface of electrospun PDO
biomaterials.
The binding of neutrophils to ICs and biomaterials is an important mechanism for
innate immunity, the activation of neutrophils, and inflammation. IC-induced NET
release requires opsonization of the antigen or pathogen with IgG to mediate FcγR
binding and has been shown to occur in the context of soluble and immobilized ICs and
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IgG-coated beads 129, 130, 264. In this work, we found that increasing the surface-adsorbed
IgG on our biomaterials up-regulated the release of NETs, which occurred independent of
electrospun fiber size. When the concentration of IgG exceeded the mass needed to
saturate the material surface, no further increase in NET release was observed, indicating
that the IgG must be bound to the material surface to have a stimulatory effect. Indeed,
the high concentration of IgG in circulation does not stimulate NET release from
circulating neutrophils, and others have shown that free Fc fragments not bound to a
substrate and free IgG were unable to stimulate NET formation in the context of ICs 264,
265

. Likewise, we also showed that decreasing the surface-adsorbed IgG down-regulated

the release of NETs, but this occurred in a fiber size dependent manner. Reduced IgG
adsorption on the small fibers, but not the large fibers, significantly reduced NET release,
suggesting that other stimuli, whether surface adsorbed or secreted by the neutrophils in
an autocrine loop, may also participate in stimulating NET release on our biomaterials
136

. Nonetheless, given the magnitude of IgG adsorption on the biomaterial surface, our

data provide evidence for IgG as the predominant stimulatory and regulatory protein in
electrospun biomaterial-induced NET release.
Several FcγRs can bind IgG and induce outside-in signaling to trigger the release
of NETs. Both FcγRIIa and FcγRIIIb have been implicated in IC-induced NET release
through their independent engagement and cooperative signaling 129, 130, 135. Additionally,
Mac-1 has been found to participate in FcγRIIIb-induced NET formation both through its
activation and crosstalk with other receptors through shared signaling molecules 129.
Although it is not constitutively expressed, FcγRI is up-regulated within several hours of
neutrophil activation, indicating it may also bind IgG during an inflammatory response

98

256-258

. In our experiments, we found that blocking of FcγRIIIb significantly attenuated

NET release on the small fiber biomaterials to the level of the large fibers whereas
blocking of FcγRI, FcγRIIa, or CD11b had no significant effect. Despite the decrease
observed on the small fiber biomaterials, we found that blocking of FcγRIIIb had no
effect on the large fiber biomaterials, suggesting another stimulus or compensatory
mechanism of NET release when FcγRIIIb is blocked 136. This may also explain why
NET release was reduced but not completely abrogated on the small fiber biomaterials
upon blocking FcγRIIIb. Moreover, the release of NETs is an active process that occurs
after direct neutrophil contact with the stimulus, and others have demonstrated the ability
of the neutrophil to modulate its response based on the stimuli, their size, and their
valency 130, 141.
FcγRIIIb is a GPI-linked receptor that lacks transmembrane and cytoplasmic
domains 266. Compared to FcγRIIa, FcγRIIIb is 4- to 5-fold more abundant on the
neutrophil membrane and is highly mobile with the ability to protrude further due to its
GPI anchor 267, 268. Despite lacking a transmembrane and cytoplasmic domain, FcγRIIIb
signaling for NET release occurs through TAK1 and is dependent on NOX2 and ERK
activation 129, 254, 269. To further demonstrate the involvement of FcγRIIIb in biomaterialinduced NET release, we blocked TAK1 and showed a significant decrease in NETs on
both small and large fiber biomaterials. The decrease in NET release on both biomaterials
was unexpected because we did not observe a decrease in NETs on the large fibers when
surface adsorbed IgG was reduced. However, TAK1 can be activated by other receptors,
including Toll like receptors, indicating that signaling pathways may participate in
biomaterial-induced NET release 136, 270. When NOX2 is activated downstream of TAK1,
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ROS are produced, which can in turn activate PAD4 to citrullinate histones and enhance
NET generation 63. We previously showed that citrullinated histones are found in
biomaterial-induced NETs and that we could inhibit biomaterial-induced NET release
using Cl-amidine, an inhibitor of PAD4, but were unable to explain the pathway leading
to PAD4 activation 31, 76. Given that ligation of FcγRIIa has been found to activate PAD4
135

, our present study suggests that for our electrospun biomaterials, PAD4 activation is

linked to IgG engagement of FcγRIIIb and signaling through TAK1, although the precise
mechanism remains to be explored.
The adsorption of IgG to the surface of biomaterials has long been considered
significant in the design of biocompatible biomaterials that regulate inflammation, and
IgG adsorption is consistently observed on many different biomaterial surfaces 271-275.
Prior work has focused on the adsorption of IgG as an activator of complement and
monocytes 271, 276, but one group has explored IgG adsorption on expanded
polytetrafluoroethylene and its impact on neutrophil activation and phagocytosis for
preventing infection 272, 273. To our knowledge, we are the first to explore the role of IgG
adsorption in biomaterial-induced NET release in tissue engineering applications.
Because we now know that neutrophils are important effector cells in the response to
biomaterials 17, our work highlights the importance of considering IgG adsorption in the
context of preconditioning biomaterial-neutrophil interactions. Future investigations are
needed to determine if IgG adsorption can be regulated independent of fiber size and how
altering the protein adsorption profile impacts NET release and the potential for tissue
healing in vivo. Ultimately, we have demonstrated that surface adsorbed IgG, ligation of
FcγRIIIb, and activation of TAK1 are involved in electrospun biomaterial-induced NET
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release, and modulation of this pathway may have beneficial therapeutic effects for
regulating neutrophil-mediated inflammation, fibrosis, and in situ tissue regeneration.
Conclusion
Electrospun biomaterials have great potential for a variety of in situ tissue
engineering applications, but regulating the neutrophil-driven inflammatory response to
promote tissue regeneration remains a challenge. In our prior work, we found that IgG
adsorption on electrospun PDO is 100- to 200-times greater than the adsorption of other
serum proteins and that it may be linked to the increased propensity to form NETs on
electrospun biomaterials. The results presented here demonstrate that IgG adsorption
does in fact stimulate and regulate biomaterial-induced NET release through FcγRIIIb
and activation of TAK1. While the present study only investigated electrospun PDO with
differing fiber sizes in the context of tissue engineering, these data garner important
insights that are applicable to the design of other biomaterials, including degradable and
non-degradable devices. More broadly, an understanding of how adsorbed proteins
regulate NET formation during the acute inflammatory response can facilitate the design
of new biomaterials for the desired biological outcome, set in motion by the neutrophil
and its effector functions.
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CHAPTER 6
LOCALIZED DELIVERY OF CL-AMIDINE FROM ELECTROSPUN
POLYDIOXANONE TEMPLATES TO REGULATE ACUTE NEUTROPHIL
NETOSIS: A PRELIMINARY EVALUATION OF THE PAD4 INHIBITOR FOR
TISSUE ENGINEERING
Introduction
When a biomaterial template is implanted in the body, a highly orchestrated series
of events is triggered that ideally harnesses the body as a bioreactor, resulting in in situ
tissue regeneration. Almost instantly, soluble blood serum proteins adsorb on the surface
of the biomaterial. The neutrophils swarming into the local microenvironment around the
template interact with these proteins and other cells to begin orchestrating the complex
responses leading to tissue integration, repair, and regeneration or fibrosis. Regulating the
body’s innate immune response to an acellular template to harness it as a bioreactor to
promote in situ tissue regeneration is an emerging focus of tissue engineering. Instead of
designing inert materials, tissue engineers aim to develop temporary templates that
prevent fibrosis while dynamically guiding tissue integration and regeneration, driven
by the innate immune system.
In terms of biomaterial-guided in situ tissue regeneration, the critical link between
the innate immune response and the healing outcome may be the neutrophil. Historically,
neutrophils have been regarded as the rapidly cleared, suicidal killers of the innate
immune response. They functioned to simply clean up the microenvironment around a
biomaterial before undergoing apoptosis and swift removal by macrophages. However,

insightful research in the last decade suggests that the neutrophil is capable of much more
than previously understood with regards to biomaterial-guided tissue regeneration 17.
Neutrophils adopt distinct phenotypes, similar to macrophages, which are
influenced by their microenvironment 181. They release signals through degradation of the
ECM and rapidly secrete pre-packaged granules that can modulate their phenotype and
influence the recruitment of additional cells 23, 277. Additionally, neutrophils are able to
survive significantly longer after extravasation than once accepted 278, suggesting their
ability to synthesize and secrete factors for early-stage immune system modulation that
may have long-term effects. Finally, several recent studies have identified that
neutrophils can actually reverse migrate from an area of inflammation, relocating to new
areas of the body to potentially educate the immune system 279, 280.
Importantly, neutrophils are able to expel their DNA along with granular contents
to form NETs through a specialized form of anti-microbial cell death called NETosis 27.
During NETosis, chromatin within the nucleus decondenses while the nuclear envelop
and granule membranes disintegrate, resulting in a mixing of the potent granule cargo and
DNA. Eventually, a cloud-like, fibrillary network of DNA that is decorated with antimicrobial proteins, proteases, and histones is extruded into the microenvironment.
Importantly, NETing neutrophils are protected from pre-emptive clearing by
macrophages, resulting in NETs that are difficult to contain 141.
During NETosis, chromatin decondensation occurs with deimination of histone
H3 to CitH3 by the enzyme PAD4 128, 132. The basic amino acid residue, arginine, is
converted to a neutral citrulline residue, which weakens the interaction between the
histone and chromatin, leading to an unraveling of chromatin. When the activity of PAD4
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is blocked with an inhibitor or eliminated in a mouse knockout model, the production of
NETs is severely reduced for anti-bacterial immunity and in pathological deep vein
thrombosis 119, 133, 134.
While functioning as a classic anti-microbial response, NETosis has also been
implicated in various forms of tissue fibrosis, thus making it a prominent therapeutic
target. In particular, neutrophils have been linked to pulmonary fibrosis, fibrosis after
myocardial infarction, and atherosclerosis 281-283. Dysregulated release of NETs appears
to contribute to the overproduction of dense fibrotic matrix in tissue fibrosis. In terms of
tissue regeneration, our group has recently demonstrated that the excessive presence of
NETs inhibits tissue integration with an electrospun biomaterial and may promote
fibrotic encapsulation 31. In the study, we electrospun PDO, a synthetic resorbable
biomaterial, to create two distinct material architectures, templates with SD (0.3 ± 0.1
μm) or LD (1.9 ± 1.0 μm) fibers and pores. Using fresh human peripheral blood
neutrophils in vitro and a subcutaneous rat implant model, we showed that the
microenvironment created by the template architecture differentially modulates NETosis
and formation of fibrotic tissue in vivo, respectively.
In the present work, we confirmed the experiments of our previous study and
extended them by incorporating varying concentrations of Cl-amidine, a
haloacetamidine-based compound that irreversibly inhibits PAD4 284, into the electrospun
templates. Cl-amidine covalently modifies the cysteine residue in the active site that is
critical for PAD4 enzymatic activity and functions in a dose-dependent manner 118. The
purpose of this study was to incorporate Cl-amidine into electrospun PDO templates for
local delivery, measure its activity, and further assess the potential of the drug elution to
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inhibit PAD4-mediated citrullination of histone H3 and reduce template-induced
NETosis. We hypothesized that elution of Cl-amidine from the templates would attenuate
NETosis with the greatest effect seen on SD templates. SD and LD templates were
fabricated with 0-5 mg/mL Cl-amidine, and NETosis was evaluated in response to the
templates in vitro with freshly isolated, human peripheral blood neutrophils and in vivo
with a subcutaneous implant model in a rat. The results were analyzed based on the
temporal degree of NETosis in response to the template architectures and Cl-amidine
concentrations. Ultimately, regulating the release of template-preconditioning NETs from
the interacting neutrophils may modulate the early-stage innate immune response,
promoting or even enhancing guided tissue regeneration.
Materials and Methods
Activity of Cl-amidine After Solvent Exposure
Cl-amidine (trifluoroacetate salt) (Cayman Chemical, Item No. 10599, Batch No.
0468497-71) activity was quantified by a PAD4 Inhibitor Screening Assay (Cayman
Chemical, Item No. 700560) following manufacturer protocol to evaluate activity after
exposure to the organic electrospinning solvent HFP (Oakwood Products, Inc.),
simulating processing. Cl-amidine was suspended in HFP, and 1x HBSS to result in final
assay concentrations of 147.8, 29.5, 5.9, 1.18, 0.24, 0.047, and 0 μM. 40 μL of each HFP
sample (n = 4) were pipetted into the wells of a 96-well culture plate, and the plate was
placed in fume hood to allow evaporation of HFP overnight at room temperature. Then,
the drug was resuspended in 40 μL of HBSS for detection. 5 μL of the HBSS and
resuspended HFP samples were assayed according to manufacturer protocol and were
read on a SpectraMax i3x Multi-Mode Microplate Reader (excitation 410 nm and
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emission 475 nm) to determine fluorescent intensity. After taking the log transform of
molarity, the average fluorescent intensity and standard deviation for each sample were
plotted against Cl-amidine concentration.
Template Fabrication and Characterization
PDO (Sigma Aldrich Co.) was dissolved overnight in HFP at varying
concentrations (Table 7) ranging from 65 to 100 and 170 to 200 mg/mL to create SD and
LD templates, respectively. 0, 1, 2.5, or 5 mg/mL of Cl-amidine was added to the
polymer solution and dissolved for 2 hours with gentle agitation before electrospinning.
Solutions were loaded into a syringe with an 18-gauge blunt needle tip attached to the
positive lead of a power source (Spellman CZE1000R, Spellman High Voltage
Electronics Corp.) and placed on a syringe pump (Model No. 78-01001, Fisher
Scientific). Solutions were electrospun with optimized flow rate, airgap distance, and
applied voltage (Table 7). Fibers were collected on a grounded, stainless steel rectangular
mandrel (20 x 75 x 5 mm) that was rotating at 1250 rpm and translating 6.5 cm/s over 13
cm. The templates (thickness 0.10 - 0.25 mm) were stored at -20°C until analyses.
For scanning electron microscopy, templates were coated with 5 nm of goldpalladium by sputter coating in an argon gas field. The materials were then imaged with a
FEI Nova NanoSEM 650 with field emission gun at +20 kV with a working distance of
5mm to generate SEMs. Fiber diameter and pore diameter were characterized by
analyzing the SEMs in FibraQuant 1.3 software (nanoTemplate Technologies, LLC).
Average fiber and pore diameters with corresponding standard deviations were
determined from a minimum of 250 semi-automated random measurements per image
and 60 random manual measurements per image, respectively.
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Table 7. Electrospun templates were fabricated with optimized parameters. Polymer and
Cl-amidine concentration were varied to create two distinct groups of SD and
LD templates.
Fiber Size Polymer
Cl-amidine
Flow Rate Airgap
Applied
Concentration concentration [mL/h]
Distance
Voltage
[mg/mL]
[mg/mL]
[cm]
[+kV]
65
0
2
13
22
100
1
2.5
15
18
SD
100
2.5
2.5
15
18
100
5
2.5
15
18
170
0
6
13
22
200
1
3
18
28
LD
200
2.5
3
18
28
200
5
3
18
28
Cl-amidine Template Elution
Electrospun templates were characterized for the delivery of Cl-amidine into
supernatant over 5 days. 10 mm diameter discs of the templates (n = 6) were placed in a
48-well culture plate, and 300 μL of HBSS were added to each well. After incubation at
37°C for 15, 30, 45 minutes, 1, 2, 3, 6, 12 hours, 1, 2, 3, 4, and 5 days, the supernatant
was removed and refreshed with 300 uL of HBSS. The collected supernatant was frozen
and stored at -20°C until analysis. Activity of Cl-amidine was detected using the PAD4
Inhibitor Screening Assay following manufacturer protocol, and the resulting fluorescent
intensities were used to determine Cl-amidine concentration within the samples. An
average and standard deviation were determined for each template type.
In Vitro Evaluation with Fresh Human Peripheral Blood Neutrophils
Neutrophils were isolated from blood obtained from healthy donors from
Tennessee Blood Services in accordance with protocols approved by the University of
Tennessee Institutional Review Board as previously described 31. Informed and written
consent was obtained by Tennessee Blood Services. After isolation, neutrophils were
resuspended at a density of 2.4 x 106 cells/mL in HBSS without calcium and magnesium
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and with 10mM HEPES and 0.2% autologous serum. 10 mm diameter discs of the PDO
templates (n = 4) were disinfected by ultraviolet irradiation with a Spectroline handheld
lamp (8 watt, Part No. EN280L) for 10 minute per side in a sterile laminar flow hood
with 365 nm wavelength at a working distance of 9.5 cm. The templates were placed in a
48-well culture plate and hydrated with 50 μL of sterile HBSS. Immediately following
hydration, 250 μL of the cell suspension containing 600,000 cells were pipetted onto the
templates, and the templates were cultured at 37°C and 5% CO2. After 3 and 6 hours, the
plates were placed on ice, inhibiting further stimulation of the neutrophils. Supernatant
was carefully removed, and the cells were fixed in the wells with 10% neutral buffered
formalin. Cellularized templates were stored in 10% formalin at 4°C until analysis.
Fluorescence Quantification of NETs
Fluorescence microscopy of the templates (n = 4) was used to quantify the degree
of NETosis as previously described 31. Briefly, templates were stained with 100 nM SG
extracellular DNA stain (Life Technologies, Cat. No. S7020) in DI water for extruded
NETs followed by DAPI fixed cell nuclei stain (Life Technologies, Cat. No. R37606) at
stock concentration for intact nuclei. To determine the relative degree of NETosis, the
B:G ratio, representing the area of intact cell nuclei to extruded NETs, within an image
was quantified using MATLAB Release 2012a. The B:G ratios were normalized to cell
number within an image, and an average and standard deviation were calculated for each
template type.
IR Scanning and Quantification of CitH3
An On-cell Western assay was performed to quantify template-bound CitH3 as
described 31. Briefly, human histone H3 (citrulline R2 + R8 + R17) peptide (Abcam,
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Product code ab32876) was spotted on an Immobilon-FL PVDF membrane and dried
overnight to create a standard curve. The standard curve and cellularized templates (n =
4) were blocked with 5% non-fat milk for 1 hour at room temperature, then incubated
with rabbit anti-human histone H3 (citrulline R2 + R8 + R17) antibody (Abcam, Product
code ab5103) at a 1:200 dilution in 5% milk overnight at 4°C. After incubation with
primary antibody, three washes were performed with 0.1% Tween-20 in HBSS for 5
minutes at room temperature with gentle agitation. Following, the standard curve and
templates were incubated with IRDye 800CW donkey anti-rabbit (LI-COR, Part no. 92632213) at a 1:20,000 dilution in 5% milk with 0.1% Tween-20 and 0.01% SDS for 1 hour
at room temperature. Non-cellularized templates were incubated with secondary antibody
only, serving as negative controls. After two washes with 0.1% Tween-20 in HBSS and
one final wash with HBSS, the standard curve and templates were scanned on the 800 nm
channel of the Odyssey CLx IR Imaging System (LI-COR) to generate full-thickness
template fluorescence. The scans were analyzed with Image Studio Version 5.x (LICOR).
For the standard curve, relative fluorescent intensities were acquired by placing
circular markers over the area of a spot. The average and standard deviations were plotted
against the mass of CitH3 to create a standard curve. For the templates, the relative
fluorescent intensities were measured by encompassing the area of the sample and
extrapolating it to the area for a 10 mm diameter disc, which was normalized to template
thickness. The final relative fluorescent intensity was converted to mass of CitH3 using
the standard curve, and an average and standard deviation were generated for each
template type.
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In Vivo Rat Subcutaneous Implant Model
Ten-millimeter diameter discs of the templates (n = 3) were implanted on the back
of Sprague-Dawley rats (300-325 g, male) following the protocol approved by the
University of Memphis Institutional Animal Care and Use Committee as previously
described 31. Briefly, templates were disinfected with ultraviolet irradiation for 10
minutes on each side, and all materials were handled aseptically. One template lying flat
was implanted per subcutaneous pocket, and the skin was closed with 2-3 staples. Four
templates were implanted randomly on the back of each rat (Figure 25A). Additionally,
to ensure drug-eluting materials exerted their effects locally without diffusion or
convection to adjacent samples, two SD templates with 0 mg/mL Cl-amidine were
implanted between four SD templates with 5 mg/mL Cl-amidine (n = 3), and two SD
templates with 0 mg/mL Cl-amidine (n = 3) were implanted alone (Figures 25B,C). One
day after implantation, the animals were euthanized, the subcutaneous pockets were
opened, and the templates were explanted, fixed, and stored in 10% neutral buffered
formalin at 4°C.
Fixed templates were processed, sectioned at 10 μm, and stained with H&E
following standard protocol. The sections were evaluated and scored by a board-certified
veterinary pathologist blinded to sample identity for presence of surface DNA, invasion
into the template, and degree of neutrophil degeneration (Table 8). The presence of
surface DNA was evaluated based on prevalence of DNA on the surfaces of the templates
seen as a blue-stained acellular layer, invasion into the templates was scored based on
number of invading neutrophils and depth of invasion, and the degree of neutrophil
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degeneration was assessed based on the abundance of neutrophils showing degenerative,
morphological changes (i.e., loss of lobulated nuclei, fragmentation, apoptotic bodies,
etc.). Finally, the surface of the 1-day templates were evaluated for template-bound
CitH3 through an On-cell Western blot following the in vitro protocol.

Figure 25. Electrospun templates with 0-5 mg/mL Cl-amidine were implanted
subcutaneously on the dorsa of rats. (A) One template was implanted randomly per
subcutaneous pocket. In addition, to determine if the drug-eluting materials had systemic
effects due to diffusion or convection, (B) SD templates with 0 mg/mL
Cl-amidine were implanted between SD templates with 5 mg/mL Cl-amidine and (C) SD
templates with 0 mg/mL Cl-amidine were implanted alone.
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Table 8. Electrospun templates were evaluated by a veterinary pathologist in a
blinded fashion at 1 day after implantation in a subcutaneous rat implant model.
Score Presence of Surface
Invasion into the
Degree of Neutrophil
DNA
Template
Degeneration
1
DNA adherent to some
Slight invasion into the
Most invading nonsurfaces of the template template near a fold or
degenerate
defect
2
DNA adherent to most
Slight invasion into the
Many invading nonsurfaces of the template template
degenerative
3
Dense DNA layer
Moderate invasion with Occasional invading
adherent to some
reduced invasion
non-degenerative
surfaces of the template towards the center
4
Dense DNA layer
Moderate invasion
Few non-degenerating
adherent to most
throughout the thickness neutrophils not deeply
surfaces of the template of the template
invaded
5
Conspicuous, dense
Dense invasion
Diffuse degenerating
DNA layer adherent to
throughout the thickness neutrophils near surface
the surfaces of the
of the template
template
Statistical Analysis
Significant differences in Cl-amidine activity were determined by an unpaired ttest to compare activity for each concentration. The plot of average fluorescent intensity
against Cl-amidine concentration was fit with a four-parameter logistic regression, and a
lack of fit test was executed. The plot of relative fluorescence against mass of CitH3 was
fit with a linear regression. For all other in vitro methods, analysis of data was conducted
using a two-way ANOVA and a Tukey multiple comparison procedure. All in vitro
statistical analyses were performed in GraphPad Prism 6 at a significance level of 0.05.
For the in vivo methods, the data sets were resampled (n = 1,000) using
bootstrapping and then evaluated with a two-way ANOVA and a Tukey multiple
comparison procedure to ensure the data did not violate the assumptions of normality 285,
286

. Resampling and analyses were performed in SAS 9.4 and GraphPad Prism 6,

respectively, at a significance level of 0.05.
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Results
Cl-amidine Retains Activity During Template Production
Before incorporating the drug into the electrospun templates, the activity of Clamidine was verified after exposure to the harsh organic solvent, HFP, that is used during
electrospinning. Figure 26 shows the four-parameter regression curve for the HFP
samples along with the HBSS samples. As the concentration of drug increases, the
relative fluorescence decreases, signifying an increase in the inhibition of PAD4. The
assayed drug concentrations were selected to provide a range that includes the inhibitory
concentration 50 of Cl-amidine against PAD4, which is 5.9 μM in an in vitro model 284.
Exposure of Cl-amidine to HFP significantly reduced its activity against PAD4 at two
concentrations, 5.9 and 29.5 μM (p < 0.0001). However, the drug was still active
producing a sigmoidal curve similar to that of the HBSS samples. This loss of Cl-amidine
activity upon exposure to HFP was reproducible and therefore could be compensated for
by increasing the drug concentration. Nonetheless, the drug retained efficacy after
exposure to HFP and inhibited PAD4 activity at concentrations as low as 1.2 μM,
demonstrating the potential to incorporate it into electrospun templates for release and
activity against PAD4.
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Figure 26. Cl-amidine retains activity after exposure to HFP. Plot of drug concentration
against relative fluorescence for HBSS and HFP exposed samples. Veh. is HBSS only.
The four-parameter regression of the HFP exposed samples has no evidence of lack of fit
(p = 0.28). *Significant difference in relative fluorescence (p < 0.05) (mean ± standard
deviation, n = 4).
In addition to determining the activity of Cl-amidine, the samples exposed to HFP
were used to create a standard curve for quantifying unknown Cl-amidine concentrations.
The four-parameter logistic regression of the HFP exposed samples (Equation 7, x =
logarithmic transform of Cl-amidine concentration and y = relative fluorescence) has an
R2 value of 0.996, and there is no evidence of an inadequate model from the lack of fit
test (p = 0.28).
𝑦=

2.65
1+105.25+1.14𝑥

(7)

Template Characteristics Incorporating Cl-amidine
Low and high polymer concentration solutions incorporating Cl-amidine resulted
in two distinct templates groups, SD and LD templates, which had uniform fiber and pore
morphologies comparable to SD and LD templates without drug (Figures 27A,B). During
electrospinning, the addition of a charged entity to the solution reduces fiber diameter, so
we increased polymer concentration to prevent reduction in fiber diameter for Cl-amidine
templates 287. Figures 27C,D show the results of the fiber and pore diameter analyses,
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respectively. Within the SD and LD template groups, the templates did not have
significantly different fiber diameters between 0 and 5 mg/mL Cl-amidine. At each drug
concentration, the SD templates had significantly smaller fiber diameters with an average
of 0.36 ± 0.16 μm compared to the LD templates with average fiber diameters of 1.82 ±
0.59 μm (p < 0.05). Similarly, the pore diameters of the SD and LD templates were not
different between templates with 0-5 mg/mL Cl-amidine, but at each drug concentration,
the SD templates had significantly smaller pore diameters near 1.76 ± 0.79 μm compared
to the LD templates with average pore diameters of 7.34 ± 2.42 μm. Together, these data
indicate that the increase in polymer concentration for SD and LD templates compensated
for the addition of Cl-amidine to produce templates with consistent fiber and pore
diameters.
Elution Kinetics of Cl-amidine From Templates
The electrospun templates eluted Cl-amidine to varying degrees based on fiber
diameter and drug content over 5 days (Figures 28A–D). At 3 0min, the SD template with
5 mg/mL Cl-amidine eluted significantly more drug than the LD template, and from 45
minutes to 6 hours, the SD templates with 2.5 and 5 mg/mL Cl-amidine eluted more drug

115

Figure 27. PDO electrospins at low and high concentrations with Cl-amidine.
Representative SEMs of (A) SD and (B) LD templates with 0–5 mg/mL Cl-amidine
(scale bars = 20μm). For all drug concentrations, all SD and all LD templates have
statistically equivalent (C) fiber and (D) pore diameters; however, at each drug
concentration, SD templates have significantly smaller (C) fiber and (D) pore diameters
than the LD templates. *Significant difference (p < 0.05). (mean ±
standard deviation, n > 250 for fiber diameter analysis and n = 60 for pore diameter
analysis).
than the LD templates (p < 0.05) (Figures 28A,B). These significant trends were seen
over the 5-day period (Figures 28C,D), and by 2 days, all of the SD templates eluted
significantly more Cl-amidine than the LD templates (p < 0.05). Because HFP reduces
the activity of Cl-amidine, there is potential that some Cl-amidine was eluted from the
fibers and not detected in the activity assay. In addition, it is likely that some Cl-amidine
was retained within the fibers and had yet to elute from the templates in the 5-day period.
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Figure 28. SD and LD templates elute Cl-amidine over 5 days. From 0 minutes to 6
hours, the (A) SD templates eluted significantly more drug than the (B) LD templates.
This trend was observed from 6 hours to 5 days for the (C) SD and (D) LD templates.
*Significant difference between 2.5 mg/mL Cl-amidine and 5 mg/mL Cl-amidine from 0
mg/mL Cl-amidine templates (p < 0.05). **Significant difference between 5 mg/mL Clamidine from 0 mg/mL Cl-amidine templates (p < 0.05). +Significant difference between
SD and LD templates with 5 mg/mL Cl-amidine (p < 0.05). ++Significant difference
between SD and LD templates with 2.5 mg/mL and 5 mg/mL Cl-amidine (p < 0.05).
+++Significant difference between all SD and LD templates (p < 0.05) (mean ± standard
deviation, n = 6).
The potential effects of low-level elution from the templates after the initial critical hours
is negligible due to the short half-life of Cl-amidine in vivo 284.
At 3 hours, the SD templates with 1, 2.5, and 5 mg/mL Cl-amidine had eluted the
drug to reach concentrations of 108.7 ± 16.5, 172.4 ± 24.2, and 250.6 ± 39.5 μM Clamidine. Contrastingly, the LD templates with 1, 2.5, and 5 mg/mL Cl-amidine only
eluted the drug to reach concentrations 74.4 ± 12.2, 99.2 ± 13.3, and 160.1 ± 30.2 μM Clamidine. Despite the equivalent drug content during fabrication, these differences result
from the high SAVR of the SD templates, leading to a more significant burst release of
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Cl-amidine. Because the SD templates elicit the highest degree of NETosis, the greater
elution of Cl-amidine from the SD templates at 3 hours may counteract template-induced
NETosis 31. Furthermore, by 3 hours, the SD and LD templates eluted nearly 60% of the
drug released over the 5-day period. This burst release is due to the characteristic
segregation of the charged drug to the outer surface of the electrospun fibers 214. Since the
swarming of neutrophils to the site of inflammation occurs in the first 3 hours, the
substantial local release in the initial hours may be desired to regulate the critical
interaction that directs the ensuing response 12.
Templates Eluting Cl-amidine Modulate NETosis In Vitro
Fluorescence microscopy revealed contrasting degrees of NETosis in response to
the different template fiber diameters and drug concentrations at 3 and 6 hours (Figures
29 and 30). Blue (DAPI) stains condensed chromatin, and green (SG) stains decondensed
NET chromatin, respectively. SG cannot penetrate an intact cell membrane 288. Therefore,
cyan, an overlap of DAPI and SG staining, indicates cells with an intact nucleus but
compromised cell membrane. Because the cells retain their plasma membrane integrity
while the nuclear and granular membranes disintegrate, these cyan stained neutrophils
have compromised cell membranes and may be undergoing cell death other than
NETosis. The varying degrees of NETosis were quantified with a B:G ratio using a
MATLAB image analysis algorithm (Figures 31A,B). A B:G ratio >1 indicates that more
image area of the template is covered by intact cells than extruded NETs, signifying a
low degree of NETosis, with the inverse for a B:G ratio <1, signifying a high degree of
NETosis.
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Figure 29. Neutrophils interacting with Cl-amidine eluting templates exhibit different
degrees of NETosis at 3 hours. Representative fluorescent micrographs of (A) SD and
(B) LD templates indicate different degrees of NETosis based on drug content (scale bars
= 100 μm). Blue is DAPI. Green is SG.

Figure 30. Neutrophils interacting with Cl-amidine eluting templates exhibit equivalent
degrees of NETosis at 6 hours. Representative fluorescent micrographs of (A) SD and
(B) LD templates indicate near equivalent degrees of NETosis based on drug content
(scale bars = 100 μm). Blue is DAPI. Green is SG.
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Figure 31. Cl-amidine significantly decreases NETosis on SD templates. The B:G ratio
for templates at (A) 3 and (B) 6 hours indicate that template architecture modulates
NETosis. In addition, the elution of Cl-amidine significantly affects NETosis at 3 hours
with minimal effects at 6 hours. *Significant difference (p < 0.05). +Significant
difference between 3 and 6 hours (p < 0.05) (mean ± standard deviation, n = 4).
At 3 hours, the SD templates with 0 mg/mL Cl-amidine elicited a statistically
higher degree of NETosis, with a B:G ratio of 0.47 ± 0.19, than the LD template with 0
mg/mL Cl-amidine, which had a B:G ratio of 2.98 ± 1.21 (p < 0.05). These results were
anticipated and replicate, to the same magnitude, those of our previous experiments
where we showed that SD PDO templates increase NETosis in vitro while LD PDO
templates led to a significant reduction 31. As seen in Figure 31A, with increasing Clamidine concentration, the degree of NETosis in response to the SD templates
significantly decreases in a dose-dependent manner. The SD templates with 5 mg/mL Clamidine have a B:G ratio of 4.4 ± 1.84, nearly 10 times greater than the SD templates
without drug (p < 0.05). These results suggest that the addition of Cl-amidine to the SD
templates attenuates NETosis through the inhibition of PAD4, and that these effects are
concentration dependent.
For the LD templates at 3 hours, the incorporation of Cl-amidine into the
templates decreases the B:G ratio in a dose-dependent manner down to 1.39 ± 0.52 for
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the templates with 5 mg/mL Cl-amidine. While not significant, this trend is opposite of
the SD templates and suggests that in the microenvironment created by the LD templates
with Cl-amidine, NETosis is increased. Nonetheless, the B:G ratio for all of the LD
templates with Cl-amidine is >1, indicating that there is still more surface area on the
template covered by intact neutrophils than extruded NETs. Taken together, these
contrasting effects of Cl-amidine at 3 hours in vitro suggest that there may be another
mechanism in addition to PAD4-regulated NETosis that modulates the generation of
NETs based on the template architecture. By 6 hours, the B:G ratios for the SD and LD
templates decreased to values around 1, suggesting that there is an equivalent amount of
area covered by viable neutrophils and extruded NETs on the templates (Figure 31B).
As a concomitant method to quantify NETosis, an On-cell Western assay was
used to quantify template-bound CitH3 at 3 and 6 hours in vitro (Figures 32A,B). Histone
H3 is citrullinated by PAD4 during NETosis, generating CitH3, which is then complexed
with released NETs 128. Previously, we showed that detection of CitH3 can be used in
addition to fluorescence microscopy to quantify the degree of NETosis in response to
electrospun templates 31. The linear regression of mass of CitH3 against relative
fluorescence (Equation 8, x = mass in ng of CitH3 and y = IR intensity) has an R2-value
of 0.966, which indicates a well-fitting line, and linear relationship that can be used to
quantify CitH3.
𝑦 = 91.1𝑥

(8)

At 3 hours, SD templates with 0 mg/mL Cl-amidine had significantly more
template-bound CitH3 than the LD templates with 0 mg/mL Cl-amidine (p < 0.05). The
SD templates had 8.1 ± 2.2 ng CitH3, nearly 4 times greater than the LD templates with
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2.2 ± 0.4 ng. These results suggest a high degree of NETosis on the SD templates, which
is supported by the results from fluorescence microscopy. In Figure 32A, Cl-amidine
significantly decreased the amount of detectable CitH3 on SD templates, which suggests
a decrease in NETosis similar to the results from fluorescence microscopy (p < 0.05).
Likewise, for the LD templates, the templates with Cl-amidine correlated to higher
amounts of template-bound CitH3. All of the LD templates with drug had more
detectable CitH3 than their SD template counterparts. These similar results were also
observed at 6 hours (Figure 32B). However, while it increased on the LD templates, the
amount of template-bound CitH3 did not increase on the SD templates with Cl-amidine.
Clearly, the elution of Cl-amidine from the electrospun PDO templates regulates NETosis
from the interacting neutrophils in a dynamic manner dependent on the template
microenvironment.

Figure 32. Cl-amidine significantly decreases template-bound CitH3 on SD templates.
Template-bound CitH3 at (A) 3 and (B) 6 hours suggests that template architecture and
Cl-amidine concentration regulate NETosis. *Significant difference (p < 0.05).
**Significant difference between SD and LD templates (p < 0.05). +Significant
difference between 3 and 6 hours (p < 0.05) (mean ± standard deviation, n = 4).
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PDO Templates Eluting Cl-amidine Modulate NETosis In Vivo
Next, the Cl-amidine eluting electrospun templates were implanted
subcutaneously on the back of rats. H&E staining of templates after 1 day (Figures
33A,B) indicated that SD and LD templates initiated differing responses based on
template architecture and drug content, which were quantified by a veterinary pathologist
in a blinded fashion. At 1 day, the presence of surface DNA, invasion into the template,
and degree of neutrophil degeneration were evaluated (Figures 34A-C). The presence of
surface DNA (Figure 34A) scored significantly higher on SD templates with 0 mg/mL
Cl-amidine at 3.7 ± 0.5 compared to LD templates with 0 mg/mL Cl-amidine at 1.7 ± 0.5
(p < 0.05). A dense DNA layer was adherent to most surfaces on the SD the templates
whereas only some DNA was adherent to the LD template surfaces, similar to the trends
seen in vitro. For the SD templates, Cl-amidine significantly decreased the scores for the
presence of surface DNA, while for LD templates, the opposite was observed (p < 0.05).
Again, these data reflect the fluorescence microscopy results in vitro, suggesting that Clamidine elution results in similar effects in a physiological environment. Interestingly, for
the SD templates with 5 mg/mL Cl-amidine, the score for surface DNA was greater than
the score for 1 and 2.5 mg/mL Cl-amidine, but the score was still significantly lower
compared to SD templates with 0 mg/mL Cl-amidine.
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Figure 33. Cl-amidine eluting electrospun templates modulate neutrophil behavior in
vivo. Representative light microscopy images of H&E stained sections of (A) SD and (B)
LD templates removed after 1 day (scale bars = 100 μm).

Figure 34. Cl-amidine eluting templates modulate cell behavior in vivo. Histological
scores obtained from a blinded, veterinary pathologist for (A) presence of surface DNA,
(B) invasion into the template, and (C) degree of neutrophil degeneration after 1 day
implantation. *Significant difference (p < 0.05). +Significant difference between SD and
LD templates (p < 0.05) (mean ± standard deviation, n = 3).
124

Invasion of neutrophils into the templates (Figure 34B) was also modulated by
architecture and drug concentration. LD templates scored significantly higher with
moderate invasion throughout the thickness of the template compared to SD templates
with slight invasion into the template (p < 0.05). Because of the restrictive pore diameters
of the SD templates, which are 3 times smaller than the LD template pore diameters, it is
not surprising that the SD templates exhibited less invasion. Interestingly, the elution of
Cl-amidine from SD templates significantly decreased invasion into the templates
compared to the SD template with 0 mg/mL Cl-amidine (p < 0.05). This is not observed
for the LD templates, which all scored with moderate invasion.
The degree of neutrophil degeneration (Figure 34C) was significantly different in
response to the templates after acute interaction in vivo. As noted, the degeneration of
neutrophils was classified by the degree of morphological changes. All of the SD
templates scored significantly higher at 4.0 ± 0.2 compared to LD templates at or below
2.6 ± 0.5 (p < 0.05). This equates to minimal non-degenerating neutrophils that are not
deeply invaded and many invading, non-degenerative neutrophils, respectively.
Importantly, with increasing Cl-amidine concentration, the LD templates scored
significantly better for neutrophil degeneration, decreasing from 2.6 ± 0.5 for 0 mg/mL
Cl-amidine to 1.3 ± 0.5 for 5 mg/mL Cl-amidine (p < 0.05). The decreasing scores
suggest that with increasing Cl-amidine concentration, a greater portion of the interacting
neutrophils are viable and exerting their potential long-term effector functions to
modulate the early-stage innate immune response.
In addition to pathological evaluation, the templates excised after 1 day were
evaluated for template-bound CitH3 (Figure 35). The results show that the SD templates
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with 0 mg/mL Cl-amidine had significantly more template-bound CitH3 with 7.3 ± 0.4
ng compared to the LD templates with 0 mg/mL Cl-amidine at 3.6 ± 0.3 ng (p < 0.05).
With increasing drug concentration, the amount of template-bound CitH3 significantly
decreased on the SD templates, while the opposite was observed on LD templates (p <
0.05). However, the SD templates with 5 mg/mL Cl-amidine resulted in more CitH3
compared to 1 and 2.5 mg/mL Cl-amidine. These significant trends validate the scores
categorized by the pathologist for presence of surface DNA on the templates, indicating
that the Cl-amidine eluting templates modulate NETosis in vivo.

Figure 35. PDO templates eluting Cl-amidine modulate NETosis in vivo. Cl-amidine
attenuates NETosis as indicated by CitH3 on SD templates while increasing NETosis on
LD templates. *Significant difference (p < 0.05). +Significant difference between SD and
LD templates (p < 0.05) (mean ± standard deviation, n = 3).
To ensure the Cl-amidine eluting templates exhibited only local inhibition of
PAD4, SD templates with 0 mg/mL Cl-amidine were implanted between templates with 5
mg/mL Cl-amidine (Figure 25). SD templates with 0 and 5 mg/mL Cl-amidine were
selected to maximally challenge the effects of Cl-amidine through its high and rapid
release from the SD templates. The SD templates with 0 mg/mL Cl-amidine adjacent to
templates with 5 mg/mL Cl-amidine were compared to SD templates with 0 mg/mL Clamidine that were implanted alone (Figure 25). After 1-day, histological scores were not
significantly different for presence of surface DNA, invasion into the template, and
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degree of neutrophil degeneration for the SD adjacent templates and the SD template
controls (p < 0.05). The presence of DNA scored 2.0 ± 0.8 and 2.3 ± 0.8, the invasion
into the templates scored 3.0 ± 0.7 and 3.0 ± 0.9, and the degree of neutrophil
degeneration scored 4.2 ± 0.4 and 4.2 ± 0.2 for the SD adjacent templates and the SD
template controls, respectively. Together, these data verify that the Cl-amidine eluting
templates only exert local effects in the first 24 hours in vivo and do not affect the
response to adjacent materials through diffusion or local convection.
Discussion
The unregulated release of NETs from the acute neutrophil response may inhibit
biomaterial-guided tissue regeneration. Aggregated NETs have been shown to degrade
the potent cytokines and chemokines secreted by neutrophils to direct wound healing,
impairing the healing response and potential for tissue regeneration 143. Moreover, NETs
are linked to the formation of fibrotic tissue 227. In particular, the up-regulation of
NETosis contributes to the formation of dense, fibrotic tissue in pulmonary fibrosis,
fibrosis after myocardial infarction, and atherosclerosis 281-283. Riehl et al. linked NETs to
fibrosis through NET-bound, histone-induced activation of platelets resulting in TGF-β
secretion and the differentiation and activation of myofibroblasts 227. Indeed, our initial
work evaluating the neutrophil response to electrospun templates indicates that abundant
template-preconditioning NETs induce fibrotic tissue formation in vivo and impair tissue
integration with the biomaterial 31.
We attempted to modulate the degree of NETosis by incorporating Cl-amidine
into electrospun templates for local delivery into the template microenvironment. Clamidine, which irreversibly inhibits PAD4, has a short half-life in vivo of < 15 minutes
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and preferentially antagonizes the active form of PAD4 through covalent binding, which
together reduces off target effects outside of an inflammatory environment 119, 284. We are
not the first to use Cl-amidine to inhibit NETosis through irreversible inhibition of
PAD4-mediated histone H3 citrullination. Kusunoki et al. used intraperitoneal injections
of Cl-amidine to reduce NETosis in a mouse model of small-vessel vasculitis 289. In
another study, subcutaneous injections of Cl-amidine were used to attenuate NETs in a
model of obesity-associated, low-grade chronic inflammation 290. However, we are the
first, to our knowledge, to incorporate it into a delivery vehicle for local elution into a
biomaterial-induced, inflammatory microenvironment.
First, we demonstrated that Cl-amidine can be incorporated into electrospun
templates, creating templates with distinct architectures that have been shown to polarize
macrophages and previously regulate NETosis 31, 224. Next, we showed that Cl-amidine
eluted from the templates rapidly, which is characteristic of electrospun materials
incorporating charge carries (i.e., Cl-amidine) that segregate to the outer surface of the
fibers 214. The burst release is highly desired for this application because the swarming of
neutrophils to a site of inflammation occurs in the first 3 hours after injury. After 3 hours,
swarming has nearly ceased so that the neutrophils can begin exerting their effector
functions 12. Thus, our delivery vehicle ideally released most of its potent payload in the
critical window of neutrophil-template interactions.
With freshly isolated human peripheral blood neutrophils, we evaluated the
neutrophil interactions with the electrospun templates in vitro for 3 and 6 hours. The LD
templates with 0 mg/mL Cl-amidine significantly attenuated NETosis compared to the
SD templates, which was quantified with fluorescence microscopy and template-bound
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CitH3. As the concentration of Cl-amidine increased in the SD templates, the degree of
NETosis was significantly reduced in a dose-dependent manner. Intriguingly, the
opposite effect was observed for the LD templates.
By 6 hours in vitro, all of the SD and LD templates triggered nearly equivalent
degrees of NETosis, regardless of drug content. Those templates that attenuated NETosis
at 3 hours were unable to inhibit it at 6 hours, which may be an artifact of in vitro culture
from decreased neutrophil viability. Interestingly, while the fluorescent quantification
reflects the increase in NETs on SD templates with Cl-amidine at 6 hours, the IR
detection of template-bound CitH3 did not. Considering the increase in NETosis on LD
templates with Cl-amidine, these data suggest that template-induced NETosis may also
be occurring independent of PAD4-mediated histone H3 deimination.
Three models of NETosis have been proposed: suicidal NETosis dependent on
ROS, vital NETosis independent of ROS, and vital NETosis dependent on ROS 291.
While the mechanisms are not yet fully understood, suicidal NETosis depends on ROS
for deimination of histone H3 by PAD4 119. This is the model that we speculated is
involved in template-preconditioning NETosis. Contrastingly, both forms of vital
NETosis can occur independent of histone citrullination 72, 292. Therefore, our data
suggest that they may also be involved in the neutrophil response to PDO templates.
The different types of NETosis are in part regulated by receptor signaling through
TLRs, complement receptors, cytokine receptors, and integrins 27, 69, 95, 293. Because these
same receptors interact with soluble proteins adsorbed on the template surface, variation
in ligand binding and activation of outside-in signaling likely contributes to the activation
of the different mechanisms triggering NETosis. We hypothesize that protein adsorption
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and the conformational changes regulate outside-in signaling for template-induced
responses. Particularly, we anticipate greater protein adsorption on SD templates (i.e.,
high SAVR) that is dynamic as described by the Vroman effect, and that exposure of
protein domains through conformational changes induced by hydrophobic interactions
engage different signaling pathways, topics of further investigation 294. This type of
regulation provides an explanation for the contrasting affects of Cl-amidine based on
fiber diameter. The ability of Cl-amidine to inhibit template-induced NETosis may be
intimately linked to protein adsorption on the template and the engagement of neutrophil
surface receptors, which will be addressed in future studies.
The results of the subcutaneous rat implant model were similar to the in vitro
evaluation with freshly isolated human neutrophils and indicated dose-dependent trends
modulating the early-stage innate immune response. With the addition of Cl-amidine to
the SD templates, the degree of NETosis significantly decreased, except for the SD
templates with 5 mg/mL Cl-amidine, and the opposite was observed for LD templates.
We anticipated that the dose-dependent effects observed in vitro would translate to the in
vivo model. Therefore, this interesting discrepancy for SD templates with 5 mg/mL Clamidine between the in vitro and in vivo data suggests that the physiological complexity
of the in vivo microenvironment masks the dose-dependent effects of Cl-amidine for the
SD templates.
Despite the increase in NETosis, all of the LD templates had significantly greater
neutrophil invasion compared to the SD templates after 1 day in vivo. Invasion into the
templates may be a critical driving force for tissue integration and regeneration.
Neutrophils secrete potent pro-angiogenic factors in large quantities, like TIMP-free
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MMP-9, to guide and direct the growth of new blood vessels 49. Without neutrophils, Lin
et al. found vascularization of their biomaterial abrogated 295. Regulating NETosis and
neutrophil invasion may work in tandem to enhance tissue integration and regeneration.
We previously suggested that the restrictive pores of the SD templates may be
increasing NETosis due to the decreased invasion of neutrophils into the templates 31.
However, considering the histological scores for the presence of surface DNA and
invasion, the restrictive pore diameters are not a factor that could be increasing NETosis
with the LD templates incorporating Cl-amidine. Since neutrophils have been shown to
sense size and selectively release NETs, it may be the diameter of the fibers (i.e., micronsized) that are up-regulating NETosis on the LD templates eluting Cl-amidine 141.
Importantly, the templates modulated acute neutrophil degeneration in vivo with
all of the SD templates significantly increasing degeneration compared to LD templates.
Degeneration was ranked based on the proportion of neutrophils showing degenerative
signs, such as loss of lobulated nuclei and fragmentation. Thus, the SD templates promote
significant degeneration at 24 hours in vivo. Because the scores for the presence of DNA
improved with Cl-amidine, these data suggest that the cells interacting with the SD
templates may be dying through other forms of cell death in addition to NETosis, like
rapid apoptosis or necrosis. Moreover, the degeneration scores for the LD templates
eluting Cl-amidine decreased significantly in a dose-dependent manner, despite an
increase in the presence of surface DNA. Therefore, a greater portion of the neutrophils
that are interacting with the template, invading it, and surviving are able to employ their
long-term effector functions like the secretion MMP-9 for biomaterial-guided
angiogenesis 296. Taken together, these data suggest that engineering a Cl-amidine
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delivery vehicle with the pore diameters of the LD templates and the fiber diameters of
the SD templates may create the ideal microenvironment for regulated NETosis.
While PAD4 is a prominent therapeutic target that can be antagonized with Clamidine to regulate NETosis, there are many mechanisms involved in the NETosis
response to biomaterials that provide other targets for intervention 251, 297. Our
preliminary evaluation suggests that other pathways may be regulating the release of
NETs in the presence of Cl-amidine and that the complexity of the physiological
environment should be considered. The deimination of substrates by PAD4 may be
linked to TNF-α signaling, suggesting that synergistically targeting cytokine and
chemokine production may further modulate NETosis 298. Another recent study identified
that PAD4 inhibition could impact neutrophil cytokine secretion, which may impact
neutrophil polarization and the release of innate immune regulators 299. Future work
should examine how fiber and pore diameters regulate NETosis independently, other
mechanisms that may be regulating NETosis in the template microenvironment, and how
Cl-amidine elution effects neutrophil polarization. Extended in vivo studies should also
be performed to understand the long-term effects of PAD4 inhibition by Cl-amidine in
tissue regeneration. Clearly, local delivery of Cl-amidine modulates neutrophil NETosis
in vitro and in vivo and may have significant implications in biomaterial-guided tissue
regeneration and other medical devices that fail through fibrotic encapsulation.
Conclusion
Our preliminary evaluation of Cl-amidine eluting, electrospun PDO templates
demonstrates that Cl-amidine can be used to modulate NETosis in response to a
biomaterial, thereby regulating acute inflammation and the early innate immune response.
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We demonstrated the efficacy of using electrospun templates to deliver Cl-amidine
locally as well as its ability to regulate NETosis in a dose-dependent manner in vitro with
fresh human peripheral blood neutrophils and in vivo with a rat subcutaneous implant
model. It is evident that the innate immune response is highly complex and much remains
to be characterized. However, we have shown the significance of designing
immunomodulatory biomaterials that regulate the neutrophil interaction to potentially
improve tissue integration and regeneration. Further investigation of the neutrophil
response to biomaterials and the therapeutic potential of Cl-amidine is needed and will
likely yield significant insight in the field of tissue engineering and regenerative
medicine.
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CHAPTER 7
ELECTROSPUN POLYDIOXANONE BIOMATERIALS LOADED WITH
CHLOROQUINE MODULATE TEMPLATE-INDUCED NET RELEASE AND
THE INFLAMMATORY RESPONSE FROM HUMAN NEUTROPHILS
Introduction
Biomaterial-guided in situ tissue regeneration utilizes a tissue engineering
approach to guide the regeneration of diseased, damaged, or missing tissues 1. However,
compared to exogenous delivery in traditional tissue engineering, in situ tissue
regeneration relies on the body’s endogenous cells and signals to drive the repair and
regeneration processes. Electrospun biomaterials have great potential for guiding in situ
tissue regeneration because their ECM-mimicking fibers can be fabricated from a variety
of biocompatible polymers and modified to suit tissue-specific applications 2, 4.
Additionally, fabrication of electrospun biomaterials is relatively simple, cost-effective,
and easy to scale up for mass production. As such, electrospun templates are an excellent
platform for developing biomaterials that guide in situ tissue regeneration with the
potential for a far-reaching clinical impact.
Independent of location, the implantation of a biomaterial quickly initiates a tissue
repair program to restore homeostasis that is initially characterized by an influx of
neutrophils 8, 300. During the acute inflammatory response, neutrophils condition the
microenvironment through multiple mechanisms before recruiting additional immune
cells in the tissue repair program. Two of their most significant effector functions include
the extrusion of NETs and the secretion of soluble signals 17, 27, 301. Together, these

mechanisms shape the microenvironment for resolution and healing or further
perturbations of homeostasis.
NETs are composed of DNA that is complexed with anti-bacterial neutrophilderived proteins, including histones, NE, and MPO 27. They are released in response to
bacterial signals for the purpose of killing pathogens and are also released in response to
inflammatory mediators, such as IL-8 and TNF-α, activated endothelial cells, and
platelets 104, 109, 128, 302. While they are indispensable for preventing pathogen
dissemination, the dysregulated release of NETs is associated with aberrant effects in
sterile inflammation due to the localization of noxious cargo that can damage host cells
109, 162, 223, 303

. Of particular interest to tissue engineers is the ability of NETs to initiate

thrombosis and fibrosis, both of which can be detrimental to functional tissue
regeneration 85, 94, 134, 162, 227, 303. In fact, our group has previously shown that NETs are
released in response to the surface area-dependent, topographical cues of electrospun
PDO biomaterials, functioning as a pre-conditioning event in the tissue repair program 31.
Similar to the release of NETs, neutrophil degranulation and the secretion of
soluble signals are meant to neutralize pathogens and initiate the tissue repair program,
but they can become dysregulated, leading to tissue damage 17, 301. The combination of
neutrophil recruitment and tissue damage is typically attributed to the release of
proteinases that breakdown the ECM, such as MMP-9, and the release of proinflammatory chemotactic factors, such as IL-8 304-308. With continual neutrophil
recruitment and degranulation, the acute response can develop into a non-resolving,
chronic response through a perpetual cycle of recruitment and activation 306, 308. Despite
these potential deleterious outcomes, neutrophil degranulation and the secretion of
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signaling molecules have also been shown to be tissue-restorative and pro-angiogenic 49,
174, 182

. Neutrophils secrete VEGF-A and HGF, both of which support and guide

angiogenesis 309, 310. Moreover, MMP-9 is also pro-angiogenic and has been shown to
initiate and guide endothelial cell sprouting 49, 311. Taken together, these data suggest that
regulating neutrophil NET release and their secretion of signaling molecules at the onset
of the tissue repair program is pertinent for regulating acute neutrophil-driven
inflammation 21, 175, 295, 312.
In this work, we evaluated chloroquine diphosphate as an electrospun biomaterial
additive to regulate in vitro NET release and the secretion of pro-inflammatory and prohealing mediators from human neutrophils. Chloroquine is an FDA-approved, antimalarial drug that has more recently been investigated as an immunomodulatory and antithrombotic drug for treating rheumatoid arthritis, systemic lupus erythematosus, and
cancer 313-316. Furthermore, chloroquine has been shown to inhibit NET formation,
indicating its potential benefit as an additive for regulating biomaterial-induced NET
release and inflammation 126, 127, 317, 318. Here, we show that electrospun PDO biomaterials
loaded with chloroquine modulate template-induced NET release and the inflammatory
response from human neutrophils. We found that chloroquine suppresses NET release in
a surface area-dependent manner at early time points while modulating pro-inflammatory
and healing signals at both early and late time points. Ultimately, our findings
demonstrate a novel repurposing of chloroquine as a template additive for in situ tissue
engineering that modulates the in vitro acute inflammatory response to biomaterials.
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Materials and Methods
Biomaterial Fabrication
PDO (Cat. No. 6100, Bezwada Biomedical, Hillsborough, NJ, USA) was
dissolved overnight in HFP (Cat. No. 003409-1KG, Oakwood Chemical, Estill, SC,
USA) at varying concentrations (Table 9) to generate biomaterials composed of small and
large fibers, previously shown to regulate NET release through their surface areadependent, topographical cues 31, 76. Chloroquine diphosphate (Cat. No. 0219391910, MP
Biomedicals, Solon, OH, USA) was added to the solutions at a concentration of 0.07
mg/mL and dissolved for 1.5 hours with gentle agitation before electrospinning.
Following, the solutions were loaded into a syringe with a 22.5-gauge blunt needle for the
67 mg/mL PDO solution and an 18-gauge blunt needle for all other solutions and
electrospun with optimized parameters (Table 9) 76. Fibers were collected on a 20 x 750 x
5 mm grounded, stainless steel rectangular mandrel that was rotating 1250 rpm and
translating 6.5 cm/s over 13 cm. Additional higher concentrations of chloroquine were
incorporated into the electrospun biomaterials during optimization (See Appendix). For
all experiments, 8 mm diameter discs of the electrospun biomaterials were cut using a
biopsy punch (Cat. No. P825, Acuderm Inc., Fr. Lauderdale, FL, USA) and stored in a
desiccator until use. Prior to cell culture, the biomaterials were irradiated with ultraviolet
light at a wavelength of 365 nm using an 8 W lamp (Cat. No. EN280L, Spectroline,
Westbury, NY, USA) at a working distance of 9.5 cm. The samples were disinfected for
10 minutes on each side in a sterile, laminar flow hood and kept disinfected until cell
culture.

137

Small
Fibers

67

0

0.25

13

14

70

0.07

0.5

12

13

Large
Fibers

Table 9. Electrospun biomaterials were fabricated with optimized parameters.
Polymer
Chloroquine
Flow
Airgap
Applied
Concentration Concentration
Rate
Distance
Voltage [+
[mg/mL]
[mg/mL]
[mL/h]
[cm]
kV]

138

0

4.0

28

25

138

0.07

3.2

28

25

Biomaterial Characterization
The biomaterials were imaged with a scanning electron microscope, and SEMs
were analyzed in FibraQuant 1.3 software (nanoTemplate Technologies, LLC) to
quantify fiber diameter as previously described 76. Briefly, 150 semi-automated random
measurements per SEM were taken to determine the average and corresponding standard
deviation for fiber diameter.
Chloroquine Elution from Biomaterials
The elution of chloroquine from the biomaterials was quantified over the first 24
hours using a microplate reader to measure absorbance as described 319. The biomaterials
(n = 4) were placed in a 96-well cell culture plate, and 150 µL of 1x HBSS (calcium,
magnesium, and phenol red free, Cat. No. 14175095, Thermo Fisher Scientific, Waltham,
MA, USA) were added to each well. After incubating at 37°C for 30 minutes, 1 hour, 3
hours, 6 hours, and 24 hours, the supernatant was removed and refreshed with 150 µL of
HBSS. The absorbance of the collected supernatant was read on a SpectraMax i3x MultiMode Microplate Reader at 330 nm, and the chloroquine concentration was interpolated
from a standard dilution ranging from 333 µg/mL to 0 µg/mL in HBSS (See Appendix
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Supplementary Figure 1). In addition to concentration, the average percent release and
standard deviation were calculated for each biomaterial.
Isolation and Culture of Primary Human Neutrophils
Heparinized, whole blood from healthy donors was obtained by venipuncture
from Tennessee Blood Services. Since purchased or donated samples are not traceable
back to the donor, it does not qualify as human subjects research as determined by the
University of Memphis Institutional Review Board on November 22, 2016. Neutrophils
were then isolated as previously described using Isolymph density separation 31, 76, 259.
After isolation, neutrophils were resuspended in HBSS with 10 mM HEPES and 0.2%
autologous serum at a concentration of 1 million neutrophils/mL. The disinfected
biomaterials (n = 3) were placed in a 96-well plate, and 40 µL of the cell culture media
were added to each well to hydrate the biomaterials. Negative and positive TCP wells (n
= 3) received 30 µL of the cell culture media prior to cell seeding. Subsequently, 100 µL
of cell culture media containing 100,000 neutrophils were added to each well followed by
10 µL of heparin (Cat. No. H3393, Sigma Aldrich, St. Louis, MO, USA) at a final
concentration of 10 U/mL heparin. Heparin was added to dissociate NET-associated
MPO as previously described 50, 88. The negative vehicle and positive controls added to
TCP wells were 0.15% DMSO in 10 µL of HBSS and 100 nM PMA (Cat. No. P8139,
Sigma Aldrich, St. Louis, MO, USA) in 10 µL of HBSS, respectively. The neutrophils
were cultured at 37°C and 5% CO2 for 3 and 6 hours. Following incubation, the samples
were placed on ice for 10 minutes to inhibit neutrophil stimulation prior to processing.
Three experiments were performed with unique donors (male, between 18 and 40 years
of age), and the results were pooled for analysis.
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Quantification of NETs and Secreted Signals
Supernatants were collected and assayed using a ProcartaPlex multiplex
immunomagnetic assay (Cat. No. PPX, Thermo Fisher Scientific, Waltham, MA, USA)
on a MAGPIX® microplate reader (Luminex Corporation, Austin, TX, USA). The
assayed analytes included angiopoietin, fibroblast growth factor 2, GM-CSF, HGF, IL1β, interleukin 1 receptor antagonist, interleukin 6, IL-8, interleukin 10, interleukin 22,
monocyte chemoattractant protein 1, MMP-9, MPO, TNF-α, and VEGF-A. To quantify
percent NET release, the concentration of MPO was normalized to the concentration of
MPO in the positive control at 6 hours 50, 88.
Fluorescent Microscopy
Samples were fixed with 10% buffered formalin (Cat. No. SF1004, Thermo
Fisher Scientific, Waltham, MA, USA) and stained with 5 µM SYTOX orange (Cat. No.
S34861, Thermo Fisher Scientific, Waltham, MA, USA) and NucBlue™ Fixed Cell
ReadyProbes™ Reagent (DAPI, Cat. No. R37606, Thermo Fisher Scientific, Waltham,
MA, USA) as described 88. Briefly, samples were sequentially incubated with each stain
for 5 minutes at room temperature. Three washes with 1x PBS for 5 minutes each were
performed between each step. Cells and NETs were visualized on an Olympus BX43
fluorescent microscope.
Statistical Analysis
Statistical significance between fiber diameters was tested with a Kruskal Wallis
and Dunn’s multiple comparisons test. All other statistical significance was tested with an
ANOVA and Holm-Sidak’s multiple comparisons test. Statistical analyses were
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performed in Prism version 8.4.3 (GraphPad Software, San Diego, CA, USA) at a
significance level of 0.05. Data are reported as mean ± standard deviation.
Results
Electrospun PDO Rapidly Elutes Chloroquine
PDO was electrospun to create biomaterials with small fibers and large fibers
(Figure 36A). Based on our previous work, the small and large fiber biomaterials in this
study represent materials that trigger two distinct neutrophil NET responses and two
distinct potentials for tissue regeneration 31, 76. In order to make comparisons independent
of fiber size, the polymer concentration was adjusted for the small and large fiber
biomaterials so that the addition of chloroquine did not alter the resulting fibers (Figure
36B). Any differences in the neutrophil inflammatory response can therefore be attributed
to chloroquine elution. Both the small and large fiber biomaterials rapidly eluted
chloroquine with near 100% elution within the first hour and no detectable increase after
3 hours (Figure 36C). The elution equated to a concentration of 11.8 ± 1.33 µM and 12.2
± 1.63 µM chloroquine for the small and large fiber biomaterials, respectively (Figure
36D). This elution was optimized by changing chloroquine incorporation during
biomaterial fabrication to achieve an eluted concentration near those previously reported
in the literature 317, 320. Additional biomaterials were also fabricated to elute higher
concentrations of chloroquine (See Appendix Supplementary Figure 2).
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Figure 36. Chloroquine incorporation into electrospun biomaterials results in uniform
fibers that rapidly elute the additive. (A) Representative SEMs of the control and
chloroquine-loaded biomaterials. Micrographs were acquired at 1000x magnification and
scale bars are 30 µm. (B) Fiber diameters of the electrospun biomaterials. Measurements
(n = 150) were taken in FibraQuant 1.3 software. (C) Percent chloroquine released from
the biomaterials and (D) eluted chloroquine concentration at 3 hours. There was no
increase in concentration after 3 hours. See Supplementary Figure 1 for the standard
curve used to interpolate concentration (n = 4) from absorbance. Graphs show mean ±
standard deviation. * p < 0.0001 was determined using a Kruskal Wallis and Dunn’s
multiple comparisons test.
Chloroquine Elution Inhibits NET Release on Small Fibers
Neutrophils were isolated from the whole blood of healthy donors and seeded on
electrospun biomaterials with or without chloroquine to trigger biomaterial-induced NET
release. As anticipated, neutrophils had an increased propensity to form NETs on the
small fibers compared to the large fibers at 3 hours (Figure 37A). More importantly, the
elution of chloroquine from the small fiber biomaterials significantly reduced NET
release to the level of the large fibers at 3 hours while having no effect upon elution from
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the large fibers (Figure 37B). By 6 hours, the difference between small and large fibers
was less pronounced, and increased NET release was observed on both chloroquineeluting biomaterials, suggesting a temporal, therapeutic window for inhibiting acute NET
release (Figure 37B).

Figure 37. Chloroquine elution inhibits NET release on small fibers but has no effect on
large fibers. (A) Fluorescent micrographs of neutrophils on the electrospun biomaterials
at 3 and 6 hours after seeding. Staining of NETs (red) and nuclei (purple) reveals that
chloroquine elution from the small fibers attenuates NET formation at the early time
point, but not at the late time point. Conversely, chloroquine elution from the large fibers
does not modulate NET release. Scale bar is 50 µm. (B) Percent NET release at 3 (left)
and 6 (right) hours as quantified by the ELISA for NET-disassociated MPO. The
quantification of percent NET release (n = 3) indicates that chloroquine elution from the
small fibers reduces NET release to the level of the large fibers at 3 hours with no effect
at 6 hours. The data represent the mean ± standard deviation of three independent
experiments with unique donors. * p < 0.0001 was determined using an ANOVA and
Holm-Sidak’s multiple comparisons test.
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Chloroquine Elution Decreases Inflammatory Signal Secretion
Given the documented anti-inflammatory effects, we also evaluated if chloroquine
elution would modulate the inflammatory response through the secretion of soluble
signals using a multiplexed immunomagnetic assay. Of the assayed inflammatory
analytes, only IL-8 and MMP-9 were detected in the supernatant (Figure 38). IL-8 is the
archetypal neutrophil chemoattractant secreted by damaged cells as well as neutrophils
during an acute inflammatory response. At both 3 and 6 hours, IL-8 secretion was
significantly greater on the small fiber biomaterials compared to the large fibers (Figure
38A). Since the small fibers appear to up-regulate NET release in a pro-inflammatory
response, it is not surprising that IL-8 secretion mimicked the trends in NET release.
However, despite observing a temporal inhibition of acute NET release at 3 hours only,
the elution of chloroquine from both small and large fibers continued to significantly
suppress IL-8 secretion at 6 hours. These data suggest there is independent regulation of
NET release and IL-8 synthesis and secretion in the context of biomaterial-induced
activation, which may be important for reducing aberrant neutrophil recruitment during
the tissue repair program 321-323. Similar to IL-8, MMP-9 secretion was significantly
greater on the small fiber biomaterials compared to the large fibers with chloroquine
elution suppressing secretion at 3 hours (Figure 38B). However, unlike IL-8, MMP-9
secretion was near equivalent on all biomaterials by 6 hours, suggesting a temporal
modulation of MMP-9. As a promiscuous endopeptidase, elevated MMP-9 is correlated
with tissue degradation and chronic inflammation, so its acute suppression by
chloroquine may prevent triggering a continuum of matrix destruction during the initial
inflammatory response 304-306.
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Figure 38. Chloroquine-eluting biomaterials suppress inflammatory IL-8 and MMP-9
secretion from neutrophils. (A) IL-8 and (B) MMP-9 secretion at 3 (left) and 6 (right)
hours after neutrophil seeding. Chloroquine elution down-regulated IL-8 secretion at both
time points whereas it only attenuates the acute secretion of MMP-9. The data (n = 3)
represent the mean ± standard deviation of three independent experiments with unique
donors. * p < 0.05 and ** p < 0.0001 were determined using an ANOVA and HolmSidak’s multiple comparisons test.
Chloroquine Elution Increases Regenerative Signal Secretion
Although well characterized for its anti-inflammatory effects, chloroquine is not
well studied for its potential regenerative effects. Therefore, we also evaluated if
chloroquine elution would regulate the secretion of regenerative signals from biomaterialinteracting neutrophils. While several regenerative and anti-inflammatory analytes were
assayed, only HGF, VEGF-A, and IL-22 were detected (Figure 39). The secretion of
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HGF (Figure 39A) and VEGF-A (Figure 39B) followed very similar trends at 3 hours
with both having significantly greater secretion on large fibers compared to small fibers,
which is the inverse of NET release. Additionally, the elution of chloroquine from the
small fibers increased the secretion of HGF and VEGF-A to the level of the large fibers.
By 6 hours, the trends remained the same with an overall increase in the magnitude of
secretion. Since they are classic angiogenic signals 181, 309, 310, 324, 325, these data indicate
that chloroquine elution may help establish a more regenerative microenvironment
around a biomaterial. Likewise, IL-22 secretion followed the same trends as HGF and
VEGF-A, but its secretion was not detectable until 6 hours, suggesting an absence of
readily available stores 326. Nonetheless, as a proliferative and pro-angiogenic signal 326,
327

, the increased IL-22 secretion observed in response to chloroquine elution from the

small fibers further suggests that chloroquine modulates the neutrophil phenotype
towards healing and regeneration.
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Figure 39. Chloroquine-eluting biomaterials increase regenerative HGF, VEGF-A, and
IL-22 secretion from neutrophils. (A) HGF and (B) VEGF-A were up-regulated with
chloroquine elution at 3 (left) and 6 (right) hours after seeding whereas (C) IL-22 was
only detectable and up-regulated at 6 hours after seeding. The data (n = 3) represent the
mean ± standard deviation of three independent experiments with unique donors. * p <
0.05 and ** p < 0.0001 were determined using an ANOVA and Holm-Sidak’s multiple
comparisons test.
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Discussion
Electrospun biomaterials are excellent candidates for guided in situ tissue
regeneration applications because they have a biomimetic structure that can also function
as a drug delivery system to modulate acute inflammation 2, 5. In recent years, neutrophils
have gained attention as an important part of the acute inflammatory response to a
biomaterial and the initiation of the tissue repair program 17, 31, 88, 175. Neutrophil
recruitment, the release of NETs, and the secretion of soluble mediators can have
diametrically opposed effects, leading to the resolution of inflammation and healing or
chronic inflammation and fibrosis 17. Indeed, seminal work in neutrophil biology has
highlighted the phenotypic plasticity of neutrophils and their ability to regulate the tissue
environment 176, 181, 328. Given the emphasis on endogenous cells for in situ tissue
regeneration, regulation of the neutrophil response during acute inflammation is of
utmost importance for cell integration and regeneration.
In this work, we developed electrospun PDO biomaterials that elute chloroquine
to regulate biomaterial-induced neutrophil activation. Chloroquine is an inexpensive drug
historically used to treat malaria that has more recently garnered attention for its
immunomodulatory and anti-thrombotic effects 313-315, 329. As a weak base that
concentrates in acidic vesicles, it is classified as an inhibitor of lysosomes, lysosomal
degradation, and endosomal TLR signaling as well as an inhibitor of autophagy 139, 330, 331.
Recently, several groups have shown that chloroquine can be used to inhibit NET release
126, 127, 317, 318, 320

. Since it is implicated in tissue fibrosis and thrombosis, NET formation is

an appealing pharmacological target, especially in the context of biomaterial-induced
NET release 100, 162, 303, 332, 333. Our group has shown that neutrophils have an increased
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propensity to form NETs on the surface of small fiber electrospun biomaterials, leading
to fibrotic encapsulation, whereas large fiber biomaterials down-regulate NET release
and guide tissue integration 31. Jhunjhunwala et al. observed similar outcomes with
implanted microcapsules that up-regulated NET release 21, thus indicating the need to
engineer biomaterials that attenuate NET formation during the acute inflammatory
response.
In these experiments, we incorporated chloroquine into the electrospun
biomaterials to modulate NET release. At a dose 99.9% lower than the daily oral dose for
malaria prophylaxis 334, 335, we found that chloroquine eluted from small fiber
biomaterials down-regulated NET release to the level of the large fiber biomaterials while
chloroquine elution from large fibers had no effect on NET release at the early time point.
These findings are quite interesting given that both materials eluted the same
concentration of drug with near identical release profiles. We observed a similar effect
upon incorporating Cl-amidine into the electrospun biomaterials, which inhibits the
enzyme PAD4 that is involved in NET formation 63, 76. In both cases, these data suggest
several mechanisms may be governing the release of NETs on electrospun biomaterials.
Additionally, by the later time point, increased NET release was observed on both
chloroquine-eluting biomaterials, suggesting a temporal, therapeutic window for
inhibiting acute NET release. Since the half-life of chloroquine is estimated to be 13 to 55
days, the observed increase in NET formation at 6 hours again suggests that other
regulatory mechanisms are involved in biomaterial-induced NET release 329, 334. Last,
biomaterials that eluted higher concentrations of chloroquine (See Appendix
Supplementary Figure 2) were developed to determine the therapeutic range of NET
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inhibition by chloroquine. Our data (See Appendix Supplementary Figure 3) indicate that
increasing the chloroquine concentration did not inhibit biomaterial-induced NET release
and may have resulted in cytotoxic effects as previously reported 336.
Although we and others have shown that chloroquine can inhibit NET release,
one group has found that a concentration of chloroquine similar to ours did not inhibit
NET formation 126, 127, 317, 318, 320. When chloroquine was shown to be effective at blocking
NET release, neutrophils were stimulated with platelet activating factor, LPS, or our
electrospun biomaterials 317, 318. When chloroquine was shown to be ineffective,
neutrophils were primed with GM-CSF and stimulated with C5a, which initiates
distinctly different, vital NET release, or the release of mitochondrial NETs 72, 320. These
data indicate that the therapeutic efficacy of chloroquine for inhibiting NET formation is
stimuli dependent and that there may be some overlap in the signaling pathways for
biomaterial-induced NET release and other reported triggers of NET release 86, 89, 254.
Further work is needed to determine the specific signaling pathway involved in
biomaterial-induced NET release, but our current data suggests involvement of surfaceadsorbed IgG 114.
In addition to inhibiting NETs, chloroquine has been reported to have
immunomodulatory effects by altering the secretion of pro-inflammatory mediators. IL1β, IL-8, MMP-9, and TGF-β have all been shown to decrease with chloroquine
treatment to attenuate inflammation 337-340. Likewise, in this work, we found that IL-8 and
MMP-9 secretion were suppressed on the chloroquine-eluting biomaterials. IL-8
secretion is significantly up-regulated in neutrophils several hours after stimulation
before returning to baseline levels, after which monocytes become the major source of
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IL-8 in vivo 322. Although neutrophils are necessary for tissue healing 176, 178, 295, these
data suggest that suppression of IL-8 by chloroquine at both early and later time points
may down-regulate acute inflammation by reducing pernicious neutrophil chemotaxis 341.
Similar to IL-8, MMP-9 is robustly secreted from neutrophils during acute inflammation
and functions to degrade the ECM for enhanced cell motility 182, 342. Consequently,
MMP-9 can drive both tissue destruction through excessive ECM degradation and the
rapid induction of angiogenesis 49, 296, 304, 306, 343, 344. While angiogenesis is paramount for
tissue regeneration, elevated levels of MMP-9 could perpetuate inflammation and cyclic
matrix destruction, so its suppression by chloroquine may approximate levels more
conducive to regeneration, although this remains to be determined.
In conjunction with pro-inflammatory signals, we also evaluated the potential
impact of chloroquine elution on regenerative signals. To our knowledge, no one has yet
to explore this aspect of chloroquine’s anti-inflammatory effects. We found that both
HGF and VEGF-A secretion were increased with chloroquine elution from the
biomaterials. HGF is a pro-angiogenic growth factor that promotes regeneration and
homeostasis while inhibiting chronic inflammation and fibrosis in various tissues 310, 324,
325, 345

. Similarly, VEGF-A is the canonical angiogenic signal secreted by neutrophils that

has also been shown to recruit a pro-angiogenic subset of neutrophils 181, 309, 311, 346. IL-22
closely followed the trends for HGF and VEGF-A, but was only detectable at the later
time point, likely because of the time needed to up-regulate synthesis and secretion 347.
IL-22 has been shown to be both protective and inflammatory depending on the disease
and model 326, 348, 349. However, it was more recently found to support angiogenesis in the
tumor microenvironment by inducing endothelial cell proliferation, survival, and
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chemotaxis 327. Together, the increased secretion of HGF, VEGF-A, and IL-22 on
chloroquine-eluting biomaterials suggests a previously unrecognized aspect of
chloroquine’s immunomodulatory effects.
Conclusion
Taken together, our novel incorporation of chloroquine into electrospun
biomaterials illustrates the potential therapeutic benefit of this drug for biomaterialguided, in situ tissue regeneration applications. Although we are the first to repurpose it
as an electrospun template additive for tissue engineering applications, chloroquine has
been incorporated into a coating for urine catheters to reduce sterile inflammation by
reducing neutrophil necrosis and IL-8 secretion 350. Likewise, our data indicate that local
delivery through electrospun PDO biomaterials may down regulate acute neutrophildriven inflammation while simultaneously up-regulating their regenerative phenotype.
The mechanisms underlying chloroquine’s regulation of NET formation and signal
secretion as well as its in vivo efficacy are the subject of further investigations.
Additional future work includes evaluation of these biomaterials with platelets and
platelet-neutrophil interactions to begin elucidating if chloroquine’s anti-thrombotic
properties are correlated with its inhibition of NET formation 126, 351. In conclusion, we
have shown that our chloroquine-eluting biomaterials regulate acute neutrophil-driven
inflammatory responses in vitro by down-regulating NET release and inflammatory
signals while up-regulating regenerative signals. These responses may have synergistic
effects that are advantageous for biomaterial-guided in situ tissue regeneration.
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CHAPTER 8
CONCLUSION
The goal of biomaterial-guided in situ tissue regeneration is to design biomaterials
that harness the body’s endogenous, regenerative processes to drive functional tissue
repair at sites of tissue loss, injury, or disease. Because of their versatility, costeffectiveness, and relatively simple fabrication, electrospun biomaterials have great
potential for the realization of in situ tissue regeneration. The key steps that must occur
for success are resolution of acute inflammation, rapid cell migration into the biomaterial,
integration with the surrounding ECM, robust angiogenesis, and eventually neotissue
formation. Therefore, the success of in situ tissue regeneration is largely dependent on the
efficiency of the first step, resolution of acute neutrophil-driven inflammation.
In this work, we evaluated NET release in response to electrospun biomaterials in
an effort to address a significant gap in the literature and elucidate how the release of
NETs may be regulated to improve biomaterial-guided in situ tissue regeneration. In
Chapter 3, we found that NETs are differentially released on electrospun biomaterials
based on the polymer composition and electrospun fiber size of the biomaterial with the
most dramatic differences in NET release observed on small and large fiber PDO.
Moreover, we showed that the increased propensity to release NETs on electrospun PDO
with small fibers inhibited tissue integration in vivo and nucleated fibrosis, demonstrating
for the first time a negative physiological impact of NETs on electrospun biomaterials. In
Chapters 4 and 5, we delved into the mechanisms of regulation on electrospun PDO with
small and large fibers and demonstrated that the SAVR regulates the adsorption of IgG,
which then drives NET release through outside-in signaling via FcγRIIIb. Finally,

Chapters 6 and 7 illustrated that electrospun biomaterial-induced NET release can be
inhibited with the incorporation and release of drugs from the biomaterials, improving
tissue integration and promoting a regenerative neutrophil phenotype. Taken together, the
results of this dissertation suggest that neutrophils and their release of NETs are
significant in the preconditioning of an electrospun biomaterial and an increased
understanding of the neutrophil response may improve the design of immunomodulatory
biomaterials for in situ tissue regeneration.
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CHAPTER 9
FUTURE WORK
Although it sheds light on the role of neutrophils and NETs in preconditioning
biomaterials for in situ tissue regeneration, this dissertation raises a number of important
questions for future research. One group of questions is related directly to the work in
Chapters 3-7, continuing the investigation of NETs on electrospun biomaterials. Another
group of questions is tangentially related and inspired by this work, focusing on the
neutrophil’s actions as a pro-healing cell when it is not releasing NETs. In addition, this
work was largely conducted without emphasis on a specific application and discussed in
a broad context of in situ tissue regeneration. While applicable to many electrospun
biomaterial-guided tissue regeneration applications, the findings and implications of this
work are especially important for blood-contacting biomaterials such as small diameter
vascular grafts. Therefore, this chapter will emphasize vascular tissue engineering. I will
describe ideas for future work that will build upon the findings of this dissertation and
additionally bring attention to studying the neutrophil as a pro-healing cell capable of
driving angiogenesis.
Continuing Research on NETs
Chapter 3
In Chapter 3, we showed that the collagen electrospun biomaterials significantly
attenuated NET release compared to the PDO biomaterials, regardless of the electrospun
fiber size. Although this was not further investigated in the dissertation, it is an important
finding because it suggests that natural polymers attenuate NET release independent of
the biomaterial’s design features, which could provide more flexibility in design criteria.
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Given the assortment of natural polymers, it would be beneficial to study the ability of
others to attenuate electrospun-biomaterial induced NET release. However, electrospun
biomaterials fabricated from natural polymers do not provide sufficient mechanical
properties for vascular tissue engineering, and a synthetic component is needed for
increased mechanical integrity. In Chapter 3, we also found that PC biomaterials induced
a similar level of NET release compared to the pure PDO biomaterials. Although this
suggests the attenuation of NETs is lost in a blend, it may be that increasing the collagen
component beyond 10% rescues the effect. Therefore, I propose that investigating various
blends of natural polymers with PDO at a variety of ratios could generate important data
for regulating NET release on a mechanically sound vascular graft, independent of
electrospun fiber size.
Additionally, Chapter 3 also illustrated that abundant NETs promote fibrotic
encapsulation of an electrospun biomaterial in a subcutaneous pocket, but the mechanism
was not resolved. In order to better understand how NETs are linked to fibrosis on a
biomaterial, and additionally thrombosis, co-culture experiments are necessary. Given the
importance of macrophage polarization 352, neutrophil and macrophage co-cultures or
serial seeding on electrospun biomaterials would be interesting to assess phenotype
modulation of both populations. Similarly, platelet-neutrophil crosstalk is significant in
the response to small diameter vascular grafts and contributes to thrombosis 48.
Evaluating neutrophils and platelets in a co-culture system would give insight into the
first multicellular interactions that occur before macrophages arrive. Later in the tissue
repair program, endothelial cells migrate onto vascular grafts to regenerate the intima, so
studying the endothelial cell response to NET-conditioned electrospun biomaterials may
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increase our understanding of problems associated with impaired neointimal
regeneration. Together, such experiments could establish functional links between NETs,
fibrosis, and thrombosis in the context of electrospun biomaterials and enhance the
design of small diameter vascular grafts.
Chapter 4 and 5
Chapter 4 and 5 began to unravel how the electrospun biomaterials modulate NET
release, illustrating that SAVR-dependent adsorption of IgG initiates outside-in signaling
for NET release through FcγRIIIb. Because we found that IgG adsorption on PDO is a
stimulator for NET formation, several questions can be asked about how to alter this
signaling, focusing on IgG. First, it may be possible to pre-coat the biomaterials with a
desired protein to inhibit or delay IgG adsorption long enough to avoid the induction of
NETs. Determining what a desirable protein is that has an affinity for the biomaterial
surface would require multiple preliminary experiments to ensure (1) the protein does not
also trigger NETs and (2) the protein is not readily replaced by IgG during competitive
adsorption/desorption 242, 294. Second, it may be possible to alter the biomaterial’s surface
chemistry to regulate the adsorption of IgG. This could be accomplished with acid or
plasma treatments through fairly straightforward procedures 215, 353. Third, it is possible
that incorporating a natural polymer, as previously discussed, alters protein adsorption in
a favorable manner to reduce NET release. Such experiments would improve our
understanding of protein adsorption on electrospun PDO and how it regulates NET
formation.
In addition, a focus on FcγRIIIb and its signaling pathway could be beneficial for
regulating electrospun biomaterial-induced NET release. This would first require a
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thorough investigation of the full signaling pathway from the receptor to the release of
the NET. Then, relevant pharmacological inhibitors could be incorporated into the
biomaterial for local delivery to modulate NET release. Likewise, signal transmission can
be blocked at the level of the receptor with neutralizing antibodies. Incorporation of
neutralizing antibodies to FcγRIIIb may be costly and would require optimization to
ensure they retain their biological activity after electrospinning, which is also necessary
for drug incorporation. Together, a more detailed understanding of how biomaterial
design regulates and modulates NET release would improve the design of vascular
biomaterials that avoid the adverse effects of NETs.
Chapter 6 and 7
In Chapter 6 and 7, we found that local delivery of two drugs with different
functionalities, Cl-amidine and chloroquine, were able to reduce biomaterial-induced
NET release. For both drugs, neither was able to completely abrogate NET formation.
Therefore, it would be interesting to continue exploring the incorporation of inhibitors,
and potential combinations of inhibitors, into electrospun biomaterials to see if a more
efficacious inhibitor or combination exists. Those with anti-inflammatory and antithrombotic properties would be most beneficial for small diameter vascular grafts. A
combination would likely provide the greatest benefits since multiple stimuli and
signaling pathways exist for triggering NET release 136, and our data indicate surface
adsorbed IgG does not appear to be the sole regulator on electrospun PDO. Moreover,
one extremely important unanswered question is the level of NETs needed for functional
tissue regeneration. It is possible that complete inhibition of NETs does more harm than
good, similar to the need for a ratio of M1 and M2 macrophages 354. Therefore,
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experiments assessing the dose-response impact of NETs on tissue regeneration would
help determine the desired level of regulation. These proposed experiments would
improve our understanding of regulatory mechanisms.
All Chapters
The experiments described in this dissertation were largely conducted in vitro
with primary human neutrophils, and several of the findings were extended to acute
subcutaneous implant models in rats to validate their physiological significance. While
important for this work, it is necessary to build on it with longer in vivo models to assess
the long-term impact of NET regulation on in situ tissue regeneration over multiple
weeks while the biomaterial is resorbed. Moreover, after characterization as a
subcutaneous implant, it is important to progress towards tissue specific models and work
in a small diameter vascular graft format. Related to this, the rat is a good animal model
for assessing the acute neutrophil inflammatory response in a subcutaneous implant, but
the rat is not appropriate for small diameter vascular grafts because it cannot
accommodate diameters and lengths on the human scale for peripheral limb applications,
such as femoral-tibial and femoropopliteal bypasses. For these studies, a larger animal
model should be carefully selected for the appropriate sizing with blood composition in
mind. In particular, it is highly important that the animal’s blood composition is similar to
humans because this dictates protein adsorption, the proportion of acutely interacting
cells, and thus the tissue repair program. Finally, it would be interesting to collect clinical
samples of failed small diameter vascular grafts and look for the presence of NETs to
strengthen our data with clinical evidence, as others have done in NET-related
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pathologies 126, 355. Together, such experiments would greatly expound upon this
dissertation.
Studying Neutrophils as Pro-Healing Cells
After focusing extensively on the neutrophil’s effects while dying and releasing a
NET, it was only logical to begin postulating what the neutrophil is doing when it is
living and not releasing a NET in the context of biomaterial-guided in situ tissue
regeneration. Recently, several benchmark publications in tumor biology recently
indicated that neutrophils are responsible for driving tumor-associated angiogenesis
through their secretion of MMP-9. First, Ardi et al. identified that MMP-9 is uniquely
released from neutrophils TIMP-free, resulting in rapid activation in vitro and in vivo to
induce angiogenesis 49, 296. Subsequently, Deryugina et al. highlighted the role of
neutrophils in tumor-induced angiogenesis by showing that TANs secrete 40- to 50-fold
more MMP-9 within 2 hours compared to macrophages cultured over 48 hours and also
found that neutrophil-derived MMP-9 was needed for pericyte recruitment and vascular
stability 182. It is believed that neutrophil-derived MMP-9 is an extremely potent inducer
of angiogenesis because it is released TIMP-free and because it has diverse enzymatic
activity 356, degrading the ECM and freeing cells for migration and proliferation.
Ultimately, these paradigm-shifting data in tumor biology provide inspiration to explore
the role of neutrophils and their pro-angiogenic delivery of MMP-9 in in situ biomaterialguided tissue regeneration.
In fact, neutrophils are involved in physiological angiogenesis and tissue growth
and development in multiple tissues and organs 357. During endometrial development,
neutrophils are the most abundant during the early growth of the decidua, decrease during
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menstruation, and are not present during tissue stability 358. In a model of hindlimb
ischemia, wildtype mice treated with GM-CSF facilitate revascularization and tissue
regeneration through enhanced recruitment of neutrophils compared to untreated controls
359

. These examples demonstrate that there are endogenous mechanisms to induce

neovascularization and overcome the ischemic load in developing tissue, driven by the
neutrophil.
Several levels of regulation could be targeted to engage neutrophils and their
MMP-9 in biomaterial-guided tissue regeneration (Figure 40). The secretion of MMP-9
could be controlled at the intracellular level through MMP-9 synthesis and degranulation,
at the extracellular level through the inhibition or activation of MMP-9 in the ECM, and
at the level of cell recruitment. Each level could be targeted by engineering the properties
of the biomaterial to elicit the appropriate immunomodulatory response. No matter the
level of regulation, the overriding effect of the biomaterial should be to engage the
neutrophils as drivers of functional tissue regeneration.
The first level of regulation is the intracellular level where MMP-9 could be
controlled at the level of synthesis and degranulation (Figure 40A). MMP-9 synthesis is
regulated at the level of transcription primarily by ERK1/2 in the mitogen-activated
protein kinase pathway 360, 361. Activation of the pathway induces MMP-9 gene
expression and could be used as a therapeutic target to regulate MMP-9 secretion. In
addition, integrin and TLR interactions can induce neutrophil degranulation and provide a
second intracellular point of intervention. Mature neutrophils circulate with proMMP-9
packaged into secretory vesicles for rapid release 362. Thus, engaging integrins (e.g. Lselectin and Mac-1) and TLRs (e.g. TLR2 and TLR4) could be used to regulate MMP-9
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secretion 363-365. Various cytokines and chemokines binding to their receptors can also
modulate neutrophil degranulation and further participate in autocrine and paracrine
neutrophil

Figure 40. Potential levels of regulation to engage neutrophil MMP9 in matrix
reprogramming. (A) Cellular targets include intracellular signaling pathways and ligation
of integrins, TLRs, and other receptors. (B) Regulation could also include the availability
of activators and inhibitors. (C) Finally, the secretion of MMP9 could be regulated at the
level of neutrophil recruitment to enhance ECM degradation and sprouting angiogenesis.
feedback loops. As an example, neutralizing TNF-α suppresses MMP-9 secretion in a
model of central nervous system tuberculosis 360. These data all suggest that MMP-9
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secretion could be regulated at the intracellular level, through transcription or outside-in
signaling, to increase the potential for biomaterial-guided angiogenesis.
Another level of MMP-9 regulation that could be targeted through biomaterial
design involves the activation or inhibition of MMP-9 after secretion into the
microenvironment (Figure 40B). MMP-9 is initially secreted as a zymogen that requires
activation 296. The availability of activators therefore affects the enzymatic potential of
MMP-9. Multiple proteases are known to active proMMP-9, including cathepsin K,
MMP-2, MMP-3, and plasmin, which explains the rapid activation upon secretion 296, 366368

. In addition, MMP-9 can be inhibited by TIMP before or after activation. Even

without neutrophils producing it, TIMP could be present in the microenvironment as it is
constitutively expressed in many tissues 369. Thus, devising a strategy to ensure efficient
MMP-9 activation in the local microenvironment while minimizing or delaying inhibition
may increase the potential for angiogenesis and regeneration.
The last regulatory level that could be targeted to engage neutrophils in
biomaterial-guided tissue regeneration is neutrophil recruitment (Figure 40C). The
knockout of neutrophils is known to impair angiogenesis and tissue regeneration 178, 295,
359

. Therefore, their recruitment to sites of inflammation is essential to wound healing,

partly due to their delivery of growth factors and chemokines that promote the resolution
of inflammation. Increasing the recruitment of a pro-angiogenic subset of neutrophils
through VEGF-A secretion may be particularly beneficial for biomaterial-guided
angiogenesis 311, 370. Nonetheless, regulating angiogenesis at the level of recruitment may
present additional challenges as the sustained recruitment of neutrophils and degradation
of the ECM play a central role in chronic inflammation and poor wound healing 304, 306,
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343

. Due to multiple levels of regulation, several points of intervention exist for engineers

to regulate neutrophil MMP-9 secretion to initiate angiogenesis and tissue regeneration.
Conclusion
In situ tissue regeneration has the potential to revolutionize the field of tissue
engineering through the design of immunomodulatory biomaterials that harness the proangiogenic potential of neutrophils to repair and regenerate. These studies lead to the idea
that the key for successful tissue regeneration lies in the swift resolution of neutrophildriven inflammation and progression in the tissue repair program. Because the
importance of neutrophils in tissue repair has only been recognized in recent years, there
are many unanswered questions for the development of immunomodulatory biomaterials
that regulate the neutrophil response, release of NETs, and resolution of inflammation for
functional tissue regeneration. The current literature suggests the readily available
neutrophils are of critical importance to wound healing beyond the release of NETs.
Given that biomaterials are immediately bombarded by the body’s highly orchestrated
innate immune response upon implantation, we should utilize what physiology has
provided as endogenous drivers of angiogenesis. Studying the abundant, circulating
neutrophils and the use of the body as the ideal bioreactor to vigorously drive in situ
biomaterial-guided tissue regeneration will generate a new knowledge base to propel the
field of tissue engineering into the next generation of biomaterials.
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APPENDIX

Supplementary Figure 1. Chloroquine concentration as determined by absorbance
follows a linear trend. The standard dilution of chloroquine was prepared in HBSS and
serially diluted by a factor of 3 from 333.3 µg/mL to 1.37 µg/mL. HBSS without
chloroquine was included as a background control. Following, 150 µL of the standard
dilution and HBSS background control (n = 2) were added to a 96-well plate and
absorbance was measured. The resulting data were fit with a line of best fit (y = 0.0065x,
R2 = 0.99) to create the standard curve for interpolating unknown eluted chloroquine
concentration.

Supplementary Figure 2. Chloroquine incorporation into electrospun biomaterials
results in uniform fibers that rapidly elute the additive. (A) Representative SEMs of the
control and chloroquine-loaded biomaterials. Micrographs were acquired at 1000x
magnification and scale bars are 30 µm. (B) Fiber diameters of the electrospun
biomaterials. Measurements (n = 150) were taken in FibraQuant 1.3 software. (C)
Concentration of eluted chloroquine at 3 hours and (D) percent chloroquine released from
the small (left) and large (right) fibers at 3 hours. There was no increase in concentration
after 3 hours. See Figure S1 for the standard curve used to interpolate concentration (n =
4) from absorbance. Graphs show mean ± standard deviation. * p < 0.05 and ** p <
0.0001 were determined using a Kruskal Wallis and Dunn’s multiple comparisons test.
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Supplementary Figure 3. Chloroquine elution inhibits NET release within a therapeutic
window. (A) Fluorescent micrographs of neutrophils on the electrospun biomaterials at 3
and 6 hours after seeding. Staining of NETs (red) and nuclei (purple) reveals that
chloroquine elution from the small fibers attenuates NET formation at the early time
point at the lowest concentration, but not at the late time point. Conversely, chloroquine
elution from the large fibers does not inhibit NET release at any concentration. Scale bar
is 50 µm. (B) Percent NET release at 3 (left) and 6 (right) hours as quantified by the
ELISA for NET-disassociated MPO. The quantification of percent NET release (n = 3)
indicates that chloroquine elution from the small fibers reduces NET release to the level
of the large fibers at 3 hours only at the lowest dose. At 6 hours, both small and large
fibers eluting higher concentrations of chloroquine result in an apparent increase in NET
release, suggesting a therapeutic window at the lowest chloroquine concentration and
potential cytotoxic effects at higher concentrations. The data represent the mean ±
standard deviation of three independent experiments with unique donors. * p < 0.0001
was determined using an ANOVA and Holm-Sidak’s multiple comparisons test.
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